id	sid	tid	token	lemma	pos
ajlm-1537	1	1	abstract	abstract	ADJ
ajlm-1537	1	2	introduction	introduction	NOUN
ajlm-1537	1	3	methods	method	NOUN
ajlm-1537	1	4	results	result	VERB
ajlm-1537	1	5	discussion	discussion	NOUN
ajlm-1537	1	6	acknowledgements	acknowledgement	NOUN
ajlm-1537	1	7	references	reference	NOUN
ajlm-1537	1	8	about	about	ADP
ajlm-1537	1	9	the	the	DET
ajlm-1537	1	10	author(s	author(s	NOUN
ajlm-1537	1	11	)	)	PUNCT
ajlm-1537	1	12	candice	candice	PROPN
ajlm-1537	1	13	l.	l.	PROPN
ajlm-1537	1	14	hendricks	hendricks	PROPN
ajlm-1537	1	15	department	department	PROPN
ajlm-1537	1	16	of	of	ADP
ajlm-1537	1	17	paediatric	paediatric	ADJ
ajlm-1537	1	18	haematology	haematology	NOUN
ajlm-1537	1	19	,	,	PUNCT
ajlm-1537	1	20	faculty	faculty	NOUN
ajlm-1537	1	21	of	of	ADP
ajlm-1537	1	22	health	health	NOUN
ajlm-1537	1	23	sciences	sciences	PROPN
ajlm-1537	1	24	,	,	PUNCT
ajlm-1537	1	25	school	school	NOUN
ajlm-1537	1	26	of	of	ADP
ajlm-1537	1	27	medicine	medicine	NOUN
ajlm-1537	1	28	,	,	PUNCT
ajlm-1537	1	29	university	university	NOUN
ajlm-1537	1	30	of	of	ADP
ajlm-1537	1	31	kwazulu	kwazulu	PROPN
ajlm-1537	1	32	-	-	PUNCT
ajlm-1537	1	33	natal	natal	ADJ
ajlm-1537	1	34	,	,	PUNCT
ajlm-1537	1	35	durban	durban	PROPN
ajlm-1537	1	36	,	,	PUNCT
ajlm-1537	1	37	south	south	PROPN
ajlm-1537	1	38	africa	africa	PROPN
ajlm-1537	1	39	department	department	PROPN
ajlm-1537	1	40	of	of	ADP
ajlm-1537	1	41	paediatric	paediatric	ADJ
ajlm-1537	1	42	haematology	haematology	NOUN
ajlm-1537	1	43	,	,	PUNCT
ajlm-1537	1	44	inkosi	inkosi	PROPN
ajlm-1537	1	45	albert	albert	PROPN
ajlm-1537	1	46	luthuli	luthuli	PROPN
ajlm-1537	1	47	central	central	PROPN
ajlm-1537	1	48	hospital	hospital	NOUN
ajlm-1537	1	49	,	,	PUNCT
ajlm-1537	1	50	durban	durban	PROPN
ajlm-1537	1	51	,	,	PUNCT
ajlm-1537	1	52	south	south	PROPN
ajlm-1537	1	53	africa	africa	PROPN
ajlm-1537	1	54	ashen	ashen	PROPN
ajlm-1537	1	55	naidoo	naidoo	PROPN
ajlm-1537	1	56	department	department	PROPN
ajlm-1537	1	57	of	of	ADP
ajlm-1537	1	58	haematology	haematology	PROPN
ajlm-1537	1	59	,	,	PUNCT
ajlm-1537	1	60	faculty	faculty	NOUN
ajlm-1537	1	61	of	of	ADP
ajlm-1537	1	62	health	health	NOUN
ajlm-1537	1	63	sciences	sciences	PROPN
ajlm-1537	1	64	,	,	PUNCT
ajlm-1537	1	65	university	university	NOUN
ajlm-1537	1	66	of	of	ADP
ajlm-1537	1	67	kwazulu	kwazulu	PROPN
ajlm-1537	1	68	-	-	PUNCT
ajlm-1537	1	69	natal	natal	ADJ
ajlm-1537	1	70	,	,	PUNCT
ajlm-1537	1	71	durban	durban	PROPN
ajlm-1537	1	72	,	,	PUNCT
ajlm-1537	1	73	south	south	PROPN
ajlm-1537	1	74	africa	africa	PROPN
ajlm-1537	1	75	national	national	PROPN
ajlm-1537	1	76	health	health	PROPN
ajlm-1537	1	77	laboratory	laboratory	PROPN
ajlm-1537	1	78	service	service	NOUN
ajlm-1537	1	79	,	,	PUNCT
ajlm-1537	1	80	inkosi	inkosi	PROPN
ajlm-1537	1	81	albert	albert	PROPN
ajlm-1537	1	82	luthuli	luthuli	PROPN
ajlm-1537	1	83	central	central	PROPN
ajlm-1537	1	84	hospital	hospital	NOUN
ajlm-1537	1	85	,	,	PUNCT
ajlm-1537	1	86	durban	durban	PROPN
ajlm-1537	1	87	,	,	PUNCT
ajlm-1537	1	88	south	south	PROPN
ajlm-1537	1	89	africa	africa	PROPN
ajlm-1537	1	90	rajendra	rajendra	PROPN
ajlm-1537	1	91	thejpal	thejpal	PROPN
ajlm-1537	1	92	department	department	PROPN
ajlm-1537	1	93	of	of	ADP
ajlm-1537	1	94	paediatric	paediatric	ADJ
ajlm-1537	1	95	haematology	haematology	NOUN
ajlm-1537	1	96	,	,	PUNCT
ajlm-1537	1	97	faculty	faculty	NOUN
ajlm-1537	1	98	of	of	ADP
ajlm-1537	1	99	health	health	NOUN
ajlm-1537	1	100	sciences	sciences	PROPN
ajlm-1537	1	101	,	,	PUNCT
ajlm-1537	1	102	school	school	NOUN
ajlm-1537	1	103	of	of	ADP
ajlm-1537	1	104	medicine	medicine	NOUN
ajlm-1537	1	105	,	,	PUNCT
ajlm-1537	1	106	university	university	NOUN
ajlm-1537	1	107	of	of	ADP
ajlm-1537	1	108	kwazulu	kwazulu	PROPN
ajlm-1537	1	109	-	-	PUNCT
ajlm-1537	1	110	natal	natal	ADJ
ajlm-1537	1	111	,	,	PUNCT
ajlm-1537	1	112	durban	durban	PROPN
ajlm-1537	1	113	,	,	PUNCT
ajlm-1537	1	114	south	south	PROPN
ajlm-1537	1	115	africa	africa	PROPN
ajlm-1537	1	116	department	department	PROPN
ajlm-1537	1	117	of	of	ADP
ajlm-1537	1	118	paediatric	paediatric	ADJ
ajlm-1537	1	119	haematology	haematology	NOUN
ajlm-1537	1	120	,	,	PUNCT
ajlm-1537	1	121	inkosi	inkosi	PROPN
ajlm-1537	1	122	albert	albert	PROPN
ajlm-1537	1	123	luthuli	luthuli	PROPN
ajlm-1537	1	124	central	central	PROPN
ajlm-1537	1	125	hospital	hospital	NOUN
ajlm-1537	1	126	,	,	PUNCT
ajlm-1537	1	127	durban	durban	PROPN
ajlm-1537	1	128	,	,	PUNCT
ajlm-1537	1	129	south	south	PROPN
ajlm-1537	1	130	africa	africa	PROPN
ajlm-1537	1	131	nadine	nadine	PROPN
ajlm-1537	1	132	rapiti	rapiti	PROPN
ajlm-1537	1	133	department	department	PROPN
ajlm-1537	1	134	of	of	ADP
ajlm-1537	1	135	haematology	haematology	PROPN
ajlm-1537	1	136	,	,	PUNCT
ajlm-1537	1	137	faculty	faculty	NOUN
ajlm-1537	1	138	of	of	ADP
ajlm-1537	1	139	health	health	NOUN
ajlm-1537	1	140	sciences	sciences	PROPN
ajlm-1537	1	141	,	,	PUNCT
ajlm-1537	1	142	university	university	NOUN
ajlm-1537	1	143	of	of	ADP
ajlm-1537	1	144	kwazulu	kwazulu	PROPN
ajlm-1537	1	145	-	-	PUNCT
ajlm-1537	1	146	natal	natal	ADJ
ajlm-1537	1	147	,	,	PUNCT
ajlm-1537	1	148	durban	durban	PROPN
ajlm-1537	1	149	,	,	PUNCT
ajlm-1537	1	150	south	south	PROPN
ajlm-1537	1	151	africa	africa	PROPN
ajlm-1537	1	152	national	national	PROPN
ajlm-1537	1	153	health	health	PROPN
ajlm-1537	1	154	laboratory	laboratory	PROPN
ajlm-1537	1	155	service	service	NOUN
ajlm-1537	1	156	,	,	PUNCT
ajlm-1537	1	157	inkosi	inkosi	PROPN
ajlm-1537	1	158	albert	albert	PROPN
ajlm-1537	1	159	luthuli	luthuli	PROPN
ajlm-1537	1	160	central	central	PROPN
ajlm-1537	1	161	hospital	hospital	NOUN
ajlm-1537	1	162	,	,	PUNCT
ajlm-1537	1	163	durban	durban	PROPN
ajlm-1537	1	164	,	,	PUNCT
ajlm-1537	1	165	south	south	PROPN
ajlm-1537	1	166	africa	africa	PROPN
ajlm-1537	1	167	beverley	beverley	PROPN
ajlm-1537	1	168	neethling	neethling	PROPN
ajlm-1537	1	169	department	department	PROPN
ajlm-1537	1	170	of	of	ADP
ajlm-1537	1	171	paediatric	paediatric	ADJ
ajlm-1537	1	172	haematology	haematology	NOUN
ajlm-1537	1	173	,	,	PUNCT
ajlm-1537	1	174	faculty	faculty	NOUN
ajlm-1537	1	175	of	of	ADP
ajlm-1537	1	176	health	health	NOUN
ajlm-1537	1	177	sciences	sciences	PROPN
ajlm-1537	1	178	,	,	PUNCT
ajlm-1537	1	179	school	school	NOUN
ajlm-1537	1	180	of	of	ADP
ajlm-1537	1	181	medicine	medicine	NOUN
ajlm-1537	1	182	,	,	PUNCT
ajlm-1537	1	183	university	university	NOUN
ajlm-1537	1	184	of	of	ADP
ajlm-1537	1	185	kwazulu	kwazulu	PROPN
ajlm-1537	1	186	-	-	PUNCT
ajlm-1537	1	187	natal	natal	ADJ
ajlm-1537	1	188	,	,	PUNCT
ajlm-1537	1	189	durban	durban	PROPN
ajlm-1537	1	190	,	,	PUNCT
ajlm-1537	1	191	south	south	PROPN
ajlm-1537	1	192	africa	africa	PROPN
ajlm-1537	1	193	department	department	PROPN
ajlm-1537	1	194	of	of	ADP
ajlm-1537	1	195	paediatric	paediatric	ADJ
ajlm-1537	1	196	haematology	haematology	NOUN
ajlm-1537	1	197	,	,	PUNCT
ajlm-1537	1	198	inkosi	inkosi	PROPN
ajlm-1537	1	199	albert	albert	PROPN
ajlm-1537	1	200	luthuli	luthuli	PROPN
ajlm-1537	1	201	central	central	PROPN
ajlm-1537	1	202	hospital	hospital	NOUN
ajlm-1537	1	203	,	,	PUNCT
ajlm-1537	1	204	durban	durban	PROPN
ajlm-1537	1	205	,	,	PUNCT
ajlm-1537	1	206	south	south	PROPN
ajlm-1537	1	207	africa	africa	PROPN
ajlm-1537	1	208	yasmin	yasmin	PROPN
ajlm-1537	1	209	goga	goga	PROPN
ajlm-1537	1	210	department	department	PROPN
ajlm-1537	1	211	of	of	ADP
ajlm-1537	1	212	paediatric	paediatric	ADJ
ajlm-1537	1	213	haematology	haematology	NOUN
ajlm-1537	1	214	,	,	PUNCT
ajlm-1537	1	215	faculty	faculty	NOUN
ajlm-1537	1	216	of	of	ADP
ajlm-1537	1	217	health	health	NOUN
ajlm-1537	1	218	sciences	sciences	PROPN
ajlm-1537	1	219	,	,	PUNCT
ajlm-1537	1	220	school	school	NOUN
ajlm-1537	1	221	of	of	ADP
ajlm-1537	1	222	medicine	medicine	NOUN
ajlm-1537	1	223	,	,	PUNCT
ajlm-1537	1	224	university	university	NOUN
ajlm-1537	1	225	of	of	ADP
ajlm-1537	1	226	kwazulu	kwazulu	PROPN
ajlm-1537	1	227	-	-	PUNCT
ajlm-1537	1	228	natal	natal	ADJ
ajlm-1537	1	229	,	,	PUNCT
ajlm-1537	1	230	durban	durban	PROPN
ajlm-1537	1	231	,	,	PUNCT
ajlm-1537	1	232	south	south	PROPN
ajlm-1537	1	233	africa	africa	PROPN
ajlm-1537	1	234	department	department	PROPN
ajlm-1537	1	235	of	of	ADP
ajlm-1537	1	236	paediatric	paediatric	ADJ
ajlm-1537	1	237	haematology	haematology	NOUN
ajlm-1537	1	238	,	,	PUNCT
ajlm-1537	1	239	inkosi	inkosi	PROPN
ajlm-1537	1	240	albert	albert	PROPN
ajlm-1537	1	241	luthuli	luthuli	PROPN
ajlm-1537	1	242	central	central	PROPN
ajlm-1537	1	243	hospital	hospital	NOUN
ajlm-1537	1	244	,	,	PUNCT
ajlm-1537	1	245	durban	durban	PROPN
ajlm-1537	1	246	,	,	PUNCT
ajlm-1537	1	247	south	south	PROPN
ajlm-1537	1	248	africa	africa	PROPN
ajlm-1537	1	249	suvarna	suvarna	PROPN
ajlm-1537	1	250	buldeo	buldeo	PROPN
ajlm-1537	1	251	department	department	PROPN
ajlm-1537	1	252	of	of	ADP
ajlm-1537	1	253	haematology	haematology	NOUN
ajlm-1537	1	254	,	,	PUNCT
ajlm-1537	1	255	faculty	faculty	NOUN
ajlm-1537	1	256	of	of	ADP
ajlm-1537	1	257	health	health	NOUN
ajlm-1537	1	258	sciences	sciences	PROPN
ajlm-1537	1	259	,	,	PUNCT
ajlm-1537	1	260	university	university	NOUN
ajlm-1537	1	261	of	of	ADP
ajlm-1537	1	262	kwazulu	kwazulu	PROPN
ajlm-1537	1	263	-	-	PUNCT
ajlm-1537	1	264	natal	natal	ADJ
ajlm-1537	1	265	,	,	PUNCT
ajlm-1537	1	266	durban	durban	PROPN
ajlm-1537	1	267	,	,	PUNCT
ajlm-1537	1	268	south	south	PROPN
ajlm-1537	1	269	africa	africa	PROPN
ajlm-1537	1	270	national	national	PROPN
ajlm-1537	1	271	health	health	PROPN
ajlm-1537	1	272	laboratory	laboratory	PROPN
ajlm-1537	1	273	service	service	NOUN
ajlm-1537	1	274	,	,	PUNCT
ajlm-1537	1	275	inkosi	inkosi	PROPN
ajlm-1537	1	276	albert	albert	PROPN
ajlm-1537	1	277	luthuli	luthuli	PROPN
ajlm-1537	1	278	central	central	PROPN
ajlm-1537	1	279	hospital	hospital	NOUN
ajlm-1537	1	280	,	,	PUNCT
ajlm-1537	1	281	durban	durban	PROPN
ajlm-1537	1	282	,	,	PUNCT
ajlm-1537	1	283	south	south	PROPN
ajlm-1537	1	284	africa	africa	PROPN
ajlm-1537	1	285	citation	citation	PROPN
ajlm-1537	1	286	hendricks	hendricks	PROPN
ajlm-1537	1	287	cl	cl	PROPN
ajlm-1537	1	288	,	,	PUNCT
ajlm-1537	1	289	naidoo	naidoo	PROPN
ajlm-1537	1	290	a	a	PROPN
ajlm-1537	1	291	,	,	PUNCT
ajlm-1537	1	292	thejpal	thejpal	ADJ
ajlm-1537	1	293	r	r	NOUN
ajlm-1537	1	294	,	,	PUNCT
ajlm-1537	1	295	et	et	PROPN
ajlm-1537	1	296	al	al	PROPN
ajlm-1537	1	297	.	.	PUNCT
ajlm-1537	2	1	childhood	childhood	PROPN
ajlm-1537	2	2	aplastic	aplastic	ADJ
ajlm-1537	2	3	anaemia	anaemia	NOUN
ajlm-1537	2	4	with	with	ADP
ajlm-1537	2	5	paroxysmal	paroxysmal	ADJ
ajlm-1537	2	6	nocturnal	nocturnal	ADJ
ajlm-1537	2	7	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	2	8	clones	clone	NOUN
ajlm-1537	2	9	:	:	PUNCT
ajlm-1537	2	10	a	a	DET
ajlm-1537	2	11	retrospective	retrospective	ADJ
ajlm-1537	2	12	single	single	ADJ
ajlm-1537	2	13	-	-	PUNCT
ajlm-1537	2	14	centre	centre	NOUN
ajlm-1537	2	15	study	study	NOUN
ajlm-1537	2	16	in	in	ADP
ajlm-1537	2	17	south	south	PROPN
ajlm-1537	2	18	africa	africa	PROPN
ajlm-1537	2	19	.	.	PUNCT
ajlm-1537	3	1	afr	afr	PROPN
ajlm-1537	3	2	j	j	PROPN
ajlm-1537	3	3	lab	lab	PROPN
ajlm-1537	3	4	med	med	PROPN
ajlm-1537	3	5	.	.	PUNCT
ajlm-1537	4	1	2022;11(1	2022;11(1	NUM
ajlm-1537	4	2	)	)	PUNCT
ajlm-1537	4	3	,	,	PUNCT
ajlm-1537	4	4	a1537	a1537	PROPN
ajlm-1537	4	5	.	.	PROPN
ajlm-1537	4	6	https://doi.org/10.4102/ajlm.v11i1.1537	https://doi.org/10.4102/ajlm.v11i1.1537	X
ajlm-1537	4	7	original	original	ADJ
ajlm-1537	4	8	research	research	NOUN
ajlm-1537	4	9	childhood	childhood	NOUN
ajlm-1537	4	10	aplastic	aplastic	ADJ
ajlm-1537	4	11	anaemia	anaemia	NOUN
ajlm-1537	4	12	with	with	ADP
ajlm-1537	4	13	paroxysmal	paroxysmal	ADJ
ajlm-1537	4	14	nocturnal	nocturnal	ADJ
ajlm-1537	4	15	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	4	16	clones	clone	NOUN
ajlm-1537	4	17	:	:	PUNCT
ajlm-1537	4	18	a	a	DET
ajlm-1537	4	19	retrospective	retrospective	ADJ
ajlm-1537	4	20	single	single	ADJ
ajlm-1537	4	21	-	-	PUNCT
ajlm-1537	4	22	centre	centre	NOUN
ajlm-1537	4	23	study	study	NOUN
ajlm-1537	4	24	in	in	ADP
ajlm-1537	4	25	south	south	PROPN
ajlm-1537	4	26	africa	africa	PROPN
ajlm-1537	4	27	candice	candice	PROPN
ajlm-1537	4	28	l.	l.	PROPN
ajlm-1537	4	29	hendricks	hendricks	PROPN
ajlm-1537	4	30	,	,	PUNCT
ajlm-1537	4	31	ashen	ashen	PROPN
ajlm-1537	4	32	naidoo	naidoo	PROPN
ajlm-1537	4	33	,	,	PUNCT
ajlm-1537	4	34	rajendra	rajendra	PROPN
ajlm-1537	4	35	thejpal	thejpal	PROPN
ajlm-1537	4	36	,	,	PUNCT
ajlm-1537	4	37	nadine	nadine	PROPN
ajlm-1537	4	38	rapiti	rapiti	PROPN
ajlm-1537	4	39	,	,	PUNCT
ajlm-1537	4	40	beverley	beverley	PROPN
ajlm-1537	4	41	neethling	neethling	PROPN
ajlm-1537	4	42	,	,	PUNCT
ajlm-1537	4	43	yasmin	yasmin	PROPN
ajlm-1537	4	44	goga	goga	PROPN
ajlm-1537	4	45	,	,	PUNCT
ajlm-1537	4	46	suvarna	suvarna	NOUN
ajlm-1537	4	47	buldeo	buldeo	NOUN
ajlm-1537	4	48	received	receive	VERB
ajlm-1537	4	49	:	:	PUNCT
ajlm-1537	4	50	08	08	NUM
ajlm-1537	4	51	feb	feb	X
ajlm-1537	4	52	.	.	PROPN
ajlm-1537	4	53	2021	2021	NUM
ajlm-1537	4	54	;	;	PUNCT
ajlm-1537	4	55	accepted	accept	VERB
ajlm-1537	4	56	:	:	PUNCT
ajlm-1537	4	57	10	10	NUM
ajlm-1537	4	58	mar	mar	PROPN
ajlm-1537	4	59	.	.	PROPN
ajlm-1537	4	60	2022	2022	NUM
ajlm-1537	4	61	;	;	PUNCT
ajlm-1537	4	62	published	publish	VERB
ajlm-1537	4	63	:	:	PUNCT
ajlm-1537	4	64	06	06	NUM
ajlm-1537	4	65	june	june	PROPN
ajlm-1537	4	66	2022	2022	NUM
ajlm-1537	4	67	copyright	copyright	NOUN
ajlm-1537	4	68	:	:	PUNCT
ajlm-1537	4	69	©	©	PROPN
ajlm-1537	4	70	2022	2022	NUM
ajlm-1537	4	71	.	.	PUNCT
ajlm-1537	5	1	the	the	DET
ajlm-1537	5	2	author(s	author(s	PROPN
ajlm-1537	5	3	)	)	PUNCT
ajlm-1537	5	4	.	.	PUNCT
ajlm-1537	6	1	licensee	licensee	NOUN
ajlm-1537	6	2	:	:	PUNCT
ajlm-1537	6	3	aosis	aosis	NOUN
ajlm-1537	6	4	.	.	PUNCT
ajlm-1537	7	1	this	this	PRON
ajlm-1537	7	2	is	be	AUX
ajlm-1537	7	3	an	an	DET
ajlm-1537	7	4	open	open	ADJ
ajlm-1537	7	5	access	access	NOUN
ajlm-1537	7	6	article	article	NOUN
ajlm-1537	7	7	distributed	distribute	VERB
ajlm-1537	7	8	under	under	ADP
ajlm-1537	7	9	the	the	DET
ajlm-1537	7	10	terms	term	NOUN
ajlm-1537	7	11	of	of	ADP
ajlm-1537	7	12	the	the	DET
ajlm-1537	7	13	creative	creative	ADJ
ajlm-1537	7	14	commons	common	NOUN
ajlm-1537	7	15	attribution	attribution	NOUN
ajlm-1537	7	16	license	license	NOUN
ajlm-1537	7	17	,	,	PUNCT
ajlm-1537	7	18	which	which	PRON
ajlm-1537	7	19	permits	permit	VERB
ajlm-1537	7	20	unrestricted	unrestricted	ADJ
ajlm-1537	7	21	use	use	NOUN
ajlm-1537	7	22	,	,	PUNCT
ajlm-1537	7	23	distribution	distribution	NOUN
ajlm-1537	7	24	,	,	PUNCT
ajlm-1537	7	25	and	and	CCONJ
ajlm-1537	7	26	reproduction	reproduction	NOUN
ajlm-1537	7	27	in	in	ADP
ajlm-1537	7	28	any	any	DET
ajlm-1537	7	29	medium	medium	NOUN
ajlm-1537	7	30	,	,	PUNCT
ajlm-1537	7	31	provided	provide	VERB
ajlm-1537	7	32	the	the	DET
ajlm-1537	7	33	original	original	ADJ
ajlm-1537	7	34	work	work	NOUN
ajlm-1537	7	35	is	be	AUX
ajlm-1537	7	36	properly	properly	ADV
ajlm-1537	7	37	cited	cite	VERB
ajlm-1537	7	38	.	.	PUNCT
ajlm-1537	8	1	abstract	abstract	ADJ
ajlm-1537	8	2	background	background	NOUN
ajlm-1537	8	3	:	:	PUNCT
ajlm-1537	8	4	paroxysmal	paroxysmal	ADJ
ajlm-1537	8	5	nocturnal	nocturnal	ADJ
ajlm-1537	8	6	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	8	7	(	(	PUNCT
ajlm-1537	8	8	pnh	pnh	NOUN
ajlm-1537	8	9	)	)	PUNCT
ajlm-1537	8	10	clones	clone	NOUN
ajlm-1537	8	11	in	in	ADP
ajlm-1537	8	12	children	child	NOUN
ajlm-1537	8	13	are	be	AUX
ajlm-1537	8	14	rare	rare	ADJ
ajlm-1537	8	15	but	but	CCONJ
ajlm-1537	8	16	commonly	commonly	ADV
ajlm-1537	8	17	associated	associate	VERB
ajlm-1537	8	18	with	with	ADP
ajlm-1537	8	19	aplastic	aplastic	ADJ
ajlm-1537	8	20	anaemia	anaemia	NOUN
ajlm-1537	8	21	(	(	PUNCT
ajlm-1537	8	22	aa	aa	NOUN
ajlm-1537	8	23	)	)	PUNCT
ajlm-1537	8	24	and	and	CCONJ
ajlm-1537	8	25	myelodysplasia	myelodysplasia	PROPN
ajlm-1537	8	26	.	.	PROPN
ajlm-1537	9	1	objective	objective	NOUN
ajlm-1537	9	2	:	:	PUNCT
ajlm-1537	9	3	this	this	DET
ajlm-1537	9	4	study	study	NOUN
ajlm-1537	9	5	aimed	aim	VERB
ajlm-1537	9	6	to	to	PART
ajlm-1537	9	7	determine	determine	VERB
ajlm-1537	9	8	the	the	DET
ajlm-1537	9	9	prevalence	prevalence	NOUN
ajlm-1537	9	10	of	of	ADP
ajlm-1537	9	11	pnh	pnh	PROPN
ajlm-1537	9	12	clones	clone	NOUN
ajlm-1537	9	13	in	in	ADP
ajlm-1537	9	14	paediatric	paediatric	ADJ
ajlm-1537	9	15	patients	patient	NOUN
ajlm-1537	9	16	with	with	ADP
ajlm-1537	9	17	idiopathic	idiopathic	ADJ
ajlm-1537	9	18	aa	aa	NOUN
ajlm-1537	9	19	,	,	PUNCT
ajlm-1537	9	20	identify	identify	VERB
ajlm-1537	9	21	differences	difference	NOUN
ajlm-1537	9	22	in	in	ADP
ajlm-1537	9	23	clinical	clinical	ADJ
ajlm-1537	9	24	and	and	CCONJ
ajlm-1537	9	25	laboratory	laboratory	NOUN
ajlm-1537	9	26	features	feature	NOUN
ajlm-1537	9	27	and	and	CCONJ
ajlm-1537	9	28	outcomes	outcome	NOUN
ajlm-1537	9	29	,	,	PUNCT
ajlm-1537	9	30	and	and	CCONJ
ajlm-1537	9	31	determine	determine	VERB
ajlm-1537	9	32	the	the	DET
ajlm-1537	9	33	impact	impact	NOUN
ajlm-1537	9	34	of	of	ADP
ajlm-1537	9	35	clone	clone	NOUN
ajlm-1537	9	36	size	size	NOUN
ajlm-1537	9	37	on	on	ADP
ajlm-1537	9	38	clinical	clinical	ADJ
ajlm-1537	9	39	presentation	presentation	NOUN
ajlm-1537	9	40	.	.	PUNCT
ajlm-1537	10	1	methods	method	NOUN
ajlm-1537	10	2	:	:	PUNCT
ajlm-1537	10	3	patients	patient	NOUN
ajlm-1537	10	4	with	with	ADP
ajlm-1537	10	5	confirmed	confirm	VERB
ajlm-1537	10	6	idiopathic	idiopathic	ADJ
ajlm-1537	10	7	aa	aa	NOUN
ajlm-1537	10	8	who	who	PRON
ajlm-1537	10	9	were	be	AUX
ajlm-1537	10	10	tested	test	VERB
ajlm-1537	10	11	for	for	ADP
ajlm-1537	10	12	pnh	pnh	PROPN
ajlm-1537	10	13	between	between	ADP
ajlm-1537	10	14	september	september	PROPN
ajlm-1537	10	15	2013	2013	NUM
ajlm-1537	10	16	and	and	CCONJ
ajlm-1537	10	17	january	january	PROPN
ajlm-1537	10	18	2018	2018	NUM
ajlm-1537	10	19	at	at	ADP
ajlm-1537	10	20	the	the	DET
ajlm-1537	10	21	inkosi	inkosi	PROPN
ajlm-1537	10	22	albert	albert	PROPN
ajlm-1537	10	23	luthuli	luthuli	PROPN
ajlm-1537	10	24	central	central	PROPN
ajlm-1537	10	25	hospital	hospital	NOUN
ajlm-1537	10	26	,	,	PUNCT
ajlm-1537	10	27	durban	durban	PROPN
ajlm-1537	10	28	,	,	PUNCT
ajlm-1537	10	29	kwazulu	kwazulu	NOUN
ajlm-1537	10	30	-	-	PUNCT
ajlm-1537	10	31	natal	natal	ADJ
ajlm-1537	10	32	,	,	PUNCT
ajlm-1537	10	33	south	south	PROPN
ajlm-1537	10	34	africa	africa	PROPN
ajlm-1537	10	35	,	,	PUNCT
ajlm-1537	10	36	were	be	AUX
ajlm-1537	10	37	included	include	VERB
ajlm-1537	10	38	.	.	PUNCT
ajlm-1537	11	1	pnh	pnh	NOUN
ajlm-1537	11	2	clones	clone	NOUN
ajlm-1537	11	3	were	be	AUX
ajlm-1537	11	4	detected	detect	VERB
ajlm-1537	11	5	in	in	ADP
ajlm-1537	11	6	neutrophils	neutrophil	NOUN
ajlm-1537	11	7	and	and	CCONJ
ajlm-1537	11	8	monocytes	monocyte	VERB
ajlm-1537	11	9	by	by	ADP
ajlm-1537	11	10	flow	flow	NOUN
ajlm-1537	11	11	cytometry	cytometry	NOUN
ajlm-1537	11	12	using	use	VERB
ajlm-1537	11	13	fluorescent	fluorescent	ADJ
ajlm-1537	11	14	aerolysin	aerolysin	NOUN
ajlm-1537	11	15	,	,	PUNCT
ajlm-1537	11	16	cd24	cd24	PROPN
ajlm-1537	11	17	,	,	PUNCT
ajlm-1537	11	18	cd66b	cd66b	VERB
ajlm-1537	11	19	and	and	CCONJ
ajlm-1537	11	20	cd14	cd14	PROPN
ajlm-1537	11	21	.	.	PUNCT
ajlm-1537	12	1	results	result	NOUN
ajlm-1537	12	2	:	:	PUNCT
ajlm-1537	12	3	twenty	twenty	NUM
ajlm-1537	12	4	-	-	PUNCT
ajlm-1537	12	5	nine	nine	NUM
ajlm-1537	12	6	children	child	NOUN
ajlm-1537	12	7	with	with	ADP
ajlm-1537	12	8	aa	aa	NOUN
ajlm-1537	12	9	were	be	AUX
ajlm-1537	12	10	identified	identify	VERB
ajlm-1537	12	11	and	and	CCONJ
ajlm-1537	12	12	11	11	NUM
ajlm-1537	12	13	were	be	AUX
ajlm-1537	12	14	excluded	exclude	VERB
ajlm-1537	12	15	.	.	PUNCT
ajlm-1537	13	1	ten	ten	NUM
ajlm-1537	13	2	patients	patient	NOUN
ajlm-1537	13	3	(	(	PUNCT
ajlm-1537	13	4	10/18	10/18	NUM
ajlm-1537	13	5	,	,	PUNCT
ajlm-1537	13	6	55.6	55.6	NUM
ajlm-1537	13	7	%	%	NOUN
ajlm-1537	13	8	)	)	PUNCT
ajlm-1537	13	9	had	have	VERB
ajlm-1537	13	10	pnh	pnh	PROPN
ajlm-1537	13	11	clones	clone	NOUN
ajlm-1537	13	12	ranging	range	VERB
ajlm-1537	13	13	from	from	ADP
ajlm-1537	13	14	0.11	0.11	NUM
ajlm-1537	13	15	%	%	NOUN
ajlm-1537	13	16	to	to	PART
ajlm-1537	13	17	24	24	NUM
ajlm-1537	13	18	%	%	NOUN
ajlm-1537	13	19	.	.	PUNCT
ajlm-1537	14	1	compared	compare	VERB
ajlm-1537	14	2	to	to	ADP
ajlm-1537	14	3	the	the	DET
ajlm-1537	14	4	pnh	pnh	PROPN
ajlm-1537	14	5	-	-	PUNCT
ajlm-1537	14	6	negative	negative	ADJ
ajlm-1537	14	7	group	group	NOUN
ajlm-1537	14	8	,	,	PUNCT
ajlm-1537	14	9	these	these	DET
ajlm-1537	14	10	children	child	NOUN
ajlm-1537	14	11	were	be	AUX
ajlm-1537	14	12	older	old	ADJ
ajlm-1537	14	13	(	(	PUNCT
ajlm-1537	14	14	median	median	NOUN
ajlm-1537	14	15	:	:	PUNCT
ajlm-1537	14	16	10	10	NUM
ajlm-1537	14	17	years	year	NOUN
ajlm-1537	14	18	vs	vs	ADP
ajlm-1537	14	19	4	4	NUM
ajlm-1537	14	20	years	year	NOUN
ajlm-1537	14	21	,	,	PUNCT
ajlm-1537	14	22	p	p	NOUN
ajlm-1537	14	23	=	=	NOUN
ajlm-1537	14	24	0.02	0.02	NUM
ajlm-1537	14	25	)	)	PUNCT
ajlm-1537	14	26	and	and	CCONJ
ajlm-1537	14	27	had	have	VERB
ajlm-1537	14	28	significantly	significantly	ADV
ajlm-1537	14	29	lower	low	ADJ
ajlm-1537	14	30	total	total	ADJ
ajlm-1537	14	31	white	white	ADJ
ajlm-1537	14	32	cell	cell	NOUN
ajlm-1537	14	33	counts	count	NOUN
ajlm-1537	14	34	(	(	PUNCT
ajlm-1537	14	35	median	median	NOUN
ajlm-1537	14	36	1.7	1.7	NUM
ajlm-1537	14	37	×	×	NOUN
ajlm-1537	14	38	109	109	NUM
ajlm-1537	14	39	/	/	SYM
ajlm-1537	14	40	l	l	NOUN
ajlm-1537	14	41	vs	vs	ADP
ajlm-1537	14	42	3.2	3.2	NUM
ajlm-1537	14	43	×	×	NOUN
ajlm-1537	14	44	109	109	NUM
ajlm-1537	14	45	/	/	SYM
ajlm-1537	14	46	l	l	NOUN
ajlm-1537	14	47	;	;	PUNCT
ajlm-1537	14	48	p	p	X
ajlm-1537	14	49	=	=	NOUN
ajlm-1537	14	50	0.04	0.04	NUM
ajlm-1537	14	51	)	)	PUNCT
ajlm-1537	14	52	.	.	PUNCT
ajlm-1537	15	1	there	there	PRON
ajlm-1537	15	2	was	be	VERB
ajlm-1537	15	3	no	no	DET
ajlm-1537	15	4	difference	difference	NOUN
ajlm-1537	15	5	in	in	ADP
ajlm-1537	15	6	median	median	ADJ
ajlm-1537	15	7	absolute	absolute	ADJ
ajlm-1537	15	8	neutrophil	neutrophil	ADJ
ajlm-1537	15	9	count	count	NOUN
ajlm-1537	15	10	or	or	CCONJ
ajlm-1537	15	11	haemoglobin	haemoglobin	ADJ
ajlm-1537	15	12	concentration	concentration	NOUN
ajlm-1537	15	13	.	.	PUNCT
ajlm-1537	16	1	four	four	NUM
ajlm-1537	16	2	patients	patient	NOUN
ajlm-1537	16	3	in	in	ADP
ajlm-1537	16	4	each	each	DET
ajlm-1537	16	5	group	group	NOUN
ajlm-1537	16	6	received	receive	VERB
ajlm-1537	16	7	immunosuppressive	immunosuppressive	ADJ
ajlm-1537	16	8	therapy	therapy	NOUN
ajlm-1537	16	9	(	(	PUNCT
ajlm-1537	16	10	ist	ist	NOUN
ajlm-1537	16	11	)	)	PUNCT
ajlm-1537	16	12	.	.	PUNCT
ajlm-1537	17	1	at	at	ADP
ajlm-1537	17	2	six	six	NUM
ajlm-1537	17	3	months	month	NOUN
ajlm-1537	17	4	,	,	PUNCT
ajlm-1537	17	5	all	all	DET
ajlm-1537	17	6	four	four	NUM
ajlm-1537	17	7	patients	patient	NOUN
ajlm-1537	17	8	with	with	ADP
ajlm-1537	17	9	pnh	pnh	PROPN
ajlm-1537	17	10	clones	clone	NOUN
ajlm-1537	17	11	had	have	AUX
ajlm-1537	17	12	responded	respond	VERB
ajlm-1537	17	13	,	,	PUNCT
ajlm-1537	17	14	compared	compare	VERB
ajlm-1537	17	15	to	to	ADP
ajlm-1537	17	16	one	one	NUM
ajlm-1537	17	17	in	in	ADP
ajlm-1537	17	18	the	the	DET
ajlm-1537	17	19	pnh	pnh	PROPN
ajlm-1537	17	20	-	-	PUNCT
ajlm-1537	17	21	negative	negative	ADJ
ajlm-1537	17	22	group	group	NOUN
ajlm-1537	17	23	.	.	PUNCT
ajlm-1537	18	1	conclusion	conclusion	NOUN
ajlm-1537	18	2	:	:	PUNCT
ajlm-1537	18	3	more	more	ADJ
ajlm-1537	18	4	than	than	ADP
ajlm-1537	18	5	half	half	NOUN
ajlm-1537	18	6	of	of	ADP
ajlm-1537	18	7	children	child	NOUN
ajlm-1537	18	8	with	with	ADP
ajlm-1537	18	9	aa	aa	NOUN
ajlm-1537	18	10	had	have	VERB
ajlm-1537	18	11	a	a	DET
ajlm-1537	18	12	pnh	pnh	PROPN
ajlm-1537	18	13	clone	clone	NOUN
ajlm-1537	18	14	.	.	PUNCT
ajlm-1537	19	1	the	the	DET
ajlm-1537	19	2	size	size	NOUN
ajlm-1537	19	3	of	of	ADP
ajlm-1537	19	4	the	the	DET
ajlm-1537	19	5	clone	clone	NOUN
ajlm-1537	19	6	did	do	AUX
ajlm-1537	19	7	not	not	PART
ajlm-1537	19	8	impact	impact	VERB
ajlm-1537	19	9	clinical	clinical	ADJ
ajlm-1537	19	10	severity	severity	NOUN
ajlm-1537	19	11	;	;	PUNCT
ajlm-1537	19	12	however	however	ADV
ajlm-1537	19	13	,	,	PUNCT
ajlm-1537	19	14	ist	ist	NOUN
ajlm-1537	19	15	use	use	NOUN
ajlm-1537	19	16	may	may	AUX
ajlm-1537	19	17	positively	positively	ADV
ajlm-1537	19	18	impact	impact	VERB
ajlm-1537	19	19	prognosis	prognosis	NOUN
ajlm-1537	19	20	.	.	PUNCT
ajlm-1537	20	1	we	we	PRON
ajlm-1537	20	2	recommend	recommend	VERB
ajlm-1537	20	3	early	early	ADJ
ajlm-1537	20	4	initiation	initiation	NOUN
ajlm-1537	20	5	of	of	ADP
ajlm-1537	20	6	ist	ist	NOUN
ajlm-1537	20	7	in	in	ADP
ajlm-1537	20	8	patients	patient	NOUN
ajlm-1537	20	9	with	with	ADP
ajlm-1537	20	10	aa	aa	PRON
ajlm-1537	20	11	to	to	PART
ajlm-1537	20	12	avoid	avoid	VERB
ajlm-1537	20	13	delays	delay	NOUN
ajlm-1537	20	14	associated	associate	VERB
ajlm-1537	20	15	with	with	ADP
ajlm-1537	20	16	human	human	ADJ
ajlm-1537	20	17	leukocyte	leukocyte	NOUN
ajlm-1537	20	18	antigen	antigen	NOUN
ajlm-1537	20	19	typing	typing	NOUN
ajlm-1537	20	20	.	.	PUNCT
ajlm-1537	21	1	keywords	keyword	NOUN
ajlm-1537	21	2	:	:	PUNCT
ajlm-1537	21	3	paroxysmal	paroxysmal	ADJ
ajlm-1537	21	4	nocturnal	nocturnal	ADJ
ajlm-1537	21	5	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	21	6	clones	clone	NOUN
ajlm-1537	21	7	;	;	PUNCT
ajlm-1537	21	8	aplastic	aplastic	ADJ
ajlm-1537	21	9	anaemia	anaemia	NOUN
ajlm-1537	21	10	;	;	PUNCT
ajlm-1537	21	11	paediatrics	paediatric	NOUN
ajlm-1537	21	12	;	;	PUNCT
ajlm-1537	21	13	flow	flow	NOUN
ajlm-1537	21	14	cytometry	cytometry	NOUN
ajlm-1537	21	15	;	;	PUNCT
ajlm-1537	21	16	hla	hla	NOUN
ajlm-1537	21	17	typing	typing	NOUN
ajlm-1537	21	18	.	.	PUNCT
ajlm-1537	22	1	introduction	introduction	NOUN
ajlm-1537	22	2	paroxysmal	paroxysmal	ADJ
ajlm-1537	22	3	nocturnal	nocturnal	ADJ
ajlm-1537	22	4	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	22	5	(	(	PUNCT
ajlm-1537	22	6	pnh	pnh	NOUN
ajlm-1537	22	7	)	)	PUNCT
ajlm-1537	22	8	is	be	AUX
ajlm-1537	22	9	an	an	DET
ajlm-1537	22	10	acquired	acquire	VERB
ajlm-1537	22	11	haematopoietic	haematopoietic	ADJ
ajlm-1537	22	12	stem	stem	NOUN
ajlm-1537	22	13	cell	cell	NOUN
ajlm-1537	22	14	disorder.1	disorder.1	NOUN
ajlm-1537	22	15	it	it	PRON
ajlm-1537	22	16	is	be	AUX
ajlm-1537	22	17	rare	rare	ADJ
ajlm-1537	22	18	in	in	ADP
ajlm-1537	22	19	children	child	NOUN
ajlm-1537	22	20	and	and	CCONJ
ajlm-1537	22	21	results	result	NOUN
ajlm-1537	22	22	from	from	ADP
ajlm-1537	22	23	a	a	DET
ajlm-1537	22	24	somatic	somatic	ADJ
ajlm-1537	22	25	mutation	mutation	NOUN
ajlm-1537	22	26	in	in	ADP
ajlm-1537	22	27	the	the	DET
ajlm-1537	22	28	glycophosphatidylinositol	glycophosphatidylinositol	NOUN
ajlm-1537	22	29	(	(	PUNCT
ajlm-1537	22	30	gpi	gpi	PROPN
ajlm-1537	22	31	)	)	PUNCT
ajlm-1537	22	32	glycan	glycan	VERB
ajlm-1537	22	33	a	a	DET
ajlm-1537	22	34	gene	gene	NOUN
ajlm-1537	22	35	on	on	ADP
ajlm-1537	22	36	the	the	DET
ajlm-1537	22	37	short	short	ADJ
ajlm-1537	22	38	arm	arm	NOUN
ajlm-1537	22	39	of	of	ADP
ajlm-1537	22	40	the	the	DET
ajlm-1537	22	41	x	x	SYM
ajlm-1537	22	42	chromosome.1,2,3	chromosome.1,2,3	ADP
ajlm-1537	22	43	the	the	DET
ajlm-1537	22	44	gpi	gpi	PROPN
ajlm-1537	22	45	glycan	glycan	VERB
ajlm-1537	22	46	a	a	DET
ajlm-1537	22	47	gene	gene	NOUN
ajlm-1537	22	48	encodes	encode	VERB
ajlm-1537	22	49	gpi	gpi	NOUN
ajlm-1537	22	50	-	-	PUNCT
ajlm-1537	22	51	anchored	anchor	VERB
ajlm-1537	22	52	markers	marker	NOUN
ajlm-1537	22	53	,	,	PUNCT
ajlm-1537	22	54	including	include	VERB
ajlm-1537	22	55	cd55	cd55	PROPN
ajlm-1537	22	56	and	and	CCONJ
ajlm-1537	22	57	cd59	cd59	PROPN
ajlm-1537	22	58	,	,	PUNCT
ajlm-1537	22	59	which	which	PRON
ajlm-1537	22	60	protect	protect	VERB
ajlm-1537	22	61	cells	cell	NOUN
ajlm-1537	22	62	from	from	ADP
ajlm-1537	22	63	complement	complement	NOUN
ajlm-1537	22	64	-	-	PUNCT
ajlm-1537	22	65	mediated	mediate	VERB
ajlm-1537	22	66	attack.4,5	attack.4,5	PROPN
ajlm-1537	22	67	although	although	SCONJ
ajlm-1537	22	68	the	the	DET
ajlm-1537	22	69	condition	condition	NOUN
ajlm-1537	22	70	is	be	AUX
ajlm-1537	22	71	classically	classically	ADV
ajlm-1537	22	72	described	describe	VERB
ajlm-1537	22	73	as	as	ADP
ajlm-1537	22	74	presenting	present	VERB
ajlm-1537	22	75	with	with	ADP
ajlm-1537	22	76	nocturnal	nocturnal	ADJ
ajlm-1537	22	77	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	22	78	,	,	PUNCT
ajlm-1537	22	79	this	this	DET
ajlm-1537	22	80	finding	finding	NOUN
ajlm-1537	22	81	is	be	AUX
ajlm-1537	22	82	not	not	PART
ajlm-1537	22	83	generally	generally	ADV
ajlm-1537	22	84	common	common	ADJ
ajlm-1537	22	85	and	and	CCONJ
ajlm-1537	22	86	is	be	AUX
ajlm-1537	22	87	particularly	particularly	ADV
ajlm-1537	22	88	rare	rare	ADJ
ajlm-1537	22	89	in	in	ADP
ajlm-1537	22	90	children.4,6	children.4,6	PROPN
ajlm-1537	22	91	patients	patient	NOUN
ajlm-1537	22	92	may	may	AUX
ajlm-1537	22	93	also	also	ADV
ajlm-1537	22	94	present	present	VERB
ajlm-1537	22	95	with	with	ADP
ajlm-1537	22	96	bone	bone	NOUN
ajlm-1537	22	97	marrow	marrow	NOUN
ajlm-1537	22	98	failure	failure	NOUN
ajlm-1537	22	99	,	,	PUNCT
ajlm-1537	22	100	and	and	CCONJ
ajlm-1537	22	101	the	the	DET
ajlm-1537	22	102	presence	presence	NOUN
ajlm-1537	22	103	of	of	ADP
ajlm-1537	22	104	pnh	pnh	PROPN
ajlm-1537	22	105	clones	clone	NOUN
ajlm-1537	22	106	has	have	AUX
ajlm-1537	22	107	been	be	AUX
ajlm-1537	22	108	shown	show	VERB
ajlm-1537	22	109	in	in	ADP
ajlm-1537	22	110	a	a	DET
ajlm-1537	22	111	large	large	ADJ
ajlm-1537	22	112	percentage	percentage	NOUN
ajlm-1537	22	113	of	of	ADP
ajlm-1537	22	114	children	child	NOUN
ajlm-1537	22	115	with	with	ADP
ajlm-1537	22	116	aplastic	aplastic	ADJ
ajlm-1537	22	117	anaemia	anaemia	NOUN
ajlm-1537	22	118	(	(	PUNCT
ajlm-1537	22	119	aa).2,7	aa).2,7	VERB
ajlm-1537	22	120	this	this	DET
ajlm-1537	22	121	association	association	NOUN
ajlm-1537	22	122	was	be	AUX
ajlm-1537	22	123	described	describe	VERB
ajlm-1537	22	124	by	by	ADP
ajlm-1537	22	125	ware	ware	NOUN
ajlm-1537	22	126	et	et	PROPN
ajlm-1537	22	127	al	al	PROPN
ajlm-1537	22	128	.	.	PROPN
ajlm-1537	23	1	in	in	ADP
ajlm-1537	23	2	1991,8	1991,8	NUM
ajlm-1537	23	3	where	where	SCONJ
ajlm-1537	23	4	the	the	DET
ajlm-1537	23	5	largest	large	ADJ
ajlm-1537	23	6	initial	initial	ADJ
ajlm-1537	23	7	paediatric	paediatric	ADJ
ajlm-1537	23	8	pnh	pnh	PROPN
ajlm-1537	23	9	cohort	cohort	NOUN
ajlm-1537	23	10	was	be	AUX
ajlm-1537	23	11	found	find	VERB
ajlm-1537	23	12	to	to	PART
ajlm-1537	23	13	have	have	VERB
ajlm-1537	23	14	features	feature	NOUN
ajlm-1537	23	15	very	very	ADV
ajlm-1537	23	16	different	different	ADJ
ajlm-1537	23	17	from	from	ADP
ajlm-1537	23	18	their	their	PRON
ajlm-1537	23	19	adult	adult	NOUN
ajlm-1537	23	20	counterparts	counterpart	NOUN
ajlm-1537	23	21	.	.	PUNCT
ajlm-1537	24	1	since	since	SCONJ
ajlm-1537	24	2	pnh	pnh	PROPN
ajlm-1537	24	3	clones	clone	NOUN
ajlm-1537	24	4	are	be	AUX
ajlm-1537	24	5	often	often	ADV
ajlm-1537	24	6	found	find	VERB
ajlm-1537	24	7	in	in	ADP
ajlm-1537	24	8	aa	aa	NOUN
ajlm-1537	24	9	,	,	PUNCT
ajlm-1537	24	10	and	and	CCONJ
ajlm-1537	24	11	patients	patient	NOUN
ajlm-1537	24	12	with	with	ADP
ajlm-1537	24	13	clinical	clinical	ADJ
ajlm-1537	24	14	pnh	pnh	PROPN
ajlm-1537	24	15	often	often	ADV
ajlm-1537	24	16	progress	progress	VERB
ajlm-1537	24	17	to	to	PART
ajlm-1537	24	18	aa,9	aa,9	VERB
ajlm-1537	24	19	what	what	PRON
ajlm-1537	24	20	is	be	AUX
ajlm-1537	24	21	the	the	DET
ajlm-1537	24	22	theory	theory	NOUN
ajlm-1537	24	23	of	of	ADP
ajlm-1537	24	24	association	association	NOUN
ajlm-1537	24	25	?	?	PUNCT
ajlm-1537	25	1	the	the	DET
ajlm-1537	25	2	prevailing	prevail	VERB
ajlm-1537	25	3	theory	theory	NOUN
ajlm-1537	25	4	is	be	AUX
ajlm-1537	25	5	that	that	SCONJ
ajlm-1537	25	6	haematopoietic	haematopoietic	ADJ
ajlm-1537	25	7	stem	stem	NOUN
ajlm-1537	25	8	cells	cell	NOUN
ajlm-1537	25	9	harbouring	harbour	VERB
ajlm-1537	25	10	the	the	DET
ajlm-1537	25	11	pnh	pnh	PROPN
ajlm-1537	25	12	clone	clone	NOUN
ajlm-1537	25	13	are	be	AUX
ajlm-1537	25	14	resistant	resistant	ADJ
ajlm-1537	25	15	to	to	ADP
ajlm-1537	25	16	the	the	DET
ajlm-1537	25	17	immune	immune	NOUN
ajlm-1537	25	18	-	-	PUNCT
ajlm-1537	25	19	mediated	mediate	VERB
ajlm-1537	25	20	damage	damage	NOUN
ajlm-1537	25	21	that	that	PRON
ajlm-1537	25	22	occurs	occur	VERB
ajlm-1537	25	23	during	during	ADP
ajlm-1537	25	24	aa	aa	NOUN
ajlm-1537	25	25	and	and	CCONJ
ajlm-1537	25	26	this	this	PRON
ajlm-1537	25	27	promotes	promote	VERB
ajlm-1537	25	28	the	the	DET
ajlm-1537	25	29	expansion	expansion	NOUN
ajlm-1537	25	30	of	of	ADP
ajlm-1537	25	31	these	these	DET
ajlm-1537	25	32	‘	'	PUNCT
ajlm-1537	25	33	unaffected	unaffected	ADJ
ajlm-1537	25	34	’	'	PUNCT
ajlm-1537	25	35	cells,5,10	cells,5,10	PROPN
ajlm-1537	25	36	also	also	ADV
ajlm-1537	25	37	termed	term	VERB
ajlm-1537	25	38	the	the	DET
ajlm-1537	25	39	“	"	PUNCT
ajlm-1537	25	40	escape	escape	NOUN
ajlm-1537	25	41	mechanism	mechanism	NOUN
ajlm-1537	25	42	”	"	PUNCT
ajlm-1537	25	43	.	.	PUNCT
ajlm-1537	26	1	according	accord	VERB
ajlm-1537	26	2	to	to	ADP
ajlm-1537	26	3	luzatto,10	luzatto,10	NOUN
ajlm-1537	26	4	the	the	DET
ajlm-1537	26	5	progression	progression	NOUN
ajlm-1537	26	6	of	of	ADP
ajlm-1537	26	7	aa	aa	NOUN
ajlm-1537	26	8	to	to	ADP
ajlm-1537	26	9	pnh	pnh	PROPN
ajlm-1537	26	10	is	be	AUX
ajlm-1537	26	11	thus	thus	ADV
ajlm-1537	26	12	“	"	PUNCT
ajlm-1537	26	13	the	the	DET
ajlm-1537	26	14	rule	rule	NOUN
ajlm-1537	26	15	rather	rather	ADV
ajlm-1537	26	16	than	than	ADP
ajlm-1537	26	17	the	the	DET
ajlm-1537	26	18	exception	exception	NOUN
ajlm-1537	26	19	”	"	PUNCT
ajlm-1537	26	20	.	.	PUNCT
ajlm-1537	27	1	very	very	ADV
ajlm-1537	27	2	little	little	ADJ
ajlm-1537	27	3	knowledge	knowledge	NOUN
ajlm-1537	27	4	exists	exist	VERB
ajlm-1537	27	5	on	on	ADP
ajlm-1537	27	6	the	the	DET
ajlm-1537	27	7	difference	difference	NOUN
ajlm-1537	27	8	in	in	ADP
ajlm-1537	27	9	clinical	clinical	ADJ
ajlm-1537	27	10	presentation	presentation	NOUN
ajlm-1537	27	11	and	and	CCONJ
ajlm-1537	27	12	response	response	NOUN
ajlm-1537	27	13	to	to	ADP
ajlm-1537	27	14	treatment	treatment	NOUN
ajlm-1537	27	15	in	in	ADP
ajlm-1537	27	16	children	child	NOUN
ajlm-1537	27	17	with	with	ADP
ajlm-1537	27	18	and	and	CCONJ
ajlm-1537	27	19	without	without	ADP
ajlm-1537	27	20	pnh	pnh	PROPN
ajlm-1537	27	21	clones	clone	NOUN
ajlm-1537	27	22	,	,	PUNCT
ajlm-1537	27	23	particularly	particularly	ADV
ajlm-1537	27	24	on	on	ADP
ajlm-1537	27	25	the	the	DET
ajlm-1537	27	26	african	african	ADJ
ajlm-1537	27	27	continent	continent	NOUN
ajlm-1537	27	28	.	.	PUNCT
ajlm-1537	28	1	though	though	SCONJ
ajlm-1537	28	2	aa	aa	NOUN
ajlm-1537	28	3	is	be	AUX
ajlm-1537	28	4	the	the	DET
ajlm-1537	28	5	most	most	ADV
ajlm-1537	28	6	common	common	ADJ
ajlm-1537	28	7	presentation	presentation	NOUN
ajlm-1537	28	8	,	,	PUNCT
ajlm-1537	28	9	there	there	PRON
ajlm-1537	28	10	have	have	AUX
ajlm-1537	28	11	been	be	AUX
ajlm-1537	28	12	case	case	NOUN
ajlm-1537	28	13	series	series	NOUN
ajlm-1537	28	14	where	where	SCONJ
ajlm-1537	28	15	thromboses	thrombose	NOUN
ajlm-1537	28	16	and	and	CCONJ
ajlm-1537	28	17	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	28	18	are	be	AUX
ajlm-1537	28	19	documented.4	documented.4	PROPN
ajlm-1537	28	20	flow	flow	NOUN
ajlm-1537	28	21	cytometry	cytometry	NOUN
ajlm-1537	28	22	-	-	PUNCT
ajlm-1537	28	23	based	base	VERB
ajlm-1537	28	24	tests	test	NOUN
ajlm-1537	28	25	are	be	AUX
ajlm-1537	28	26	the	the	DET
ajlm-1537	28	27	most	most	ADV
ajlm-1537	28	28	accurate	accurate	ADJ
ajlm-1537	28	29	tests	test	NOUN
ajlm-1537	28	30	for	for	ADP
ajlm-1537	28	31	the	the	DET
ajlm-1537	28	32	detection	detection	NOUN
ajlm-1537	28	33	of	of	ADP
ajlm-1537	28	34	pnh	pnh	PROPN
ajlm-1537	28	35	clones.7,11	clones.7,11	NOUN
ajlm-1537	28	36	classically	classically	ADV
ajlm-1537	28	37	,	,	PUNCT
ajlm-1537	28	38	granulocytes	granulocyte	NOUN
ajlm-1537	28	39	and	and	CCONJ
ajlm-1537	28	40	monocytes	monocyte	NOUN
ajlm-1537	28	41	are	be	AUX
ajlm-1537	28	42	analysed	analyse	VERB
ajlm-1537	28	43	to	to	PART
ajlm-1537	28	44	determine	determine	VERB
ajlm-1537	28	45	the	the	DET
ajlm-1537	28	46	absence	absence	NOUN
ajlm-1537	28	47	of	of	ADP
ajlm-1537	28	48	gpi	gpi	PROPN
ajlm-1537	28	49	-	-	PUNCT
ajlm-1537	28	50	linked	link	VERB
ajlm-1537	28	51	proteins.3	proteins.3	PROPN
ajlm-1537	28	52	red	red	ADJ
ajlm-1537	28	53	blood	blood	NOUN
ajlm-1537	28	54	cells	cell	NOUN
ajlm-1537	28	55	are	be	AUX
ajlm-1537	28	56	not	not	PART
ajlm-1537	28	57	thought	think	VERB
ajlm-1537	28	58	to	to	PART
ajlm-1537	28	59	represent	represent	VERB
ajlm-1537	28	60	the	the	DET
ajlm-1537	28	61	true	true	ADJ
ajlm-1537	28	62	size	size	NOUN
ajlm-1537	28	63	of	of	ADP
ajlm-1537	28	64	the	the	DET
ajlm-1537	28	65	clone	clone	NOUN
ajlm-1537	28	66	,	,	PUNCT
ajlm-1537	28	67	as	as	SCONJ
ajlm-1537	28	68	ongoing	ongoing	ADJ
ajlm-1537	28	69	haemolysis	haemolysis	NOUN
ajlm-1537	28	70	and	and	CCONJ
ajlm-1537	28	71	the	the	DET
ajlm-1537	28	72	presence	presence	NOUN
ajlm-1537	28	73	of	of	ADP
ajlm-1537	28	74	transfused	transfuse	VERB
ajlm-1537	28	75	cells	cell	NOUN
ajlm-1537	28	76	usually	usually	ADV
ajlm-1537	28	77	confound	confound	VERB
ajlm-1537	28	78	results	result	NOUN
ajlm-1537	28	79	.	.	PUNCT
ajlm-1537	29	1	paroxysmal	paroxysmal	ADJ
ajlm-1537	29	2	nocturnal	nocturnal	ADJ
ajlm-1537	29	3	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	29	4	clone	clone	NOUN
ajlm-1537	29	5	sizes	size	NOUN
ajlm-1537	29	6	<	<	X
ajlm-1537	29	7	1	1	NUM
ajlm-1537	29	8	%	%	NOUN
ajlm-1537	29	9	require	require	VERB
ajlm-1537	29	10	validation	validation	NOUN
ajlm-1537	29	11	within	within	ADP
ajlm-1537	29	12	each	each	DET
ajlm-1537	29	13	laboratory	laboratory	NOUN
ajlm-1537	29	14	to	to	PART
ajlm-1537	29	15	determine	determine	VERB
ajlm-1537	29	16	accuracy	accuracy	NOUN
ajlm-1537	29	17	.	.	PUNCT
ajlm-1537	30	1	these	these	DET
ajlm-1537	30	2	smaller	small	ADJ
ajlm-1537	30	3	clone	clone	NOUN
ajlm-1537	30	4	sizes	size	NOUN
ajlm-1537	30	5	are	be	AUX
ajlm-1537	30	6	,	,	PUNCT
ajlm-1537	30	7	however	however	ADV
ajlm-1537	30	8	,	,	PUNCT
ajlm-1537	30	9	becoming	become	VERB
ajlm-1537	30	10	more	more	ADV
ajlm-1537	30	11	important	important	ADJ
ajlm-1537	30	12	to	to	PART
ajlm-1537	30	13	identify	identify	VERB
ajlm-1537	30	14	,	,	PUNCT
ajlm-1537	30	15	as	as	SCONJ
ajlm-1537	30	16	their	their	PRON
ajlm-1537	30	17	presence	presence	NOUN
ajlm-1537	30	18	allows	allow	VERB
ajlm-1537	30	19	for	for	ADP
ajlm-1537	30	20	future	future	ADJ
ajlm-1537	30	21	monitoring	monitoring	NOUN
ajlm-1537	30	22	of	of	ADP
ajlm-1537	30	23	clone	clone	NOUN
ajlm-1537	30	24	size	size	NOUN
ajlm-1537	30	25	and	and	CCONJ
ajlm-1537	30	26	the	the	DET
ajlm-1537	30	27	potential	potential	ADJ
ajlm-1537	30	28	development	development	NOUN
ajlm-1537	30	29	of	of	ADP
ajlm-1537	30	30	classic	classic	ADJ
ajlm-1537	30	31	pnh.2	pnh.2	NOUN
ajlm-1537	30	32	a	a	DET
ajlm-1537	30	33	previous	previous	ADJ
ajlm-1537	30	34	study	study	NOUN
ajlm-1537	30	35	described	describe	VERB
ajlm-1537	30	36	the	the	DET
ajlm-1537	30	37	10	10	NUM
ajlm-1537	30	38	-	-	PUNCT
ajlm-1537	30	39	year	year	NOUN
ajlm-1537	30	40	probability	probability	NOUN
ajlm-1537	30	41	of	of	ADP
ajlm-1537	30	42	developing	develop	VERB
ajlm-1537	30	43	pnh	pnh	PROPN
ajlm-1537	30	44	disease	disease	NOUN
ajlm-1537	30	45	from	from	ADP
ajlm-1537	30	46	a	a	DET
ajlm-1537	30	47	pnh	pnh	PROPN
ajlm-1537	30	48	clone	clone	NOUN
ajlm-1537	30	49	to	to	PART
ajlm-1537	30	50	be	be	AUX
ajlm-1537	30	51	10.2%.2	10.2%.2	ADJ
ajlm-1537	30	52	historically	historically	ADV
ajlm-1537	30	53	,	,	PUNCT
ajlm-1537	30	54	patients	patient	NOUN
ajlm-1537	30	55	with	with	ADP
ajlm-1537	30	56	aa	aa	NOUN
ajlm-1537	30	57	were	be	AUX
ajlm-1537	30	58	managed	manage	VERB
ajlm-1537	30	59	either	either	CCONJ
ajlm-1537	30	60	supportively	supportively	ADV
ajlm-1537	30	61	with	with	ADP
ajlm-1537	30	62	transfusions	transfusion	NOUN
ajlm-1537	30	63	or	or	CCONJ
ajlm-1537	30	64	cured	cure	VERB
ajlm-1537	30	65	with	with	ADP
ajlm-1537	30	66	a	a	DET
ajlm-1537	30	67	haematopoietic	haematopoietic	ADJ
ajlm-1537	30	68	stem	stem	NOUN
ajlm-1537	30	69	cell	cell	NOUN
ajlm-1537	30	70	transplant	transplant	NOUN
ajlm-1537	30	71	(	(	PUNCT
ajlm-1537	30	72	hsct).12,13	hsct).12,13	PROPN
ajlm-1537	30	73	before	before	ADP
ajlm-1537	30	74	immunosuppressive	immunosuppressive	ADJ
ajlm-1537	30	75	therapy	therapy	NOUN
ajlm-1537	30	76	(	(	PUNCT
ajlm-1537	30	77	ist	ist	NOUN
ajlm-1537	30	78	)	)	PUNCT
ajlm-1537	30	79	became	become	VERB
ajlm-1537	30	80	available	available	ADJ
ajlm-1537	30	81	,	,	PUNCT
ajlm-1537	30	82	early	early	ADJ
ajlm-1537	30	83	reports	report	NOUN
ajlm-1537	30	84	from	from	ADP
ajlm-1537	30	85	africa	africa	PROPN
ajlm-1537	30	86	showed	show	VERB
ajlm-1537	30	87	very	very	ADV
ajlm-1537	30	88	high	high	ADJ
ajlm-1537	30	89	mortality	mortality	NOUN
ajlm-1537	30	90	rates	rate	NOUN
ajlm-1537	30	91	in	in	ADP
ajlm-1537	30	92	symptomatically	symptomatically	ADV
ajlm-1537	30	93	treated	treat	VERB
ajlm-1537	30	94	patients.14,15	patients.14,15	NOUN
ajlm-1537	30	95	according	accord	VERB
ajlm-1537	30	96	to	to	ADP
ajlm-1537	30	97	the	the	DET
ajlm-1537	30	98	north	north	ADJ
ajlm-1537	30	99	american	american	ADJ
ajlm-1537	30	100	pediatric	pediatric	ADJ
ajlm-1537	30	101	aplastic	aplastic	ADJ
ajlm-1537	30	102	anemia	anemia	NOUN
ajlm-1537	30	103	consortium	consortium	NOUN
ajlm-1537	30	104	,	,	PUNCT
ajlm-1537	30	105	most	most	ADJ
ajlm-1537	30	106	centres	centre	NOUN
ajlm-1537	30	107	would	would	AUX
ajlm-1537	30	108	only	only	ADV
ajlm-1537	30	109	opt	opt	VERB
ajlm-1537	30	110	for	for	ADP
ajlm-1537	30	111	hsct	hsct	NOUN
ajlm-1537	30	112	as	as	ADP
ajlm-1537	30	113	first	first	ADJ
ajlm-1537	30	114	-	-	PUNCT
ajlm-1537	30	115	line	line	NOUN
ajlm-1537	30	116	therapy	therapy	NOUN
ajlm-1537	30	117	in	in	ADP
ajlm-1537	30	118	patients	patient	NOUN
ajlm-1537	30	119	presenting	present	VERB
ajlm-1537	30	120	with	with	ADP
ajlm-1537	30	121	acquired	acquire	VERB
ajlm-1537	30	122	severe	severe	ADJ
ajlm-1537	30	123	aa	aa	NOUN
ajlm-1537	30	124	and	and	CCONJ
ajlm-1537	30	125	who	who	PRON
ajlm-1537	30	126	have	have	VERB
ajlm-1537	30	127	a	a	DET
ajlm-1537	30	128	matched	match	VERB
ajlm-1537	30	129	sibling	sible	VERB
ajlm-1537	30	130	donor.16	donor.16	PROPN
ajlm-1537	30	131	in	in	ADP
ajlm-1537	30	132	the	the	DET
ajlm-1537	30	133	absence	absence	NOUN
ajlm-1537	30	134	of	of	ADP
ajlm-1537	30	135	a	a	DET
ajlm-1537	30	136	sibling	sible	VERB
ajlm-1537	30	137	donor	donor	NOUN
ajlm-1537	30	138	,	,	PUNCT
ajlm-1537	30	139	ist	ist	VERB
ajlm-1537	30	140	with	with	ADP
ajlm-1537	30	141	anti	anti	ADJ
ajlm-1537	30	142	-	-	ADJ
ajlm-1537	30	143	thymocyte	thymocyte	ADJ
ajlm-1537	30	144	globulin	globulin	NOUN
ajlm-1537	30	145	(	(	PUNCT
ajlm-1537	30	146	atg	atg	PROPN
ajlm-1537	30	147	)	)	PUNCT
ajlm-1537	30	148	and	and	CCONJ
ajlm-1537	30	149	cyclosporin	cyclosporin	NOUN
ajlm-1537	30	150	becomes	become	VERB
ajlm-1537	30	151	the	the	DET
ajlm-1537	30	152	best	good	ADJ
ajlm-1537	30	153	option.17,18	option.17,18	NOUN
ajlm-1537	30	154	haematopoietic	haematopoietic	ADJ
ajlm-1537	30	155	stem	stem	NOUN
ajlm-1537	30	156	cell	cell	NOUN
ajlm-1537	30	157	transplant	transplant	NOUN
ajlm-1537	30	158	from	from	ADP
ajlm-1537	30	159	a	a	DET
ajlm-1537	30	160	matched	match	VERB
ajlm-1537	30	161	unrelated	unrelated	ADJ
ajlm-1537	30	162	-	-	PUNCT
ajlm-1537	30	163	donor	donor	NOUN
ajlm-1537	30	164	is	be	AUX
ajlm-1537	30	165	only	only	ADV
ajlm-1537	30	166	recommended	recommend	VERB
ajlm-1537	30	167	for	for	ADP
ajlm-1537	30	168	patients	patient	NOUN
ajlm-1537	30	169	who	who	PRON
ajlm-1537	30	170	do	do	AUX
ajlm-1537	30	171	not	not	PART
ajlm-1537	30	172	respond	respond	VERB
ajlm-1537	30	173	to	to	ADP
ajlm-1537	30	174	first	first	ADJ
ajlm-1537	30	175	-	-	PUNCT
ajlm-1537	30	176	line	line	NOUN
ajlm-1537	30	177	ist	ist	NOUN
ajlm-1537	30	178	.	.	PUNCT
ajlm-1537	31	1	in	in	ADP
ajlm-1537	31	2	our	our	PRON
ajlm-1537	31	3	setting	setting	NOUN
ajlm-1537	31	4	,	,	PUNCT
ajlm-1537	31	5	the	the	DET
ajlm-1537	31	6	majority	majority	NOUN
ajlm-1537	31	7	of	of	ADP
ajlm-1537	31	8	patients	patient	NOUN
ajlm-1537	31	9	are	be	AUX
ajlm-1537	31	10	of	of	ADP
ajlm-1537	31	11	recent	recent	ADJ
ajlm-1537	31	12	african	african	ADJ
ajlm-1537	31	13	ancestry	ancestry	NOUN
ajlm-1537	31	14	,	,	PUNCT
ajlm-1537	31	15	where	where	SCONJ
ajlm-1537	31	16	significant	significant	ADJ
ajlm-1537	31	17	human	human	ADJ
ajlm-1537	31	18	leukocyte	leukocyte	NOUN
ajlm-1537	31	19	antigen	antigen	NOUN
ajlm-1537	31	20	(	(	PUNCT
ajlm-1537	31	21	hla	hla	NOUN
ajlm-1537	31	22	)	)	PUNCT
ajlm-1537	31	23	diversity	diversity	NOUN
ajlm-1537	31	24	exists.19,20	exists.19,20	NOUN
ajlm-1537	31	25	all	all	DET
ajlm-1537	31	26	patients	patient	NOUN
ajlm-1537	31	27	diagnosed	diagnose	VERB
ajlm-1537	31	28	with	with	ADP
ajlm-1537	31	29	aa	aa	NOUN
ajlm-1537	31	30	in	in	ADP
ajlm-1537	31	31	our	our	PRON
ajlm-1537	31	32	unit	unit	NOUN
ajlm-1537	31	33	routinely	routinely	ADV
ajlm-1537	31	34	have	have	VERB
ajlm-1537	31	35	hla	hla	NOUN
ajlm-1537	31	36	typing	typing	NOUN
ajlm-1537	31	37	performed	perform	VERB
ajlm-1537	31	38	.	.	PUNCT
ajlm-1537	32	1	if	if	SCONJ
ajlm-1537	32	2	siblings	sibling	NOUN
ajlm-1537	32	3	from	from	ADP
ajlm-1537	32	4	the	the	DET
ajlm-1537	32	5	same	same	ADJ
ajlm-1537	32	6	parents	parent	NOUN
ajlm-1537	32	7	are	be	AUX
ajlm-1537	32	8	present	present	ADJ
ajlm-1537	32	9	,	,	PUNCT
ajlm-1537	32	10	they	they	PRON
ajlm-1537	32	11	too	too	ADV
ajlm-1537	32	12	are	be	AUX
ajlm-1537	32	13	tested	test	VERB
ajlm-1537	32	14	,	,	PUNCT
ajlm-1537	32	15	and	and	CCONJ
ajlm-1537	32	16	if	if	SCONJ
ajlm-1537	32	17	they	they	PRON
ajlm-1537	32	18	are	be	AUX
ajlm-1537	32	19	a	a	DET
ajlm-1537	32	20	match	match	NOUN
ajlm-1537	32	21	,	,	PUNCT
ajlm-1537	32	22	patients	patient	NOUN
ajlm-1537	32	23	are	be	AUX
ajlm-1537	32	24	referred	refer	VERB
ajlm-1537	32	25	for	for	ADP
ajlm-1537	32	26	hsct	hsct	PROPN
ajlm-1537	32	27	.	.	PUNCT
ajlm-1537	33	1	a	a	DET
ajlm-1537	33	2	donor	donor	NOUN
ajlm-1537	33	3	search	search	NOUN
ajlm-1537	33	4	for	for	ADP
ajlm-1537	33	5	local	local	ADJ
ajlm-1537	33	6	(	(	PUNCT
ajlm-1537	33	7	south	south	ADJ
ajlm-1537	33	8	african	african	ADJ
ajlm-1537	33	9	)	)	PUNCT
ajlm-1537	33	10	donors	donor	NOUN
ajlm-1537	33	11	is	be	AUX
ajlm-1537	33	12	also	also	ADV
ajlm-1537	33	13	conducted	conduct	VERB
ajlm-1537	33	14	via	via	ADP
ajlm-1537	33	15	the	the	DET
ajlm-1537	33	16	south	south	ADJ
ajlm-1537	33	17	african	african	ADJ
ajlm-1537	33	18	bone	bone	NOUN
ajlm-1537	33	19	marrow	marrow	PROPN
ajlm-1537	33	20	registry	registry	PROPN
ajlm-1537	33	21	.	.	PUNCT
ajlm-1537	34	1	uninsured	uninsured	ADJ
ajlm-1537	34	2	patients	patient	NOUN
ajlm-1537	34	3	treated	treat	VERB
ajlm-1537	34	4	within	within	ADP
ajlm-1537	34	5	the	the	DET
ajlm-1537	34	6	state	state	NOUN
ajlm-1537	34	7	/	/	SYM
ajlm-1537	34	8	public	public	ADJ
ajlm-1537	34	9	health	health	NOUN
ajlm-1537	34	10	system	system	NOUN
ajlm-1537	34	11	can	can	AUX
ajlm-1537	34	12	be	be	AUX
ajlm-1537	34	13	transplanted	transplant	VERB
ajlm-1537	34	14	within	within	ADP
ajlm-1537	34	15	the	the	DET
ajlm-1537	34	16	state	state	NOUN
ajlm-1537	34	17	/	/	SYM
ajlm-1537	34	18	public	public	ADJ
ajlm-1537	34	19	sector	sector	NOUN
ajlm-1537	34	20	if	if	SCONJ
ajlm-1537	34	21	there	there	PRON
ajlm-1537	34	22	is	be	VERB
ajlm-1537	34	23	a	a	DET
ajlm-1537	34	24	compatible	compatible	ADJ
ajlm-1537	34	25	unrelated	unrelated	ADJ
ajlm-1537	34	26	local	local	ADJ
ajlm-1537	34	27	donor	donor	NOUN
ajlm-1537	34	28	identified	identify	VERB
ajlm-1537	34	29	from	from	ADP
ajlm-1537	34	30	the	the	DET
ajlm-1537	34	31	registry	registry	NOUN
ajlm-1537	34	32	.	.	PUNCT
ajlm-1537	35	1	insured	insure	VERB
ajlm-1537	35	2	patients	patient	NOUN
ajlm-1537	35	3	can	can	AUX
ajlm-1537	35	4	in	in	ADP
ajlm-1537	35	5	some	some	DET
ajlm-1537	35	6	instances	instance	NOUN
ajlm-1537	35	7	access	access	NOUN
ajlm-1537	35	8	compatible	compatible	ADJ
ajlm-1537	35	9	international	international	ADJ
ajlm-1537	35	10	donors	donor	NOUN
ajlm-1537	35	11	.	.	PUNCT
ajlm-1537	36	1	human	human	ADJ
ajlm-1537	36	2	leukocyte	leukocyte	NOUN
ajlm-1537	36	3	antigen	antigen	NOUN
ajlm-1537	36	4	typing	typing	NOUN
ajlm-1537	36	5	and	and	CCONJ
ajlm-1537	36	6	the	the	DET
ajlm-1537	36	7	subsequent	subsequent	ADJ
ajlm-1537	36	8	registry	registry	NOUN
ajlm-1537	36	9	searches	search	NOUN
ajlm-1537	36	10	to	to	PART
ajlm-1537	36	11	find	find	VERB
ajlm-1537	36	12	matches	match	NOUN
ajlm-1537	36	13	take	take	VERB
ajlm-1537	36	14	time	time	NOUN
ajlm-1537	36	15	,	,	PUNCT
ajlm-1537	36	16	and	and	CCONJ
ajlm-1537	36	17	there	there	PRON
ajlm-1537	36	18	is	be	VERB
ajlm-1537	36	19	a	a	DET
ajlm-1537	36	20	low	low	ADJ
ajlm-1537	36	21	likelihood	likelihood	NOUN
ajlm-1537	36	22	of	of	ADP
ajlm-1537	36	23	finding	find	VERB
ajlm-1537	36	24	an	an	DET
ajlm-1537	36	25	hla	hla	NOUN
ajlm-1537	36	26	match	match	NOUN
ajlm-1537	36	27	for	for	ADP
ajlm-1537	36	28	transplantation	transplantation	NOUN
ajlm-1537	36	29	.	.	PUNCT
ajlm-1537	37	1	this	this	PRON
ajlm-1537	37	2	prolongs	prolong	VERB
ajlm-1537	37	3	symptomatic	symptomatic	ADJ
ajlm-1537	37	4	treatment	treatment	NOUN
ajlm-1537	37	5	with	with	ADP
ajlm-1537	37	6	the	the	DET
ajlm-1537	37	7	risk	risk	NOUN
ajlm-1537	37	8	of	of	ADP
ajlm-1537	37	9	multiple	multiple	ADJ
ajlm-1537	37	10	transfusion	transfusion	NOUN
ajlm-1537	37	11	exposures	exposure	NOUN
ajlm-1537	37	12	.	.	PUNCT
ajlm-1537	38	1	our	our	PRON
ajlm-1537	38	2	study	study	NOUN
ajlm-1537	38	3	was	be	AUX
ajlm-1537	38	4	conducted	conduct	VERB
ajlm-1537	38	5	at	at	ADP
ajlm-1537	38	6	a	a	DET
ajlm-1537	38	7	quaternary	quaternary	ADJ
ajlm-1537	38	8	hospital	hospital	NOUN
ajlm-1537	38	9	in	in	ADP
ajlm-1537	38	10	durban	durban	PROPN
ajlm-1537	38	11	,	,	PUNCT
ajlm-1537	38	12	south	south	PROPN
ajlm-1537	38	13	africa	africa	PROPN
ajlm-1537	38	14	.	.	PUNCT
ajlm-1537	39	1	the	the	DET
ajlm-1537	39	2	haematology	haematology	NOUN
ajlm-1537	39	3	laboratory	laboratory	NOUN
ajlm-1537	39	4	provides	provide	VERB
ajlm-1537	39	5	in	in	ADP
ajlm-1537	39	6	-	-	PUNCT
ajlm-1537	39	7	house	house	NOUN
ajlm-1537	39	8	flow	flow	NOUN
ajlm-1537	39	9	cytometry	cytometry	NOUN
ajlm-1537	39	10	services	service	NOUN
ajlm-1537	39	11	and	and	CCONJ
ajlm-1537	39	12	has	have	AUX
ajlm-1537	39	13	been	be	AUX
ajlm-1537	39	14	using	use	VERB
ajlm-1537	39	15	the	the	DET
ajlm-1537	39	16	fluorescent	fluorescent	ADJ
ajlm-1537	39	17	aerolysin	aerolysin	NOUN
ajlm-1537	39	18	method	method	NOUN
ajlm-1537	39	19	to	to	PART
ajlm-1537	39	20	detect	detect	VERB
ajlm-1537	39	21	the	the	DET
ajlm-1537	39	22	presence	presence	NOUN
ajlm-1537	39	23	of	of	ADP
ajlm-1537	39	24	pnh	pnh	PROPN
ajlm-1537	39	25	clones	clone	NOUN
ajlm-1537	39	26	in	in	ADP
ajlm-1537	39	27	patients	patient	NOUN
ajlm-1537	39	28	since	since	SCONJ
ajlm-1537	39	29	september	september	PROPN
ajlm-1537	39	30	2013	2013	NUM
ajlm-1537	39	31	.	.	PUNCT
ajlm-1537	40	1	this	this	DET
ajlm-1537	40	2	study	study	NOUN
ajlm-1537	40	3	aimed	aim	VERB
ajlm-1537	40	4	to	to	PART
ajlm-1537	40	5	determine	determine	VERB
ajlm-1537	40	6	the	the	DET
ajlm-1537	40	7	prevalence	prevalence	NOUN
ajlm-1537	40	8	of	of	ADP
ajlm-1537	40	9	pnh	pnh	PROPN
ajlm-1537	40	10	clones	clone	NOUN
ajlm-1537	40	11	in	in	ADP
ajlm-1537	40	12	paediatric	paediatric	ADJ
ajlm-1537	40	13	patients	patient	NOUN
ajlm-1537	40	14	with	with	ADP
ajlm-1537	40	15	aa	aa	PROPN
ajlm-1537	40	16	,	,	PUNCT
ajlm-1537	40	17	identify	identify	VERB
ajlm-1537	40	18	differences	difference	NOUN
ajlm-1537	40	19	in	in	ADP
ajlm-1537	40	20	clinical	clinical	ADJ
ajlm-1537	40	21	and	and	CCONJ
ajlm-1537	40	22	laboratory	laboratory	NOUN
ajlm-1537	40	23	features	feature	NOUN
ajlm-1537	40	24	and	and	CCONJ
ajlm-1537	40	25	treatment	treatment	NOUN
ajlm-1537	40	26	responses	response	NOUN
ajlm-1537	40	27	between	between	ADP
ajlm-1537	40	28	patients	patient	NOUN
ajlm-1537	40	29	with	with	ADP
ajlm-1537	40	30	and	and	CCONJ
ajlm-1537	40	31	without	without	ADP
ajlm-1537	40	32	pnh	pnh	PROPN
ajlm-1537	40	33	clones	clone	NOUN
ajlm-1537	40	34	,	,	PUNCT
ajlm-1537	40	35	and	and	CCONJ
ajlm-1537	40	36	determine	determine	VERB
ajlm-1537	40	37	the	the	DET
ajlm-1537	40	38	impact	impact	NOUN
ajlm-1537	40	39	of	of	ADP
ajlm-1537	40	40	clone	clone	NOUN
ajlm-1537	40	41	size	size	NOUN
ajlm-1537	40	42	on	on	ADP
ajlm-1537	40	43	clinical	clinical	ADJ
ajlm-1537	40	44	presentation	presentation	NOUN
ajlm-1537	40	45	.	.	PUNCT
ajlm-1537	41	1	methods	method	NOUN
ajlm-1537	41	2	ethical	ethical	ADJ
ajlm-1537	41	3	considerations	consideration	NOUN
ajlm-1537	41	4	ethics	ethic	NOUN
ajlm-1537	41	5	approval	approval	NOUN
ajlm-1537	41	6	was	be	AUX
ajlm-1537	41	7	obtained	obtain	VERB
ajlm-1537	41	8	from	from	ADP
ajlm-1537	41	9	the	the	DET
ajlm-1537	41	10	biomedical	biomedical	ADJ
ajlm-1537	41	11	research	research	PROPN
ajlm-1537	41	12	ethics	ethic	NOUN
ajlm-1537	41	13	committee	committee	PROPN
ajlm-1537	41	14	of	of	ADP
ajlm-1537	41	15	the	the	DET
ajlm-1537	41	16	university	university	PROPN
ajlm-1537	41	17	of	of	ADP
ajlm-1537	41	18	kwazulu	kwazulu	PROPN
ajlm-1537	41	19	-	-	PUNCT
ajlm-1537	41	20	natal	natal	ADJ
ajlm-1537	41	21	(	(	PUNCT
ajlm-1537	41	22	bca325/18	bca325/18	NOUN
ajlm-1537	41	23	)	)	PUNCT
ajlm-1537	41	24	.	.	PUNCT
ajlm-1537	42	1	individual	individual	ADJ
ajlm-1537	42	2	patient	patient	ADJ
ajlm-1537	42	3	consent	consent	NOUN
ajlm-1537	42	4	was	be	AUX
ajlm-1537	42	5	not	not	PART
ajlm-1537	42	6	required	require	VERB
ajlm-1537	42	7	due	due	ADP
ajlm-1537	42	8	to	to	ADP
ajlm-1537	42	9	the	the	DET
ajlm-1537	42	10	study	study	NOUN
ajlm-1537	42	11	being	be	AUX
ajlm-1537	42	12	retrospective	retrospective	ADJ
ajlm-1537	42	13	.	.	PUNCT
ajlm-1537	43	1	data	datum	NOUN
ajlm-1537	43	2	were	be	AUX
ajlm-1537	43	3	password	password	NOUN
ajlm-1537	43	4	-	-	PUNCT
ajlm-1537	43	5	protected	protect	VERB
ajlm-1537	43	6	,	,	PUNCT
ajlm-1537	43	7	and	and	CCONJ
ajlm-1537	43	8	patient	patient	ADJ
ajlm-1537	43	9	confidentiality	confidentiality	NOUN
ajlm-1537	43	10	was	be	AUX
ajlm-1537	43	11	maintained	maintain	VERB
ajlm-1537	43	12	by	by	ADP
ajlm-1537	43	13	only	only	ADV
ajlm-1537	43	14	including	include	VERB
ajlm-1537	43	15	patient	patient	ADJ
ajlm-1537	43	16	hospital	hospital	NOUN
ajlm-1537	43	17	numbers	number	NOUN
ajlm-1537	43	18	on	on	ADP
ajlm-1537	43	19	the	the	DET
ajlm-1537	43	20	final	final	ADJ
ajlm-1537	43	21	datasheets	datasheet	NOUN
ajlm-1537	43	22	.	.	PUNCT
ajlm-1537	44	1	study	study	NOUN
ajlm-1537	44	2	population	population	NOUN
ajlm-1537	44	3	the	the	DET
ajlm-1537	44	4	electronic	electronic	ADJ
ajlm-1537	44	5	database	database	NOUN
ajlm-1537	44	6	of	of	ADP
ajlm-1537	44	7	the	the	DET
ajlm-1537	44	8	paediatric	paediatric	ADJ
ajlm-1537	44	9	haematology	haematology	NOUN
ajlm-1537	44	10	-	-	PUNCT
ajlm-1537	44	11	oncology	oncology	NOUN
ajlm-1537	44	12	unit	unit	NOUN
ajlm-1537	44	13	of	of	ADP
ajlm-1537	44	14	the	the	DET
ajlm-1537	44	15	inkosi	inkosi	PROPN
ajlm-1537	44	16	albert	albert	PROPN
ajlm-1537	44	17	luthuli	luthuli	PROPN
ajlm-1537	44	18	central	central	PROPN
ajlm-1537	44	19	hospital	hospital	NOUN
ajlm-1537	44	20	,	,	PUNCT
ajlm-1537	44	21	durban	durban	PROPN
ajlm-1537	44	22	,	,	PUNCT
ajlm-1537	44	23	south	south	PROPN
ajlm-1537	44	24	africa	africa	PROPN
ajlm-1537	44	25	,	,	PUNCT
ajlm-1537	44	26	was	be	AUX
ajlm-1537	44	27	screened	screen	VERB
ajlm-1537	44	28	to	to	PART
ajlm-1537	44	29	identify	identify	VERB
ajlm-1537	44	30	patients	patient	NOUN
ajlm-1537	44	31	with	with	ADP
ajlm-1537	44	32	a	a	DET
ajlm-1537	44	33	diagnosis	diagnosis	NOUN
ajlm-1537	44	34	of	of	ADP
ajlm-1537	44	35	aa	aa	NOUN
ajlm-1537	44	36	between	between	ADP
ajlm-1537	44	37	01	01	NUM
ajlm-1537	44	38	september	september	PROPN
ajlm-1537	44	39	2013	2013	NUM
ajlm-1537	44	40	and	and	CCONJ
ajlm-1537	44	41	31	31	NUM
ajlm-1537	44	42	january	january	PROPN
ajlm-1537	44	43	2018	2018	NUM
ajlm-1537	44	44	.	.	PUNCT
ajlm-1537	45	1	the	the	DET
ajlm-1537	45	2	diagnosis	diagnosis	NOUN
ajlm-1537	45	3	was	be	AUX
ajlm-1537	45	4	based	base	VERB
ajlm-1537	45	5	on	on	ADP
ajlm-1537	45	6	pancytopenia	pancytopenia	NOUN
ajlm-1537	45	7	secondary	secondary	ADJ
ajlm-1537	45	8	to	to	ADP
ajlm-1537	45	9	bone	bone	NOUN
ajlm-1537	45	10	marrow	marrow	PROPN
ajlm-1537	45	11	hypoplasia	hypoplasia	NOUN
ajlm-1537	45	12	in	in	ADP
ajlm-1537	45	13	the	the	DET
ajlm-1537	45	14	absence	absence	NOUN
ajlm-1537	45	15	of	of	ADP
ajlm-1537	45	16	a	a	DET
ajlm-1537	45	17	clonal	clonal	ADJ
ajlm-1537	45	18	malignant	malignant	ADJ
ajlm-1537	45	19	disorder	disorder	NOUN
ajlm-1537	45	20	.	.	PUNCT
ajlm-1537	46	1	patients	patient	NOUN
ajlm-1537	46	2	who	who	PRON
ajlm-1537	46	3	had	have	VERB
ajlm-1537	46	4	an	an	DET
ajlm-1537	46	5	inherited	inherit	VERB
ajlm-1537	46	6	bone	bone	NOUN
ajlm-1537	46	7	marrow	marrow	NOUN
ajlm-1537	46	8	failure	failure	NOUN
ajlm-1537	46	9	syndrome	syndrome	NOUN
ajlm-1537	46	10	such	such	ADJ
ajlm-1537	46	11	as	as	ADP
ajlm-1537	46	12	fanconi	fanconi	PROPN
ajlm-1537	46	13	anaemia	anaemia	PROPN
ajlm-1537	46	14	,	,	PUNCT
ajlm-1537	46	15	or	or	CCONJ
ajlm-1537	46	16	who	who	PRON
ajlm-1537	46	17	were	be	AUX
ajlm-1537	46	18	not	not	PART
ajlm-1537	46	19	tested	test	VERB
ajlm-1537	46	20	for	for	ADP
ajlm-1537	46	21	pnh	pnh	PROPN
ajlm-1537	46	22	,	,	PUNCT
ajlm-1537	46	23	were	be	AUX
ajlm-1537	46	24	excluded	exclude	VERB
ajlm-1537	46	25	.	.	PUNCT
ajlm-1537	47	1	the	the	DET
ajlm-1537	47	2	electronic	electronic	ADJ
ajlm-1537	47	3	medical	medical	ADJ
ajlm-1537	47	4	files	file	NOUN
ajlm-1537	47	5	of	of	ADP
ajlm-1537	47	6	these	these	DET
ajlm-1537	47	7	children	child	NOUN
ajlm-1537	47	8	were	be	AUX
ajlm-1537	47	9	searched	search	VERB
ajlm-1537	47	10	on	on	ADP
ajlm-1537	47	11	the	the	DET
ajlm-1537	47	12	hospital	hospital	NOUN
ajlm-1537	47	13	information	information	NOUN
ajlm-1537	47	14	system	system	NOUN
ajlm-1537	47	15	(	(	PUNCT
ajlm-1537	47	16	meditech	meditech	PROPN
ajlm-1537	47	17	,	,	PUNCT
ajlm-1537	47	18	westwood	westwood	PROPN
ajlm-1537	47	19	,	,	PUNCT
ajlm-1537	47	20	massachusetts	massachusetts	PROPN
ajlm-1537	47	21	,	,	PUNCT
ajlm-1537	47	22	united	united	PROPN
ajlm-1537	47	23	states	states	PROPN
ajlm-1537	47	24	)	)	PUNCT
ajlm-1537	47	25	as	as	ADV
ajlm-1537	47	26	well	well	ADV
ajlm-1537	47	27	as	as	ADP
ajlm-1537	47	28	the	the	DET
ajlm-1537	47	29	laboratory	laboratory	NOUN
ajlm-1537	47	30	information	information	NOUN
ajlm-1537	47	31	system	system	NOUN
ajlm-1537	47	32	(	(	PUNCT
ajlm-1537	47	33	trak	trak	PROPN
ajlm-1537	47	34	care	care	PROPN
ajlm-1537	47	35	,	,	PUNCT
ajlm-1537	47	36	intersystems	intersystem	NOUN
ajlm-1537	47	37	,	,	PUNCT
ajlm-1537	47	38	cambridge	cambridge	PROPN
ajlm-1537	47	39	,	,	PUNCT
ajlm-1537	47	40	massachusetts	massachusetts	PROPN
ajlm-1537	47	41	,	,	PUNCT
ajlm-1537	47	42	united	united	PROPN
ajlm-1537	47	43	states	states	PROPN
ajlm-1537	47	44	)	)	PUNCT
ajlm-1537	47	45	to	to	PART
ajlm-1537	47	46	retrieve	retrieve	VERB
ajlm-1537	47	47	demographic	demographic	ADJ
ajlm-1537	47	48	and	and	CCONJ
ajlm-1537	47	49	clinical	clinical	ADJ
ajlm-1537	47	50	information	information	NOUN
ajlm-1537	47	51	,	,	PUNCT
ajlm-1537	47	52	as	as	ADV
ajlm-1537	47	53	well	well	ADV
ajlm-1537	47	54	as	as	ADP
ajlm-1537	47	55	laboratory	laboratory	NOUN
ajlm-1537	47	56	test	test	NOUN
ajlm-1537	47	57	results	result	NOUN
ajlm-1537	47	58	.	.	PUNCT
ajlm-1537	48	1	patients	patient	NOUN
ajlm-1537	48	2	with	with	ADP
ajlm-1537	48	3	and	and	CCONJ
ajlm-1537	48	4	without	without	ADP
ajlm-1537	48	5	a	a	DET
ajlm-1537	48	6	pnh	pnh	PROPN
ajlm-1537	48	7	clone	clone	NOUN
ajlm-1537	48	8	were	be	AUX
ajlm-1537	48	9	compared	compare	VERB
ajlm-1537	48	10	with	with	ADP
ajlm-1537	48	11	respect	respect	NOUN
ajlm-1537	48	12	to	to	ADP
ajlm-1537	48	13	demographics	demographic	NOUN
ajlm-1537	48	14	,	,	PUNCT
ajlm-1537	48	15	laboratory	laboratory	NOUN
ajlm-1537	48	16	parameters	parameter	NOUN
ajlm-1537	48	17	,	,	PUNCT
ajlm-1537	48	18	presenting	present	VERB
ajlm-1537	48	19	complaints	complaint	NOUN
ajlm-1537	48	20	,	,	PUNCT
ajlm-1537	48	21	management	management	NOUN
ajlm-1537	48	22	and	and	CCONJ
ajlm-1537	48	23	outcomes	outcome	NOUN
ajlm-1537	48	24	.	.	PUNCT
ajlm-1537	49	1	the	the	DET
ajlm-1537	49	2	severity	severity	NOUN
ajlm-1537	49	3	of	of	ADP
ajlm-1537	49	4	aa	aa	NOUN
ajlm-1537	49	5	was	be	AUX
ajlm-1537	49	6	determined	determine	VERB
ajlm-1537	49	7	based	base	VERB
ajlm-1537	49	8	on	on	ADP
ajlm-1537	49	9	camitta	camitta	PROPN
ajlm-1537	49	10	’s	’s	PART
ajlm-1537	49	11	criteria	criterion	NOUN
ajlm-1537	49	12	(	(	PUNCT
ajlm-1537	49	13	cited	cite	VERB
ajlm-1537	49	14	by	by	ADP
ajlm-1537	49	15	marsh	marsh	PROPN
ajlm-1537	49	16	et	et	PROPN
ajlm-1537	49	17	al.).21	al.).21	PROPN
ajlm-1537	49	18	haematuria	haematuria	PROPN
ajlm-1537	49	19	was	be	AUX
ajlm-1537	49	20	measured	measure	VERB
ajlm-1537	49	21	using	use	VERB
ajlm-1537	49	22	a	a	DET
ajlm-1537	49	23	urine	urine	NOUN
ajlm-1537	49	24	dipstick	dipstick	NOUN
ajlm-1537	49	25	and	and	CCONJ
ajlm-1537	49	26	therefore	therefore	ADV
ajlm-1537	49	27	was	be	AUX
ajlm-1537	49	28	not	not	PART
ajlm-1537	49	29	distinguished	distinguish	VERB
ajlm-1537	49	30	from	from	ADP
ajlm-1537	49	31	haemoglobinuria	haemoglobinuria	PROPN
ajlm-1537	49	32	.	.	PUNCT
ajlm-1537	50	1	immunosuppressive	immunosuppressive	ADJ
ajlm-1537	50	2	therapy	therapy	NOUN
ajlm-1537	50	3	was	be	AUX
ajlm-1537	50	4	administered	administer	VERB
ajlm-1537	50	5	in	in	ADP
ajlm-1537	50	6	the	the	DET
ajlm-1537	50	7	form	form	NOUN
ajlm-1537	50	8	of	of	ADP
ajlm-1537	50	9	rabbit	rabbit	NOUN
ajlm-1537	50	10	or	or	CCONJ
ajlm-1537	50	11	horse	horse	NOUN
ajlm-1537	50	12	atg	atg	NOUN
ajlm-1537	50	13	,	,	PUNCT
ajlm-1537	50	14	where	where	SCONJ
ajlm-1537	50	15	appropriate	appropriate	ADJ
ajlm-1537	50	16	.	.	PUNCT
ajlm-1537	51	1	all	all	DET
ajlm-1537	51	2	patients	patient	NOUN
ajlm-1537	51	3	received	receive	VERB
ajlm-1537	51	4	premedication	premedication	NOUN
ajlm-1537	51	5	with	with	ADP
ajlm-1537	51	6	antihistamines	antihistamine	NOUN
ajlm-1537	51	7	and	and	CCONJ
ajlm-1537	51	8	antipyretics	antipyretic	NOUN
ajlm-1537	51	9	prior	prior	ADV
ajlm-1537	51	10	to	to	ADP
ajlm-1537	51	11	the	the	DET
ajlm-1537	51	12	daily	daily	ADJ
ajlm-1537	51	13	infusion	infusion	NOUN
ajlm-1537	51	14	,	,	PUNCT
ajlm-1537	51	15	as	as	ADV
ajlm-1537	51	16	well	well	ADV
ajlm-1537	51	17	as	as	ADP
ajlm-1537	51	18	intravenous	intravenous	ADJ
ajlm-1537	51	19	methylprednisone	methylprednisone	NOUN
ajlm-1537	51	20	daily	daily	ADV
ajlm-1537	51	21	during	during	ADP
ajlm-1537	51	22	the	the	DET
ajlm-1537	51	23	administration	administration	NOUN
ajlm-1537	51	24	of	of	ADP
ajlm-1537	51	25	the	the	DET
ajlm-1537	51	26	drug	drug	NOUN
ajlm-1537	51	27	course	course	NOUN
ajlm-1537	51	28	,	,	PUNCT
ajlm-1537	51	29	followed	follow	VERB
ajlm-1537	51	30	by	by	ADP
ajlm-1537	51	31	a	a	DET
ajlm-1537	51	32	course	course	NOUN
ajlm-1537	51	33	of	of	ADP
ajlm-1537	51	34	oral	oral	ADJ
ajlm-1537	51	35	prednisone	prednisone	NOUN
ajlm-1537	51	36	and	and	CCONJ
ajlm-1537	51	37	cyclosporin	cyclosporin	NOUN
ajlm-1537	51	38	.	.	PUNCT
ajlm-1537	52	1	response	response	NOUN
ajlm-1537	52	2	to	to	PART
ajlm-1537	52	3	ist	ist	VERB
ajlm-1537	52	4	was	be	AUX
ajlm-1537	52	5	monitored	monitor	VERB
ajlm-1537	52	6	at	at	ADP
ajlm-1537	52	7	6	6	NUM
ajlm-1537	52	8	months	month	NOUN
ajlm-1537	52	9	and	and	CCONJ
ajlm-1537	52	10	1	1	NUM
ajlm-1537	52	11	-	-	PUNCT
ajlm-1537	52	12	year	year	NOUN
ajlm-1537	52	13	post	post	NOUN
ajlm-1537	52	14	-	-	NOUN
ajlm-1537	52	15	administration	administration	NOUN
ajlm-1537	52	16	.	.	PUNCT
ajlm-1537	53	1	a	a	DET
ajlm-1537	53	2	response	response	NOUN
ajlm-1537	53	3	was	be	AUX
ajlm-1537	53	4	deemed	deem	VERB
ajlm-1537	53	5	complete	complete	ADJ
ajlm-1537	53	6	if	if	SCONJ
ajlm-1537	53	7	full	full	ADJ
ajlm-1537	53	8	blood	blood	NOUN
ajlm-1537	53	9	count	count	NOUN
ajlm-1537	53	10	parameters	parameter	NOUN
ajlm-1537	53	11	normalised	normalise	VERB
ajlm-1537	53	12	(	(	PUNCT
ajlm-1537	53	13	absolute	absolute	ADJ
ajlm-1537	53	14	neutrophil	neutrophil	ADJ
ajlm-1537	53	15	count	count	NOUN
ajlm-1537	54	1	[	[	X
ajlm-1537	54	2	anc	anc	X
ajlm-1537	54	3	]	]	X
ajlm-1537	54	4	≥	≥	NUM
ajlm-1537	54	5	1.5	1.5	NUM
ajlm-1537	54	6	×	×	NOUN
ajlm-1537	54	7	109	109	NUM
ajlm-1537	54	8	/	/	SYM
ajlm-1537	54	9	l	l	NOUN
ajlm-1537	54	10	,	,	PUNCT
ajlm-1537	54	11	haemoglobin	haemoglobin	PROPN
ajlm-1537	54	12	≥	≥	NUM
ajlm-1537	54	13	11	11	NUM
ajlm-1537	54	14	g	g	PROPN
ajlm-1537	54	15	/	/	SYM
ajlm-1537	54	16	dl	dl	PROPN
ajlm-1537	54	17	,	,	PUNCT
ajlm-1537	54	18	and	and	CCONJ
ajlm-1537	54	19	platelet	platelet	NOUN
ajlm-1537	54	20	count	count	NOUN
ajlm-1537	54	21	≥	≥	NUM
ajlm-1537	54	22	100	100	NUM
ajlm-1537	54	23	×	×	NOUN
ajlm-1537	54	24	109	109	NUM
ajlm-1537	54	25	/	/	SYM
ajlm-1537	54	26	l	l	NOUN
ajlm-1537	54	27	)	)	PUNCT
ajlm-1537	54	28	,	,	PUNCT
ajlm-1537	54	29	partial	partial	ADJ
ajlm-1537	54	30	if	if	SCONJ
ajlm-1537	54	31	there	there	PRON
ajlm-1537	54	32	was	be	VERB
ajlm-1537	54	33	transfusion	transfusion	NOUN
ajlm-1537	54	34	independence	independence	NOUN
ajlm-1537	54	35	in	in	ADP
ajlm-1537	54	36	the	the	DET
ajlm-1537	54	37	presence	presence	NOUN
ajlm-1537	54	38	of	of	ADP
ajlm-1537	54	39	cytopenias	cytopenia	NOUN
ajlm-1537	54	40	,	,	PUNCT
ajlm-1537	54	41	and	and	CCONJ
ajlm-1537	54	42	none	none	NOUN
ajlm-1537	54	43	if	if	SCONJ
ajlm-1537	54	44	there	there	PRON
ajlm-1537	54	45	was	be	VERB
ajlm-1537	54	46	continued	continue	VERB
ajlm-1537	54	47	transfusion	transfusion	NOUN
ajlm-1537	54	48	dependence.22	dependence.22	PROPN
ajlm-1537	54	49	laboratory	laboratory	NOUN
ajlm-1537	54	50	analysis	analysis	NOUN
ajlm-1537	54	51	flow	flow	NOUN
ajlm-1537	54	52	cytometry	cytometry	NOUN
ajlm-1537	54	53	(	(	PUNCT
ajlm-1537	54	54	facscanto	facscanto	PROPN
ajlm-1537	54	55	ii	ii	PROPN
ajlm-1537	54	56	,	,	PUNCT
ajlm-1537	54	57	becton	becton	PROPN
ajlm-1537	54	58	dickinson	dickinson	PROPN
ajlm-1537	54	59	,	,	PUNCT
ajlm-1537	54	60	san	san	PROPN
ajlm-1537	54	61	jose	jose	PROPN
ajlm-1537	54	62	,	,	PUNCT
ajlm-1537	54	63	california	california	PROPN
ajlm-1537	54	64	,	,	PUNCT
ajlm-1537	54	65	united	united	PROPN
ajlm-1537	54	66	states	states	PROPN
ajlm-1537	54	67	)	)	PUNCT
ajlm-1537	54	68	was	be	AUX
ajlm-1537	54	69	performed	perform	VERB
ajlm-1537	54	70	to	to	PART
ajlm-1537	54	71	detect	detect	VERB
ajlm-1537	54	72	pnh	pnh	PROPN
ajlm-1537	54	73	clones	clone	NOUN
ajlm-1537	54	74	using	use	VERB
ajlm-1537	54	75	non	non	ADJ
ajlm-1537	54	76	-	-	ADJ
ajlm-1537	54	77	gpi	gpi	ADJ
ajlm-1537	54	78	-	-	PUNCT
ajlm-1537	54	79	linked	link	VERB
ajlm-1537	54	80	markers	marker	NOUN
ajlm-1537	54	81	(	(	PUNCT
ajlm-1537	54	82	cd15	cd15	PROPN
ajlm-1537	54	83	and	and	CCONJ
ajlm-1537	54	84	cd33	cd33	PROPN
ajlm-1537	54	85	)	)	PUNCT
ajlm-1537	54	86	to	to	PART
ajlm-1537	54	87	identify	identify	VERB
ajlm-1537	54	88	the	the	DET
ajlm-1537	54	89	monocytes	monocyte	NOUN
ajlm-1537	54	90	and	and	CCONJ
ajlm-1537	54	91	neutrophils	neutrophil	NOUN
ajlm-1537	54	92	,	,	PUNCT
ajlm-1537	54	93	and	and	CCONJ
ajlm-1537	54	94	gpi	gpi	PROPN
ajlm-1537	54	95	-	-	PUNCT
ajlm-1537	54	96	linked	link	VERB
ajlm-1537	54	97	markers	marker	NOUN
ajlm-1537	54	98	(	(	PUNCT
ajlm-1537	54	99	fluorescent	fluorescent	ADJ
ajlm-1537	54	100	aerolysin	aerolysin	NOUN
ajlm-1537	54	101	,	,	PUNCT
ajlm-1537	54	102	cd24	cd24	PROPN
ajlm-1537	54	103	,	,	PUNCT
ajlm-1537	54	104	cd66b	cd66b	VERB
ajlm-1537	54	105	and	and	CCONJ
ajlm-1537	54	106	cd14	cd14	PROPN
ajlm-1537	54	107	)	)	PUNCT
ajlm-1537	54	108	to	to	PART
ajlm-1537	54	109	detect	detect	VERB
ajlm-1537	54	110	the	the	DET
ajlm-1537	54	111	loss	loss	NOUN
ajlm-1537	54	112	of	of	ADP
ajlm-1537	54	113	gpi	gpi	PROPN
ajlm-1537	54	114	anchors	anchor	NOUN
ajlm-1537	54	115	in	in	ADP
ajlm-1537	54	116	a	a	DET
ajlm-1537	54	117	sequential	sequential	ADJ
ajlm-1537	54	118	gating	gate	VERB
ajlm-1537	54	119	strategy	strategy	NOUN
ajlm-1537	54	120	(	(	PUNCT
ajlm-1537	54	121	figure	figure	NOUN
ajlm-1537	54	122	1	1	NUM
ajlm-1537	54	123	)	)	PUNCT
ajlm-1537	54	124	.	.	PUNCT
ajlm-1537	55	1	after	after	ADP
ajlm-1537	55	2	performing	perform	VERB
ajlm-1537	55	3	doublet	doublet	ADJ
ajlm-1537	55	4	discrimination	discrimination	NOUN
ajlm-1537	55	5	using	use	VERB
ajlm-1537	55	6	forward	forward	ADV
ajlm-1537	55	7	scatter	scatter	NOUN
ajlm-1537	55	8	-	-	PUNCT
ajlm-1537	55	9	area	area	NOUN
ajlm-1537	55	10	vs	vs	ADP
ajlm-1537	55	11	forward	forward	ADJ
ajlm-1537	55	12	scatter	scatter	NOUN
ajlm-1537	55	13	-	-	PUNCT
ajlm-1537	55	14	height	height	NOUN
ajlm-1537	55	15	and	and	CCONJ
ajlm-1537	55	16	removing	remove	VERB
ajlm-1537	55	17	debris	debris	NOUN
ajlm-1537	55	18	,	,	PUNCT
ajlm-1537	55	19	all	all	DET
ajlm-1537	55	20	white	white	ADJ
ajlm-1537	55	21	blood	blood	NOUN
ajlm-1537	55	22	cells	cell	NOUN
ajlm-1537	55	23	were	be	AUX
ajlm-1537	55	24	gated	gate	VERB
ajlm-1537	55	25	using	use	VERB
ajlm-1537	55	26	cd45	cd45	PROPN
ajlm-1537	55	27	.	.	PUNCT
ajlm-1537	56	1	neutrophils	neutrophil	NOUN
ajlm-1537	56	2	were	be	AUX
ajlm-1537	56	3	then	then	ADV
ajlm-1537	56	4	discriminated	discriminate	VERB
ajlm-1537	56	5	by	by	ADP
ajlm-1537	56	6	gating	gate	VERB
ajlm-1537	56	7	on	on	ADP
ajlm-1537	56	8	cd15	cd15	PROPN
ajlm-1537	56	9	-	-	PUNCT
ajlm-1537	56	10	positive	positive	ADJ
ajlm-1537	56	11	,	,	PUNCT
ajlm-1537	56	12	cd33	cd33	NOUN
ajlm-1537	56	13	-	-	PUNCT
ajlm-1537	56	14	dim	dim	ADJ
ajlm-1537	56	15	and	and	CCONJ
ajlm-1537	56	16	high	high	ADJ
ajlm-1537	56	17	-	-	PUNCT
ajlm-1537	56	18	side	side	NOUN
ajlm-1537	56	19	scatter	scatter	NOUN
ajlm-1537	56	20	white	white	ADJ
ajlm-1537	56	21	blood	blood	NOUN
ajlm-1537	56	22	cells	cell	NOUN
ajlm-1537	56	23	.	.	PUNCT
ajlm-1537	57	1	monocytes	monocyte	NOUN
ajlm-1537	57	2	were	be	AUX
ajlm-1537	57	3	discriminated	discriminate	VERB
ajlm-1537	57	4	by	by	ADP
ajlm-1537	57	5	gating	gate	VERB
ajlm-1537	57	6	on	on	ADP
ajlm-1537	57	7	cd33	cd33	PROPN
ajlm-1537	57	8	-	-	PUNCT
ajlm-1537	57	9	bright	bright	ADJ
ajlm-1537	57	10	,	,	PUNCT
ajlm-1537	57	11	cd15	cd15	PROPN
ajlm-1537	57	12	-	-	PUNCT
ajlm-1537	57	13	negative	negative	ADJ
ajlm-1537	57	14	and	and	CCONJ
ajlm-1537	57	15	low	low	ADJ
ajlm-1537	57	16	-	-	PUNCT
ajlm-1537	57	17	side	side	NOUN
ajlm-1537	57	18	scatter	scatter	NOUN
ajlm-1537	57	19	white	white	ADJ
ajlm-1537	57	20	blood	blood	NOUN
ajlm-1537	57	21	cells	cell	NOUN
ajlm-1537	57	22	.	.	PUNCT
ajlm-1537	58	1	neutrophil	neutrophil	PROPN
ajlm-1537	58	2	pnh	pnh	PROPN
ajlm-1537	58	3	clones	clone	NOUN
ajlm-1537	58	4	were	be	AUX
ajlm-1537	58	5	defined	define	VERB
ajlm-1537	58	6	as	as	ADP
ajlm-1537	58	7	clones	clone	NOUN
ajlm-1537	58	8	negative	negative	ADJ
ajlm-1537	58	9	for	for	ADP
ajlm-1537	58	10	cd24	cd24	PROPN
ajlm-1537	58	11	,	,	PUNCT
ajlm-1537	58	12	cd66b	cd66b	VERB
ajlm-1537	58	13	and	and	CCONJ
ajlm-1537	58	14	fluorescent	fluorescent	ADJ
ajlm-1537	58	15	aerolysin	aerolysin	NOUN
ajlm-1537	58	16	,	,	PUNCT
ajlm-1537	58	17	and	and	CCONJ
ajlm-1537	58	18	monocyte	monocyte	PROPN
ajlm-1537	58	19	pnh	pnh	PROPN
ajlm-1537	58	20	clones	clone	NOUN
ajlm-1537	58	21	were	be	AUX
ajlm-1537	58	22	clones	clone	NOUN
ajlm-1537	58	23	negative	negative	ADJ
ajlm-1537	58	24	for	for	ADP
ajlm-1537	58	25	cd14	cd14	PROPN
ajlm-1537	58	26	and	and	CCONJ
ajlm-1537	58	27	fluorescent	fluorescent	ADJ
ajlm-1537	58	28	aerolysin	aerolysin	PROPN
ajlm-1537	58	29	.	.	PUNCT
ajlm-1537	59	1	figure	figure	VERB
ajlm-1537	59	2	1	1	NUM
ajlm-1537	59	3	:	:	PUNCT
ajlm-1537	59	4	gating	gate	VERB
ajlm-1537	59	5	strategy	strategy	NOUN
ajlm-1537	59	6	for	for	ADP
ajlm-1537	59	7	paroxysmal	paroxysmal	ADJ
ajlm-1537	59	8	nocturnal	nocturnal	ADJ
ajlm-1537	59	9	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	59	10	clones	clone	NOUN
ajlm-1537	59	11	,	,	PUNCT
ajlm-1537	59	12	south	south	PROPN
ajlm-1537	59	13	africa	africa	PROPN
ajlm-1537	59	14	,	,	PUNCT
ajlm-1537	59	15	september	september	PROPN
ajlm-1537	59	16	2013	2013	NUM
ajlm-1537	59	17	–	–	PUNCT
ajlm-1537	59	18	january	january	PROPN
ajlm-1537	59	19	2018	2018	NUM
ajlm-1537	59	20	.	.	PUNCT
ajlm-1537	60	1	(	(	PUNCT
ajlm-1537	60	2	a	a	X
ajlm-1537	60	3	)	)	PUNCT
ajlm-1537	60	4	all	all	DET
ajlm-1537	60	5	white	white	ADJ
ajlm-1537	60	6	blood	blood	NOUN
ajlm-1537	60	7	cells	cell	NOUN
ajlm-1537	60	8	gated	gate	VERB
ajlm-1537	60	9	using	use	VERB
ajlm-1537	60	10	cd45	cd45	PROPN
ajlm-1537	60	11	;	;	PUNCT
ajlm-1537	60	12	(	(	PUNCT
ajlm-1537	60	13	b	b	X
ajlm-1537	60	14	)	)	PUNCT
ajlm-1537	60	15	gated	gate	VERB
ajlm-1537	60	16	neutrophils	neutrophil	NOUN
ajlm-1537	60	17	;	;	PUNCT
ajlm-1537	60	18	(	(	PUNCT
ajlm-1537	60	19	c	c	X
ajlm-1537	60	20	)	)	PUNCT
ajlm-1537	60	21	gated	gate	VERB
ajlm-1537	60	22	monocytes	monocyte	NOUN
ajlm-1537	60	23	;	;	PUNCT
ajlm-1537	60	24	(	(	PUNCT
ajlm-1537	60	25	d	d	X
ajlm-1537	60	26	,	,	PUNCT
ajlm-1537	60	27	e	e	NOUN
ajlm-1537	60	28	,	,	PUNCT
ajlm-1537	60	29	f	f	X
ajlm-1537	60	30	)	)	PUNCT
ajlm-1537	60	31	the	the	DET
ajlm-1537	60	32	dual	dual	ADJ
ajlm-1537	60	33	-	-	PUNCT
ajlm-1537	60	34	negative	negative	ADJ
ajlm-1537	60	35	granulocytes	granulocyte	NOUN
ajlm-1537	60	36	;	;	PUNCT
ajlm-1537	60	37	(	(	PUNCT
ajlm-1537	60	38	g	g	NOUN
ajlm-1537	60	39	,	,	PUNCT
ajlm-1537	60	40	h	h	NOUN
ajlm-1537	60	41	)	)	PUNCT
ajlm-1537	60	42	dual	dual	ADJ
ajlm-1537	60	43	-	-	PUNCT
ajlm-1537	60	44	negative	negative	ADJ
ajlm-1537	60	45	monocytes	monocyte	NOUN
ajlm-1537	60	46	.	.	PUNCT
ajlm-1537	61	1	a	a	DET
ajlm-1537	61	2	loss	loss	NOUN
ajlm-1537	61	3	of	of	ADP
ajlm-1537	61	4	two	two	NUM
ajlm-1537	61	5	gpi	gpi	NOUN
ajlm-1537	61	6	-	-	PUNCT
ajlm-1537	61	7	linked	link	VERB
ajlm-1537	61	8	markers	marker	NOUN
ajlm-1537	61	9	on	on	ADP
ajlm-1537	61	10	both	both	CCONJ
ajlm-1537	61	11	the	the	DET
ajlm-1537	61	12	monocyte	monocyte	NOUN
ajlm-1537	61	13	and	and	CCONJ
ajlm-1537	61	14	neutrophil	neutrophil	ADJ
ajlm-1537	61	15	lineage	lineage	NOUN
ajlm-1537	61	16	was	be	AUX
ajlm-1537	61	17	required	require	VERB
ajlm-1537	61	18	to	to	PART
ajlm-1537	61	19	detect	detect	VERB
ajlm-1537	61	20	a	a	DET
ajlm-1537	61	21	clone	clone	NOUN
ajlm-1537	61	22	.	.	PUNCT
ajlm-1537	62	1	all	all	DET
ajlm-1537	62	2	clone	clone	NOUN
ajlm-1537	62	3	sizes	size	NOUN
ajlm-1537	62	4	were	be	AUX
ajlm-1537	62	5	included	include	VERB
ajlm-1537	62	6	as	as	ADP
ajlm-1537	62	7	per	per	ADP
ajlm-1537	62	8	the	the	DET
ajlm-1537	62	9	latest	late	ADJ
ajlm-1537	62	10	guidelines	guideline	NOUN
ajlm-1537	62	11	of	of	ADP
ajlm-1537	62	12	the	the	DET
ajlm-1537	62	13	international	international	ADJ
ajlm-1537	62	14	clinical	clinical	ADJ
ajlm-1537	62	15	cytometry	cytometry	PROPN
ajlm-1537	62	16	society	society	NOUN
ajlm-1537	62	17	/	/	SYM
ajlm-1537	62	18	european	european	ADJ
ajlm-1537	62	19	society	society	NOUN
ajlm-1537	62	20	for	for	ADP
ajlm-1537	62	21	clinical	clinical	ADJ
ajlm-1537	62	22	cell	cell	NOUN
ajlm-1537	62	23	analysis,23	analysis,23	NOUN
ajlm-1537	62	24	which	which	PRON
ajlm-1537	62	25	classify	classify	VERB
ajlm-1537	62	26	clones	clone	NOUN
ajlm-1537	62	27	as	as	ADP
ajlm-1537	62	28	“	"	PUNCT
ajlm-1537	62	29	pnh	pnh	PROPN
ajlm-1537	62	30	clone	clone	NOUN
ajlm-1537	62	31	”	"	PUNCT
ajlm-1537	62	32	for	for	ADP
ajlm-1537	62	33	pnh	pnh	PROPN
ajlm-1537	62	34	populations	population	NOUN
ajlm-1537	62	35	>	>	X
ajlm-1537	62	36	1.0	1.0	NUM
ajlm-1537	62	37	%	%	NOUN
ajlm-1537	62	38	,	,	PUNCT
ajlm-1537	62	39	“	"	PUNCT
ajlm-1537	62	40	minor	minor	ADJ
ajlm-1537	62	41	population	population	NOUN
ajlm-1537	62	42	of	of	ADP
ajlm-1537	62	43	pnh	pnh	PROPN
ajlm-1537	62	44	cells	cells	PROPN
ajlm-1537	62	45	”	"	PUNCT
ajlm-1537	62	46	or	or	CCONJ
ajlm-1537	62	47	“	"	PUNCT
ajlm-1537	62	48	minor	minor	ADJ
ajlm-1537	62	49	pnh	pnh	PROPN
ajlm-1537	62	50	clone	clone	NOUN
ajlm-1537	62	51	”	"	PUNCT
ajlm-1537	62	52	for	for	ADP
ajlm-1537	62	53	pnh	pnh	PROPN
ajlm-1537	62	54	populations	population	NOUN
ajlm-1537	62	55	between	between	ADP
ajlm-1537	62	56	0.1	0.1	NUM
ajlm-1537	62	57	%	%	NOUN
ajlm-1537	62	58	and	and	CCONJ
ajlm-1537	62	59	1.0	1.0	NUM
ajlm-1537	62	60	%	%	NOUN
ajlm-1537	62	61	,	,	PUNCT
ajlm-1537	62	62	and	and	CCONJ
ajlm-1537	62	63	“	"	PUNCT
ajlm-1537	62	64	rare	rare	ADJ
ajlm-1537	62	65	cells	cell	NOUN
ajlm-1537	62	66	with	with	ADP
ajlm-1537	62	67	gpi	gpi	NOUN
ajlm-1537	62	68	deficiency	deficiency	NOUN
ajlm-1537	62	69	”	"	PUNCT
ajlm-1537	62	70	or	or	CCONJ
ajlm-1537	62	71	“	"	PUNCT
ajlm-1537	62	72	rare	rare	ADJ
ajlm-1537	62	73	cells	cell	NOUN
ajlm-1537	62	74	with	with	ADP
ajlm-1537	62	75	pnh	pnh	PROPN
ajlm-1537	62	76	phenotype	phenotype	NOUN
ajlm-1537	62	77	”	"	PUNCT
ajlm-1537	62	78	for	for	ADP
ajlm-1537	62	79	pnh	pnh	PROPN
ajlm-1537	62	80	populations	population	NOUN
ajlm-1537	62	81	<	<	X
ajlm-1537	62	82	0.1	0.1	NUM
ajlm-1537	62	83	%	%	NOUN
ajlm-1537	62	84	.	.	PUNCT
ajlm-1537	63	1	for	for	ADP
ajlm-1537	63	2	uniformity	uniformity	NOUN
ajlm-1537	63	3	,	,	PUNCT
ajlm-1537	63	4	we	we	PRON
ajlm-1537	63	5	refer	refer	VERB
ajlm-1537	63	6	to	to	ADP
ajlm-1537	63	7	all	all	DET
ajlm-1537	63	8	pnh	pnh	PROPN
ajlm-1537	63	9	populations	population	NOUN
ajlm-1537	63	10	,	,	PUNCT
ajlm-1537	63	11	even	even	ADV
ajlm-1537	63	12	if	if	SCONJ
ajlm-1537	63	13	<	<	X
ajlm-1537	63	14	1.0	1.0	NUM
ajlm-1537	63	15	%	%	NOUN
ajlm-1537	63	16	,	,	PUNCT
ajlm-1537	63	17	as	as	ADP
ajlm-1537	63	18	clones	clone	NOUN
ajlm-1537	63	19	in	in	ADP
ajlm-1537	63	20	this	this	DET
ajlm-1537	63	21	publication	publication	NOUN
ajlm-1537	63	22	.	.	PUNCT
ajlm-1537	64	1	data	datum	NOUN
ajlm-1537	64	2	analysis	analysis	NOUN
ajlm-1537	64	3	statistical	statistical	ADJ
ajlm-1537	64	4	analysis	analysis	NOUN
ajlm-1537	64	5	was	be	AUX
ajlm-1537	64	6	performed	perform	VERB
ajlm-1537	64	7	using	use	VERB
ajlm-1537	64	8	graphpad	graphpad	NOUN
ajlm-1537	64	9	prism	prism	NOUN
ajlm-1537	64	10	version	version	NOUN
ajlm-1537	64	11	8.4.3	8.4.3	NUM
ajlm-1537	64	12	(	(	PUNCT
ajlm-1537	64	13	2020	2020	NUM
ajlm-1537	64	14	,	,	PUNCT
ajlm-1537	64	15	san	san	PROPN
ajlm-1537	64	16	diego	diego	PROPN
ajlm-1537	64	17	,	,	PUNCT
ajlm-1537	64	18	california	california	PROPN
ajlm-1537	64	19	,	,	PUNCT
ajlm-1537	64	20	united	united	PROPN
ajlm-1537	64	21	states	states	PROPN
ajlm-1537	64	22	)	)	PUNCT
ajlm-1537	64	23	.	.	PUNCT
ajlm-1537	65	1	a	a	DET
ajlm-1537	65	2	multiple	multiple	ADJ
ajlm-1537	65	3	t	t	NOUN
ajlm-1537	65	4	-	-	PUNCT
ajlm-1537	65	5	test	test	NOUN
ajlm-1537	65	6	which	which	PRON
ajlm-1537	65	7	was	be	AUX
ajlm-1537	65	8	used	use	VERB
ajlm-1537	65	9	to	to	PART
ajlm-1537	65	10	determine	determine	VERB
ajlm-1537	65	11	the	the	DET
ajlm-1537	65	12	statistical	statistical	ADJ
ajlm-1537	65	13	difference	difference	NOUN
ajlm-1537	65	14	between	between	ADP
ajlm-1537	65	15	numerical	numerical	ADJ
ajlm-1537	65	16	variables	variable	NOUN
ajlm-1537	65	17	using	use	VERB
ajlm-1537	65	18	means	mean	NOUN
ajlm-1537	65	19	(	(	PUNCT
ajlm-1537	65	20	holm	holm	NOUN
ajlm-1537	65	21	-	-	PUNCT
ajlm-1537	65	22	sidak	sidak	NOUN
ajlm-1537	65	23	method	method	NOUN
ajlm-1537	65	24	)	)	PUNCT
ajlm-1537	65	25	and	and	CCONJ
ajlm-1537	65	26	a	a	DET
ajlm-1537	65	27	chi	chi	ADJ
ajlm-1537	65	28	-	-	PUNCT
ajlm-1537	65	29	square	square	ADJ
ajlm-1537	65	30	test	test	NOUN
ajlm-1537	65	31	or	or	CCONJ
ajlm-1537	65	32	fisher	fisher	PROPN
ajlm-1537	65	33	’s	’s	PART
ajlm-1537	65	34	exact	exact	ADJ
ajlm-1537	65	35	test	test	NOUN
ajlm-1537	65	36	which	which	PRON
ajlm-1537	65	37	was	be	AUX
ajlm-1537	65	38	used	use	VERB
ajlm-1537	65	39	for	for	ADP
ajlm-1537	65	40	categorical	categorical	ADJ
ajlm-1537	65	41	variables	variable	NOUN
ajlm-1537	65	42	.	.	PUNCT
ajlm-1537	66	1	a	a	DET
ajlm-1537	66	2	p	p	X
ajlm-1537	66	3	<	<	X
ajlm-1537	66	4	0.05	0.05	NUM
ajlm-1537	66	5	was	be	AUX
ajlm-1537	66	6	considered	consider	VERB
ajlm-1537	66	7	statistically	statistically	ADV
ajlm-1537	66	8	significant	significant	ADJ
ajlm-1537	66	9	.	.	PUNCT
ajlm-1537	67	1	results	result	VERB
ajlm-1537	67	2	twenty	twenty	NUM
ajlm-1537	67	3	-	-	PUNCT
ajlm-1537	67	4	nine	nine	NUM
ajlm-1537	67	5	patients	patient	NOUN
ajlm-1537	67	6	were	be	AUX
ajlm-1537	67	7	diagnosed	diagnose	VERB
ajlm-1537	67	8	with	with	ADP
ajlm-1537	67	9	aa	aa	NOUN
ajlm-1537	67	10	during	during	ADP
ajlm-1537	67	11	the	the	DET
ajlm-1537	67	12	study	study	NOUN
ajlm-1537	67	13	period	period	NOUN
ajlm-1537	67	14	,	,	PUNCT
ajlm-1537	67	15	ten	ten	NUM
ajlm-1537	67	16	of	of	ADP
ajlm-1537	67	17	whom	whom	PRON
ajlm-1537	67	18	had	have	VERB
ajlm-1537	67	19	fanconi	fanconi	PROPN
ajlm-1537	67	20	anaemia	anaemia	PROPN
ajlm-1537	67	21	and	and	CCONJ
ajlm-1537	67	22	were	be	AUX
ajlm-1537	67	23	subsequently	subsequently	ADV
ajlm-1537	67	24	excluded	exclude	VERB
ajlm-1537	67	25	(	(	PUNCT
ajlm-1537	67	26	figure	figure	NOUN
ajlm-1537	67	27	2	2	NUM
ajlm-1537	67	28	)	)	PUNCT
ajlm-1537	67	29	.	.	PUNCT
ajlm-1537	68	1	of	of	ADP
ajlm-1537	68	2	the	the	DET
ajlm-1537	68	3	remaining	remain	VERB
ajlm-1537	68	4	19	19	NUM
ajlm-1537	68	5	patients	patient	NOUN
ajlm-1537	68	6	,	,	PUNCT
ajlm-1537	68	7	only	only	ADV
ajlm-1537	68	8	one	one	NUM
ajlm-1537	68	9	patient	patient	NOUN
ajlm-1537	68	10	did	do	AUX
ajlm-1537	68	11	not	not	PART
ajlm-1537	68	12	have	have	VERB
ajlm-1537	68	13	pnh	pnh	NOUN
ajlm-1537	68	14	testing	testing	NOUN
ajlm-1537	68	15	performed	perform	VERB
ajlm-1537	68	16	.	.	PUNCT
ajlm-1537	69	1	eighteen	eighteen	NUM
ajlm-1537	69	2	patients	patient	NOUN
ajlm-1537	69	3	were	be	AUX
ajlm-1537	69	4	thus	thus	ADV
ajlm-1537	69	5	included	include	VERB
ajlm-1537	69	6	.	.	PUNCT
ajlm-1537	70	1	ten	ten	NUM
ajlm-1537	70	2	patients	patient	NOUN
ajlm-1537	70	3	had	have	VERB
ajlm-1537	70	4	a	a	DET
ajlm-1537	70	5	pnh	pnh	PROPN
ajlm-1537	70	6	clone	clone	NOUN
ajlm-1537	70	7	(	(	PUNCT
ajlm-1537	70	8	10/18	10/18	NUM
ajlm-1537	70	9	;	;	PUNCT
ajlm-1537	70	10	55.6	55.6	NUM
ajlm-1537	70	11	%	%	NOUN
ajlm-1537	70	12	)	)	PUNCT
ajlm-1537	70	13	;	;	PUNCT
ajlm-1537	70	14	six	six	NUM
ajlm-1537	70	15	of	of	ADP
ajlm-1537	70	16	which	which	PRON
ajlm-1537	70	17	were	be	AUX
ajlm-1537	70	18	classified	classify	VERB
ajlm-1537	70	19	as	as	ADP
ajlm-1537	70	20	having	have	VERB
ajlm-1537	70	21	a	a	DET
ajlm-1537	70	22	“	"	PUNCT
ajlm-1537	70	23	pnh	pnh	NOUN
ajlm-1537	70	24	clone	clone	NOUN
ajlm-1537	70	25	”	"	PUNCT
ajlm-1537	70	26	and	and	CCONJ
ajlm-1537	70	27	four	four	NUM
ajlm-1537	70	28	as	as	ADP
ajlm-1537	70	29	having	have	VERB
ajlm-1537	70	30	a	a	DET
ajlm-1537	70	31	“	"	PUNCT
ajlm-1537	70	32	minor	minor	ADJ
ajlm-1537	70	33	population	population	NOUN
ajlm-1537	70	34	of	of	ADP
ajlm-1537	70	35	pnh	pnh	PROPN
ajlm-1537	70	36	cells	cells	PROPN
ajlm-1537	70	37	”	"	PUNCT
ajlm-1537	70	38	.	.	PUNCT
ajlm-1537	71	1	figure	figure	VERB
ajlm-1537	71	2	2	2	NUM
ajlm-1537	71	3	:	:	PUNCT
ajlm-1537	71	4	study	study	VERB
ajlm-1537	71	5	inclusion	inclusion	NOUN
ajlm-1537	71	6	and	and	CCONJ
ajlm-1537	71	7	exclusion	exclusion	NOUN
ajlm-1537	71	8	criteria	criterion	NOUN
ajlm-1537	71	9	for	for	ADP
ajlm-1537	71	10	patients	patient	NOUN
ajlm-1537	71	11	with	with	ADP
ajlm-1537	71	12	aplastic	aplastic	ADJ
ajlm-1537	71	13	anaemia	anaemia	NOUN
ajlm-1537	71	14	at	at	ADP
ajlm-1537	71	15	the	the	DET
ajlm-1537	71	16	inkosi	inkosi	PROPN
ajlm-1537	71	17	albert	albert	PROPN
ajlm-1537	71	18	luthuli	luthuli	PROPN
ajlm-1537	71	19	central	central	PROPN
ajlm-1537	71	20	hospital	hospital	NOUN
ajlm-1537	71	21	,	,	PUNCT
ajlm-1537	71	22	durban	durban	PROPN
ajlm-1537	71	23	,	,	PUNCT
ajlm-1537	71	24	south	south	PROPN
ajlm-1537	71	25	africa	africa	PROPN
ajlm-1537	71	26	,	,	PUNCT
ajlm-1537	71	27	september	september	PROPN
ajlm-1537	71	28	2013	2013	NUM
ajlm-1537	71	29	–	–	PUNCT
ajlm-1537	71	30	january	january	PROPN
ajlm-1537	71	31	2018	2018	NUM
ajlm-1537	71	32	.	.	PUNCT
ajlm-1537	72	1	patients	patient	NOUN
ajlm-1537	72	2	with	with	ADP
ajlm-1537	72	3	a	a	DET
ajlm-1537	72	4	pnh	pnh	PROPN
ajlm-1537	72	5	clone	clone	NOUN
ajlm-1537	72	6	were	be	AUX
ajlm-1537	72	7	older	old	ADJ
ajlm-1537	72	8	compared	compare	VERB
ajlm-1537	72	9	to	to	ADP
ajlm-1537	72	10	those	those	PRON
ajlm-1537	72	11	without	without	ADP
ajlm-1537	72	12	the	the	DET
ajlm-1537	72	13	clone	clone	NOUN
ajlm-1537	72	14	(	(	PUNCT
ajlm-1537	72	15	median	median	ADJ
ajlm-1537	72	16	age	age	NOUN
ajlm-1537	72	17	:	:	PUNCT
ajlm-1537	72	18	10	10	NUM
ajlm-1537	72	19	years	year	NOUN
ajlm-1537	72	20	vs	vs	ADP
ajlm-1537	72	21	4	4	NUM
ajlm-1537	72	22	years	year	NOUN
ajlm-1537	72	23	;	;	PUNCT
ajlm-1537	72	24	p	p	NOUN
ajlm-1537	72	25	=	=	NOUN
ajlm-1537	72	26	0.02	0.02	NUM
ajlm-1537	72	27	)	)	PUNCT
ajlm-1537	72	28	(	(	PUNCT
ajlm-1537	72	29	table	table	NOUN
ajlm-1537	72	30	1	1	NUM
ajlm-1537	72	31	)	)	PUNCT
ajlm-1537	72	32	.	.	PUNCT
ajlm-1537	73	1	female	female	ADJ
ajlm-1537	73	2	patients	patient	NOUN
ajlm-1537	73	3	made	make	VERB
ajlm-1537	73	4	up	up	ADP
ajlm-1537	73	5	the	the	DET
ajlm-1537	73	6	majority	majority	NOUN
ajlm-1537	73	7	of	of	ADP
ajlm-1537	73	8	patients	patient	NOUN
ajlm-1537	73	9	in	in	ADP
ajlm-1537	73	10	both	both	CCONJ
ajlm-1537	73	11	the	the	DET
ajlm-1537	73	12	pnh	pnh	PROPN
ajlm-1537	73	13	-	-	PUNCT
ajlm-1537	73	14	negative	negative	ADJ
ajlm-1537	73	15	group	group	NOUN
ajlm-1537	73	16	(	(	PUNCT
ajlm-1537	73	17	5/8	5/8	NUM
ajlm-1537	73	18	;	;	PUNCT
ajlm-1537	73	19	62.5	62.5	NUM
ajlm-1537	73	20	%	%	NOUN
ajlm-1537	73	21	)	)	PUNCT
ajlm-1537	73	22	and	and	CCONJ
ajlm-1537	73	23	the	the	DET
ajlm-1537	73	24	pnh	pnh	PROPN
ajlm-1537	73	25	-	-	PUNCT
ajlm-1537	73	26	positive	positive	ADJ
ajlm-1537	73	27	group	group	NOUN
ajlm-1537	73	28	(	(	PUNCT
ajlm-1537	73	29	6/10	6/10	NUM
ajlm-1537	73	30	;	;	PUNCT
ajlm-1537	73	31	60.0	60.0	NUM
ajlm-1537	73	32	%	%	NOUN
ajlm-1537	73	33	)	)	PUNCT
ajlm-1537	73	34	.	.	PUNCT
ajlm-1537	74	1	the	the	DET
ajlm-1537	74	2	full	full	ADJ
ajlm-1537	74	3	blood	blood	NOUN
ajlm-1537	74	4	count	count	NOUN
ajlm-1537	74	5	results	result	NOUN
ajlm-1537	74	6	showed	show	VERB
ajlm-1537	74	7	no	no	DET
ajlm-1537	74	8	difference	difference	NOUN
ajlm-1537	74	9	in	in	ADP
ajlm-1537	74	10	haemoglobin	haemoglobin	ADJ
ajlm-1537	74	11	concentration	concentration	NOUN
ajlm-1537	74	12	and	and	CCONJ
ajlm-1537	74	13	platelet	platelet	NOUN
ajlm-1537	74	14	count	count	NOUN
ajlm-1537	74	15	between	between	ADP
ajlm-1537	74	16	the	the	DET
ajlm-1537	74	17	two	two	NUM
ajlm-1537	74	18	groups	group	NOUN
ajlm-1537	74	19	.	.	PUNCT
ajlm-1537	75	1	paroxysmal	paroxysmal	ADJ
ajlm-1537	75	2	nocturnal	nocturnal	ADJ
ajlm-1537	75	3	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	75	4	-	-	PUNCT
ajlm-1537	75	5	positive	positive	ADJ
ajlm-1537	75	6	patients	patient	NOUN
ajlm-1537	75	7	had	have	VERB
ajlm-1537	75	8	a	a	DET
ajlm-1537	75	9	significantly	significantly	ADV
ajlm-1537	75	10	lower	low	ADJ
ajlm-1537	75	11	median	median	ADJ
ajlm-1537	75	12	total	total	ADJ
ajlm-1537	75	13	white	white	ADJ
ajlm-1537	75	14	cell	cell	NOUN
ajlm-1537	75	15	count	count	NOUN
ajlm-1537	75	16	of	of	ADP
ajlm-1537	75	17	1.7	1.7	NUM
ajlm-1537	75	18	×	×	NOUN
ajlm-1537	75	19	109	109	NUM
ajlm-1537	75	20	/	/	SYM
ajlm-1537	75	21	l	l	NOUN
ajlm-1537	75	22	compared	compare	VERB
ajlm-1537	75	23	to	to	ADP
ajlm-1537	75	24	3.2	3.2	NUM
ajlm-1537	75	25	×	×	NOUN
ajlm-1537	75	26	109	109	NUM
ajlm-1537	75	27	/	/	SYM
ajlm-1537	75	28	l	l	NOUN
ajlm-1537	75	29	in	in	ADP
ajlm-1537	75	30	pnh	pnh	PROPN
ajlm-1537	75	31	-	-	PUNCT
ajlm-1537	75	32	negative	negative	ADJ
ajlm-1537	75	33	patients	patient	NOUN
ajlm-1537	75	34	(	(	PUNCT
ajlm-1537	75	35	p	p	X
ajlm-1537	75	36	=	=	NOUN
ajlm-1537	75	37	0.04	0.04	NUM
ajlm-1537	75	38	)	)	PUNCT
ajlm-1537	75	39	.	.	PUNCT
ajlm-1537	76	1	however	however	ADV
ajlm-1537	76	2	,	,	PUNCT
ajlm-1537	76	3	the	the	DET
ajlm-1537	76	4	median	median	ADJ
ajlm-1537	76	5	anc	anc	PROPN
ajlm-1537	76	6	was	be	AUX
ajlm-1537	76	7	similar	similar	ADJ
ajlm-1537	76	8	in	in	ADP
ajlm-1537	76	9	both	both	DET
ajlm-1537	76	10	groups	group	NOUN
ajlm-1537	76	11	:	:	PUNCT
ajlm-1537	76	12	0.26	0.26	NUM
ajlm-1537	76	13	×	×	NOUN
ajlm-1537	76	14	109	109	NUM
ajlm-1537	76	15	/	/	SYM
ajlm-1537	76	16	l	l	NOUN
ajlm-1537	76	17	in	in	ADP
ajlm-1537	76	18	the	the	DET
ajlm-1537	76	19	pnh	pnh	PROPN
ajlm-1537	76	20	-	-	PUNCT
ajlm-1537	76	21	positive	positive	ADJ
ajlm-1537	76	22	group	group	NOUN
ajlm-1537	76	23	and	and	CCONJ
ajlm-1537	76	24	0.32	0.32	NUM
ajlm-1537	76	25	×	×	NOUN
ajlm-1537	76	26	109	109	NUM
ajlm-1537	76	27	/	/	SYM
ajlm-1537	76	28	l	l	NOUN
ajlm-1537	76	29	in	in	ADP
ajlm-1537	76	30	the	the	DET
ajlm-1537	76	31	pnh	pnh	PROPN
ajlm-1537	76	32	-	-	PUNCT
ajlm-1537	76	33	negative	negative	ADJ
ajlm-1537	76	34	group	group	NOUN
ajlm-1537	76	35	.	.	PUNCT
ajlm-1537	77	1	lactate	lactate	NOUN
ajlm-1537	77	2	dehydrogenase	dehydrogenase	NOUN
ajlm-1537	77	3	results	result	NOUN
ajlm-1537	77	4	were	be	AUX
ajlm-1537	77	5	known	know	VERB
ajlm-1537	77	6	in	in	ADP
ajlm-1537	77	7	80	80	NUM
ajlm-1537	77	8	%	%	NOUN
ajlm-1537	77	9	(	(	PUNCT
ajlm-1537	77	10	8/10	8/10	NUM
ajlm-1537	77	11	)	)	PUNCT
ajlm-1537	77	12	of	of	ADP
ajlm-1537	77	13	pnh	pnh	PROPN
ajlm-1537	77	14	-	-	PUNCT
ajlm-1537	77	15	positive	positive	ADJ
ajlm-1537	77	16	and	and	CCONJ
ajlm-1537	77	17	50	50	NUM
ajlm-1537	77	18	%	%	NOUN
ajlm-1537	77	19	(	(	PUNCT
ajlm-1537	77	20	5/10	5/10	NUM
ajlm-1537	77	21	)	)	PUNCT
ajlm-1537	77	22	of	of	ADP
ajlm-1537	77	23	pnh	pnh	PROPN
ajlm-1537	77	24	-	-	PUNCT
ajlm-1537	77	25	negative	negative	ADJ
ajlm-1537	77	26	patients	patient	NOUN
ajlm-1537	77	27	and	and	CCONJ
ajlm-1537	77	28	all	all	DET
ajlm-1537	77	29	results	result	NOUN
ajlm-1537	77	30	were	be	AUX
ajlm-1537	77	31	within	within	ADP
ajlm-1537	77	32	the	the	DET
ajlm-1537	77	33	normal	normal	ADJ
ajlm-1537	77	34	range	range	NOUN
ajlm-1537	77	35	.	.	PUNCT
ajlm-1537	78	1	all	all	DET
ajlm-1537	78	2	patients	patient	NOUN
ajlm-1537	78	3	in	in	ADP
ajlm-1537	78	4	the	the	DET
ajlm-1537	78	5	pnh	pnh	PROPN
ajlm-1537	78	6	-	-	PUNCT
ajlm-1537	78	7	positive	positive	ADJ
ajlm-1537	78	8	and	and	CCONJ
ajlm-1537	78	9	pnh	pnh	ADJ
ajlm-1537	78	10	-	-	PUNCT
ajlm-1537	78	11	negative	negative	ADJ
ajlm-1537	78	12	groups	group	NOUN
ajlm-1537	78	13	had	have	VERB
ajlm-1537	78	14	complete	complete	ADJ
ajlm-1537	78	15	information	information	NOUN
ajlm-1537	78	16	relating	relate	VERB
ajlm-1537	78	17	to	to	ADP
ajlm-1537	78	18	the	the	DET
ajlm-1537	78	19	reticulocyte	reticulocyte	NOUN
ajlm-1537	78	20	production	production	NOUN
ajlm-1537	78	21	index	index	NOUN
ajlm-1537	78	22	,	,	PUNCT
ajlm-1537	78	23	which	which	PRON
ajlm-1537	78	24	was	be	AUX
ajlm-1537	78	25	low	low	ADJ
ajlm-1537	78	26	in	in	ADP
ajlm-1537	78	27	all	all	DET
ajlm-1537	78	28	patients	patient	NOUN
ajlm-1537	78	29	.	.	PUNCT
ajlm-1537	79	1	hypocellularity	hypocellularity	NOUN
ajlm-1537	79	2	was	be	AUX
ajlm-1537	79	3	also	also	ADV
ajlm-1537	79	4	confirmed	confirm	VERB
ajlm-1537	79	5	in	in	ADP
ajlm-1537	79	6	all	all	DET
ajlm-1537	79	7	patients	patient	NOUN
ajlm-1537	79	8	in	in	ADP
ajlm-1537	79	9	both	both	DET
ajlm-1537	79	10	groups	group	NOUN
ajlm-1537	79	11	by	by	ADP
ajlm-1537	79	12	bone	bone	NOUN
ajlm-1537	79	13	marrow	marrow	NOUN
ajlm-1537	79	14	aspiration	aspiration	NOUN
ajlm-1537	79	15	and	and	CCONJ
ajlm-1537	79	16	trephine	trephine	ADJ
ajlm-1537	79	17	biopsy	biopsy	NOUN
ajlm-1537	79	18	.	.	PUNCT
ajlm-1537	80	1	table	table	NOUN
ajlm-1537	80	2	1	1	NUM
ajlm-1537	80	3	:	:	PUNCT
ajlm-1537	80	4	 	 	SPACE
ajlm-1537	80	5	clinical	clinical	ADJ
ajlm-1537	80	6	characteristics	characteristic	NOUN
ajlm-1537	80	7	of	of	ADP
ajlm-1537	80	8	paroxysmal	paroxysmal	ADJ
ajlm-1537	80	9	nocturnal	nocturnal	ADJ
ajlm-1537	80	10	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	80	11	-	-	PUNCT
ajlm-1537	80	12	positive	positive	ADJ
ajlm-1537	80	13	and	and	CCONJ
ajlm-1537	80	14	-negative	-negative	ADJ
ajlm-1537	80	15	patients	patient	NOUN
ajlm-1537	80	16	at	at	ADP
ajlm-1537	80	17	the	the	DET
ajlm-1537	80	18	inkosi	inkosi	PROPN
ajlm-1537	80	19	albert	albert	PROPN
ajlm-1537	80	20	luthuli	luthuli	PROPN
ajlm-1537	80	21	central	central	PROPN
ajlm-1537	80	22	hospital	hospital	NOUN
ajlm-1537	80	23	,	,	PUNCT
ajlm-1537	80	24	durban	durban	PROPN
ajlm-1537	80	25	,	,	PUNCT
ajlm-1537	80	26	south	south	PROPN
ajlm-1537	80	27	africa	africa	PROPN
ajlm-1537	80	28	,	,	PUNCT
ajlm-1537	80	29	september	september	PROPN
ajlm-1537	80	30	2013	2013	NUM
ajlm-1537	80	31	–	–	PUNCT
ajlm-1537	80	32	january	january	PROPN
ajlm-1537	80	33	2018	2018	NUM
ajlm-1537	80	34	.	.	PUNCT
ajlm-1537	81	1	the	the	DET
ajlm-1537	81	2	majority	majority	NOUN
ajlm-1537	81	3	of	of	ADP
ajlm-1537	81	4	patients	patient	NOUN
ajlm-1537	81	5	in	in	ADP
ajlm-1537	81	6	both	both	DET
ajlm-1537	81	7	groups	group	NOUN
ajlm-1537	81	8	presented	present	VERB
ajlm-1537	81	9	with	with	ADP
ajlm-1537	81	10	severe	severe	ADJ
ajlm-1537	81	11	or	or	CCONJ
ajlm-1537	81	12	very	very	ADV
ajlm-1537	81	13	severe	severe	ADJ
ajlm-1537	81	14	aa	aa	NOUN
ajlm-1537	81	15	.	.	PUNCT
ajlm-1537	82	1	two	two	NUM
ajlm-1537	82	2	patients	patient	NOUN
ajlm-1537	82	3	without	without	ADP
ajlm-1537	82	4	the	the	DET
ajlm-1537	82	5	pnh	pnh	PROPN
ajlm-1537	82	6	clone	clone	NOUN
ajlm-1537	82	7	presented	present	VERB
ajlm-1537	82	8	with	with	ADP
ajlm-1537	82	9	haematuria	haematuria	NOUN
ajlm-1537	82	10	,	,	PUNCT
ajlm-1537	82	11	but	but	CCONJ
ajlm-1537	82	12	this	this	PRON
ajlm-1537	82	13	was	be	AUX
ajlm-1537	82	14	not	not	PART
ajlm-1537	82	15	a	a	DET
ajlm-1537	82	16	presenting	present	VERB
ajlm-1537	82	17	feature	feature	NOUN
ajlm-1537	82	18	in	in	ADP
ajlm-1537	82	19	any	any	DET
ajlm-1537	82	20	patients	patient	NOUN
ajlm-1537	82	21	with	with	ADP
ajlm-1537	82	22	the	the	DET
ajlm-1537	82	23	clone	clone	NOUN
ajlm-1537	82	24	.	.	PUNCT
ajlm-1537	83	1	bleeding	bleed	VERB
ajlm-1537	83	2	from	from	ADP
ajlm-1537	83	3	a	a	DET
ajlm-1537	83	4	peripheral	peripheral	ADJ
ajlm-1537	83	5	site	site	NOUN
ajlm-1537	83	6	was	be	AUX
ajlm-1537	83	7	noted	note	VERB
ajlm-1537	83	8	in	in	ADP
ajlm-1537	83	9	70.0	70.0	NUM
ajlm-1537	83	10	%	%	NOUN
ajlm-1537	83	11	of	of	ADP
ajlm-1537	83	12	pnh	pnh	PROPN
ajlm-1537	83	13	-	-	PUNCT
ajlm-1537	83	14	positive	positive	ADJ
ajlm-1537	83	15	and	and	CCONJ
ajlm-1537	83	16	87.5	87.5	NUM
ajlm-1537	83	17	%	%	NOUN
ajlm-1537	83	18	of	of	ADP
ajlm-1537	83	19	pnh	pnh	PROPN
ajlm-1537	83	20	-	-	PUNCT
ajlm-1537	83	21	negative	negative	ADJ
ajlm-1537	83	22	patients	patient	NOUN
ajlm-1537	83	23	,	,	PUNCT
ajlm-1537	83	24	while	while	SCONJ
ajlm-1537	83	25	no	no	DET
ajlm-1537	83	26	patients	patient	NOUN
ajlm-1537	83	27	presented	present	VERB
ajlm-1537	83	28	with	with	ADP
ajlm-1537	83	29	evidence	evidence	NOUN
ajlm-1537	83	30	of	of	ADP
ajlm-1537	83	31	thromboses	thrombose	NOUN
ajlm-1537	83	32	.	.	PUNCT
ajlm-1537	84	1	four	four	NUM
ajlm-1537	84	2	pnh	pnh	ADJ
ajlm-1537	84	3	-	-	PUNCT
ajlm-1537	84	4	positive	positive	ADJ
ajlm-1537	84	5	(	(	PUNCT
ajlm-1537	84	6	4/10	4/10	NUM
ajlm-1537	84	7	;	;	PUNCT
ajlm-1537	84	8	40.0	40.0	NUM
ajlm-1537	84	9	%	%	NOUN
ajlm-1537	84	10	)	)	PUNCT
ajlm-1537	84	11	and	and	CCONJ
ajlm-1537	84	12	four	four	NUM
ajlm-1537	84	13	pnh	pnh	ADJ
ajlm-1537	84	14	-	-	PUNCT
ajlm-1537	84	15	negative	negative	ADJ
ajlm-1537	84	16	patients	patient	NOUN
ajlm-1537	84	17	(	(	PUNCT
ajlm-1537	84	18	4/8	4/8	NUM
ajlm-1537	84	19	;	;	PUNCT
ajlm-1537	84	20	50.0	50.0	NUM
ajlm-1537	84	21	%	%	NOUN
ajlm-1537	84	22	)	)	PUNCT
ajlm-1537	84	23	were	be	AUX
ajlm-1537	84	24	given	give	VERB
ajlm-1537	84	25	ist	ist	NOUN
ajlm-1537	84	26	.	.	PUNCT
ajlm-1537	85	1	fifty	fifty	NUM
ajlm-1537	85	2	percent	percent	NOUN
ajlm-1537	85	3	of	of	ADP
ajlm-1537	85	4	patients	patient	NOUN
ajlm-1537	85	5	with	with	ADP
ajlm-1537	85	6	the	the	DET
ajlm-1537	85	7	pnh	pnh	PROPN
ajlm-1537	85	8	clone	clone	NOUN
ajlm-1537	85	9	died	die	VERB
ajlm-1537	85	10	,	,	PUNCT
ajlm-1537	85	11	compared	compare	VERB
ajlm-1537	85	12	to	to	ADP
ajlm-1537	85	13	37.5	37.5	NUM
ajlm-1537	85	14	%	%	NOUN
ajlm-1537	85	15	among	among	ADP
ajlm-1537	85	16	patients	patient	NOUN
ajlm-1537	85	17	without	without	ADP
ajlm-1537	85	18	the	the	DET
ajlm-1537	85	19	clone	clone	NOUN
ajlm-1537	85	20	.	.	PUNCT
ajlm-1537	86	1	seven	seven	NUM
ajlm-1537	86	2	of	of	ADP
ajlm-1537	86	3	the	the	DET
ajlm-1537	86	4	ten	ten	NUM
ajlm-1537	86	5	(	(	PUNCT
ajlm-1537	86	6	7/10	7/10	NUM
ajlm-1537	86	7	;	;	PUNCT
ajlm-1537	86	8	70.00	70.00	NUM
ajlm-1537	86	9	%	%	NOUN
ajlm-1537	86	10	)	)	PUNCT
ajlm-1537	86	11	pnh	pnh	ADJ
ajlm-1537	86	12	-	-	PUNCT
ajlm-1537	86	13	positive	positive	ADJ
ajlm-1537	86	14	patients	patient	NOUN
ajlm-1537	86	15	presented	present	VERB
ajlm-1537	86	16	with	with	ADP
ajlm-1537	86	17	bleeding	bleed	VERB
ajlm-1537	86	18	(	(	PUNCT
ajlm-1537	86	19	table	table	NOUN
ajlm-1537	86	20	2	2	NUM
ajlm-1537	86	21	)	)	PUNCT
ajlm-1537	86	22	.	.	PUNCT
ajlm-1537	87	1	clone	clone	NOUN
ajlm-1537	87	2	sizes	size	NOUN
ajlm-1537	87	3	in	in	ADP
ajlm-1537	87	4	the	the	DET
ajlm-1537	87	5	granulocyte	granulocyte	ADJ
ajlm-1537	87	6	population	population	NOUN
ajlm-1537	87	7	and	and	CCONJ
ajlm-1537	87	8	monocyte	monocyte	ADJ
ajlm-1537	87	9	population	population	NOUN
ajlm-1537	87	10	in	in	ADP
ajlm-1537	87	11	each	each	DET
ajlm-1537	87	12	patient	patient	NOUN
ajlm-1537	87	13	ranged	range	VERB
ajlm-1537	87	14	between	between	ADP
ajlm-1537	87	15	0.11	0.11	NUM
ajlm-1537	87	16	%	%	NOUN
ajlm-1537	87	17	and	and	CCONJ
ajlm-1537	87	18	24.00	24.00	NUM
ajlm-1537	87	19	%	%	NOUN
ajlm-1537	87	20	.	.	PUNCT
ajlm-1537	88	1	five	five	NUM
ajlm-1537	88	2	of	of	ADP
ajlm-1537	88	3	the	the	DET
ajlm-1537	88	4	total	total	ADJ
ajlm-1537	88	5	pnh	pnh	ADJ
ajlm-1537	88	6	-	-	PUNCT
ajlm-1537	88	7	positive	positive	ADJ
ajlm-1537	88	8	patient	patient	NOUN
ajlm-1537	88	9	cohort	cohort	NOUN
ajlm-1537	88	10	survived	survive	VERB
ajlm-1537	88	11	(	(	PUNCT
ajlm-1537	88	12	5/10	5/10	NUM
ajlm-1537	88	13	;	;	PUNCT
ajlm-1537	88	14	50.00	50.00	NUM
ajlm-1537	88	15	%	%	NOUN
ajlm-1537	88	16	)	)	PUNCT
ajlm-1537	88	17	,	,	PUNCT
ajlm-1537	88	18	four	four	NUM
ajlm-1537	88	19	(	(	PUNCT
ajlm-1537	88	20	40.00	40.00	NUM
ajlm-1537	88	21	%	%	NOUN
ajlm-1537	88	22	)	)	PUNCT
ajlm-1537	88	23	of	of	ADP
ajlm-1537	88	24	whom	whom	PRON
ajlm-1537	88	25	received	receive	VERB
ajlm-1537	88	26	atg	atg	PROPN
ajlm-1537	88	27	.	.	PUNCT
ajlm-1537	89	1	the	the	DET
ajlm-1537	89	2	other	other	ADJ
ajlm-1537	89	3	survivor	survivor	NOUN
ajlm-1537	89	4	went	go	VERB
ajlm-1537	89	5	on	on	ADP
ajlm-1537	89	6	to	to	PART
ajlm-1537	89	7	receive	receive	VERB
ajlm-1537	89	8	an	an	DET
ajlm-1537	89	9	hsct	hsct	NOUN
ajlm-1537	89	10	and	and	CCONJ
ajlm-1537	89	11	is	be	AUX
ajlm-1537	89	12	still	still	ADV
ajlm-1537	89	13	alive	alive	ADJ
ajlm-1537	89	14	.	.	PUNCT
ajlm-1537	90	1	the	the	DET
ajlm-1537	90	2	remaining	remain	VERB
ajlm-1537	90	3	five	five	NUM
ajlm-1537	90	4	pnh	pnh	ADJ
ajlm-1537	90	5	-	-	PUNCT
ajlm-1537	90	6	positive	positive	ADJ
ajlm-1537	90	7	patients	patient	NOUN
ajlm-1537	90	8	(	(	PUNCT
ajlm-1537	90	9	5/10	5/10	NUM
ajlm-1537	90	10	;	;	PUNCT
ajlm-1537	90	11	50.00	50.00	NUM
ajlm-1537	90	12	%	%	NOUN
ajlm-1537	90	13	)	)	PUNCT
ajlm-1537	90	14	died	die	VERB
ajlm-1537	90	15	,	,	PUNCT
ajlm-1537	90	16	two	two	NUM
ajlm-1537	90	17	from	from	ADP
ajlm-1537	90	18	sepsis	sepsis	NOUN
ajlm-1537	90	19	and	and	CCONJ
ajlm-1537	90	20	three	three	NUM
ajlm-1537	90	21	from	from	ADP
ajlm-1537	90	22	bleeding	bleed	VERB
ajlm-1537	90	23	.	.	PUNCT
ajlm-1537	91	1	one	one	NUM
ajlm-1537	91	2	of	of	ADP
ajlm-1537	91	3	these	these	DET
ajlm-1537	91	4	patients	patient	NOUN
ajlm-1537	91	5	died	die	VERB
ajlm-1537	91	6	while	while	SCONJ
ajlm-1537	91	7	awaiting	await	VERB
ajlm-1537	91	8	hla	hla	NOUN
ajlm-1537	91	9	results	result	NOUN
ajlm-1537	91	10	.	.	PUNCT
ajlm-1537	92	1	among	among	ADP
ajlm-1537	92	2	those	those	PRON
ajlm-1537	92	3	who	who	PRON
ajlm-1537	92	4	died	die	VERB
ajlm-1537	92	5	,	,	PUNCT
ajlm-1537	92	6	the	the	DET
ajlm-1537	92	7	pnh	pnh	PROPN
ajlm-1537	92	8	clone	clone	NOUN
ajlm-1537	92	9	sizes	size	NOUN
ajlm-1537	92	10	ranged	range	VERB
ajlm-1537	92	11	from	from	ADP
ajlm-1537	92	12	0.30	0.30	NUM
ajlm-1537	92	13	%	%	NOUN
ajlm-1537	92	14	to	to	ADP
ajlm-1537	92	15	15.00	15.00	NUM
ajlm-1537	92	16	%	%	NOUN
ajlm-1537	92	17	.	.	PUNCT
ajlm-1537	93	1	table	table	NOUN
ajlm-1537	93	2	2	2	NUM
ajlm-1537	93	3	:	:	PUNCT
ajlm-1537	93	4	 	 	SPACE
ajlm-1537	93	5	paroxysmal	paroxysmal	ADJ
ajlm-1537	93	6	nocturnal	nocturnal	ADJ
ajlm-1537	93	7	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	93	8	clone	clone	NOUN
ajlm-1537	93	9	sizes	size	NOUN
ajlm-1537	93	10	and	and	CCONJ
ajlm-1537	93	11	clinical	clinical	ADJ
ajlm-1537	93	12	presentation	presentation	NOUN
ajlm-1537	93	13	and	and	CCONJ
ajlm-1537	93	14	outcome	outcome	NOUN
ajlm-1537	93	15	of	of	ADP
ajlm-1537	93	16	patients	patient	NOUN
ajlm-1537	93	17	with	with	ADP
ajlm-1537	93	18	aplastic	aplastic	ADJ
ajlm-1537	93	19	anaemia	anaemia	NOUN
ajlm-1537	93	20	at	at	ADP
ajlm-1537	93	21	the	the	DET
ajlm-1537	93	22	inkosi	inkosi	PROPN
ajlm-1537	93	23	albert	albert	PROPN
ajlm-1537	93	24	luthuli	luthuli	PROPN
ajlm-1537	93	25	central	central	PROPN
ajlm-1537	93	26	hospital	hospital	NOUN
ajlm-1537	93	27	,	,	PUNCT
ajlm-1537	93	28	durban	durban	PROPN
ajlm-1537	93	29	,	,	PUNCT
ajlm-1537	93	30	south	south	PROPN
ajlm-1537	93	31	africa	africa	PROPN
ajlm-1537	93	32	,	,	PUNCT
ajlm-1537	93	33	september	september	PROPN
ajlm-1537	93	34	2013	2013	NUM
ajlm-1537	93	35	–	–	PUNCT
ajlm-1537	93	36	january	january	PROPN
ajlm-1537	93	37	2018	2018	NUM
ajlm-1537	93	38	.	.	PUNCT
ajlm-1537	94	1	eight	eight	NUM
ajlm-1537	94	2	patients	patient	NOUN
ajlm-1537	94	3	(	(	PUNCT
ajlm-1537	94	4	four	four	NUM
ajlm-1537	94	5	pnh	pnh	PROPN
ajlm-1537	94	6	-	-	PUNCT
ajlm-1537	94	7	positive	positive	ADJ
ajlm-1537	94	8	and	and	CCONJ
ajlm-1537	94	9	four	four	NUM
ajlm-1537	94	10	pnh	pnh	ADJ
ajlm-1537	94	11	-	-	PUNCT
ajlm-1537	94	12	negative	negative	ADJ
ajlm-1537	94	13	patients	patient	NOUN
ajlm-1537	94	14	)	)	PUNCT
ajlm-1537	94	15	in	in	ADP
ajlm-1537	94	16	our	our	PRON
ajlm-1537	94	17	cohort	cohort	NOUN
ajlm-1537	94	18	received	receive	VERB
ajlm-1537	94	19	atg	atg	PROPN
ajlm-1537	94	20	.	.	PUNCT
ajlm-1537	95	1	all	all	DET
ajlm-1537	95	2	patients	patient	NOUN
ajlm-1537	95	3	received	receive	VERB
ajlm-1537	95	4	equine	equine	NOUN
ajlm-1537	95	5	atg	atg	PROPN
ajlm-1537	95	6	,	,	PUNCT
ajlm-1537	95	7	and	and	CCONJ
ajlm-1537	95	8	one	one	NUM
ajlm-1537	95	9	patient	patient	NOUN
ajlm-1537	95	10	subsequently	subsequently	ADV
ajlm-1537	95	11	received	receive	VERB
ajlm-1537	95	12	an	an	DET
ajlm-1537	95	13	additional	additional	ADJ
ajlm-1537	95	14	dose	dose	NOUN
ajlm-1537	95	15	of	of	ADP
ajlm-1537	95	16	rabbit	rabbit	NOUN
ajlm-1537	95	17	atg	atg	PROPN
ajlm-1537	95	18	.	.	PUNCT
ajlm-1537	96	1	one	one	NUM
ajlm-1537	96	2	patient	patient	NOUN
ajlm-1537	96	3	in	in	ADP
ajlm-1537	96	4	the	the	DET
ajlm-1537	96	5	pnh	pnh	PROPN
ajlm-1537	96	6	-	-	PUNCT
ajlm-1537	96	7	negative	negative	ADJ
ajlm-1537	96	8	group	group	NOUN
ajlm-1537	96	9	died	die	VERB
ajlm-1537	96	10	from	from	ADP
ajlm-1537	96	11	sepsis	sepsis	NOUN
ajlm-1537	96	12	a	a	DET
ajlm-1537	96	13	few	few	ADJ
ajlm-1537	96	14	days	day	NOUN
ajlm-1537	96	15	after	after	ADP
ajlm-1537	96	16	infusion	infusion	NOUN
ajlm-1537	96	17	and	and	CCONJ
ajlm-1537	96	18	was	be	AUX
ajlm-1537	96	19	excluded	exclude	VERB
ajlm-1537	96	20	from	from	ADP
ajlm-1537	96	21	further	further	ADJ
ajlm-1537	96	22	analysis	analysis	NOUN
ajlm-1537	96	23	(	(	PUNCT
ajlm-1537	96	24	figure	figure	NOUN
ajlm-1537	96	25	3	3	NUM
ajlm-1537	96	26	)	)	PUNCT
ajlm-1537	96	27	.	.	PUNCT
ajlm-1537	97	1	at	at	ADP
ajlm-1537	97	2	both	both	DET
ajlm-1537	97	3	six	six	NUM
ajlm-1537	97	4	and	and	CCONJ
ajlm-1537	97	5	12	12	NUM
ajlm-1537	97	6	months	month	NOUN
ajlm-1537	97	7	,	,	PUNCT
ajlm-1537	97	8	one	one	NUM
ajlm-1537	97	9	patient	patient	NOUN
ajlm-1537	97	10	in	in	ADP
ajlm-1537	97	11	the	the	DET
ajlm-1537	97	12	pnh	pnh	PROPN
ajlm-1537	97	13	-	-	PUNCT
ajlm-1537	97	14	positive	positive	ADJ
ajlm-1537	97	15	group	group	NOUN
ajlm-1537	97	16	had	have	VERB
ajlm-1537	97	17	a	a	DET
ajlm-1537	97	18	complete	complete	ADJ
ajlm-1537	97	19	response	response	NOUN
ajlm-1537	97	20	and	and	CCONJ
ajlm-1537	97	21	the	the	DET
ajlm-1537	97	22	other	other	ADJ
ajlm-1537	97	23	three	three	NUM
ajlm-1537	97	24	patients	patient	NOUN
ajlm-1537	97	25	had	have	VERB
ajlm-1537	97	26	a	a	DET
ajlm-1537	97	27	partial	partial	ADJ
ajlm-1537	97	28	response	response	NOUN
ajlm-1537	97	29	.	.	PUNCT
ajlm-1537	98	1	in	in	ADP
ajlm-1537	98	2	the	the	DET
ajlm-1537	98	3	pnh	pnh	PROPN
ajlm-1537	98	4	-	-	PUNCT
ajlm-1537	98	5	negative	negative	ADJ
ajlm-1537	98	6	group	group	NOUN
ajlm-1537	98	7	,	,	PUNCT
ajlm-1537	98	8	one	one	NUM
ajlm-1537	98	9	patient	patient	NOUN
ajlm-1537	98	10	had	have	VERB
ajlm-1537	98	11	a	a	DET
ajlm-1537	98	12	partial	partial	ADJ
ajlm-1537	98	13	response	response	NOUN
ajlm-1537	98	14	at	at	ADP
ajlm-1537	98	15	six	six	NUM
ajlm-1537	98	16	months	month	NOUN
ajlm-1537	98	17	while	while	SCONJ
ajlm-1537	98	18	two	two	NUM
ajlm-1537	98	19	did	do	AUX
ajlm-1537	98	20	not	not	PART
ajlm-1537	98	21	respond	respond	VERB
ajlm-1537	98	22	.	.	PUNCT
ajlm-1537	99	1	at	at	ADP
ajlm-1537	99	2	12	12	NUM
ajlm-1537	99	3	months	month	NOUN
ajlm-1537	99	4	,	,	PUNCT
ajlm-1537	99	5	the	the	DET
ajlm-1537	99	6	patient	patient	NOUN
ajlm-1537	99	7	with	with	ADP
ajlm-1537	99	8	a	a	DET
ajlm-1537	99	9	partial	partial	ADJ
ajlm-1537	99	10	response	response	NOUN
ajlm-1537	99	11	still	still	ADV
ajlm-1537	99	12	had	have	VERB
ajlm-1537	99	13	a	a	DET
ajlm-1537	99	14	partial	partial	ADJ
ajlm-1537	99	15	response	response	NOUN
ajlm-1537	99	16	,	,	PUNCT
ajlm-1537	99	17	one	one	NUM
ajlm-1537	99	18	of	of	ADP
ajlm-1537	99	19	the	the	DET
ajlm-1537	99	20	patients	patient	NOUN
ajlm-1537	99	21	with	with	ADP
ajlm-1537	99	22	no	no	DET
ajlm-1537	99	23	response	response	NOUN
ajlm-1537	99	24	had	have	AUX
ajlm-1537	99	25	developed	develop	VERB
ajlm-1537	99	26	a	a	DET
ajlm-1537	99	27	partial	partial	ADJ
ajlm-1537	99	28	response	response	NOUN
ajlm-1537	99	29	,	,	PUNCT
ajlm-1537	99	30	while	while	SCONJ
ajlm-1537	99	31	the	the	DET
ajlm-1537	99	32	other	other	ADJ
ajlm-1537	99	33	patient	patient	NOUN
ajlm-1537	99	34	remained	remain	VERB
ajlm-1537	99	35	non	non	ADJ
ajlm-1537	99	36	-	-	ADJ
ajlm-1537	99	37	responsive	responsive	ADJ
ajlm-1537	99	38	despite	despite	SCONJ
ajlm-1537	99	39	receiving	receive	VERB
ajlm-1537	99	40	a	a	DET
ajlm-1537	99	41	second	second	ADJ
ajlm-1537	99	42	dose	dose	NOUN
ajlm-1537	99	43	of	of	ADP
ajlm-1537	99	44	atg	atg	PROPN
ajlm-1537	99	45	.	.	PUNCT
ajlm-1537	100	1	figure	figure	VERB
ajlm-1537	100	2	3	3	NUM
ajlm-1537	100	3	:	:	PUNCT
ajlm-1537	100	4	response	response	NOUN
ajlm-1537	100	5	to	to	ADP
ajlm-1537	100	6	immunosuppressive	immunosuppressive	ADJ
ajlm-1537	100	7	therapy	therapy	NOUN
ajlm-1537	100	8	among	among	ADP
ajlm-1537	100	9	paroxysmal	paroxysmal	ADJ
ajlm-1537	100	10	nocturnal	nocturnal	ADJ
ajlm-1537	100	11	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	100	12	population	population	NOUN
ajlm-1537	100	13	-	-	PUNCT
ajlm-1537	100	14	positive	positive	ADJ
ajlm-1537	100	15	and	and	CCONJ
ajlm-1537	100	16	paroxysmal	paroxysmal	ADJ
ajlm-1537	100	17	nocturnal	nocturnal	ADJ
ajlm-1537	100	18	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	100	19	population	population	NOUN
ajlm-1537	100	20	-	-	PUNCT
ajlm-1537	100	21	negative	negative	ADJ
ajlm-1537	100	22	patients	patient	NOUN
ajlm-1537	100	23	at	at	ADP
ajlm-1537	100	24	the	the	DET
ajlm-1537	100	25	inkosi	inkosi	PROPN
ajlm-1537	100	26	albert	albert	PROPN
ajlm-1537	100	27	luthuli	luthuli	PROPN
ajlm-1537	100	28	central	central	PROPN
ajlm-1537	100	29	hospital	hospital	NOUN
ajlm-1537	100	30	,	,	PUNCT
ajlm-1537	100	31	durban	durban	PROPN
ajlm-1537	100	32	,	,	PUNCT
ajlm-1537	100	33	south	south	PROPN
ajlm-1537	100	34	africa	africa	PROPN
ajlm-1537	100	35	,	,	PUNCT
ajlm-1537	100	36	september	september	PROPN
ajlm-1537	100	37	2013	2013	NUM
ajlm-1537	100	38	–	–	PUNCT
ajlm-1537	100	39	january	january	PROPN
ajlm-1537	100	40	2018	2018	NUM
ajlm-1537	100	41	.	.	PUNCT
ajlm-1537	101	1	discussion	discussion	NOUN
ajlm-1537	101	2	paroxysmal	paroxysmal	ADJ
ajlm-1537	101	3	nocturnal	nocturnal	ADJ
ajlm-1537	101	4	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	101	5	is	be	AUX
ajlm-1537	101	6	rare	rare	ADJ
ajlm-1537	101	7	in	in	ADP
ajlm-1537	101	8	children	child	NOUN
ajlm-1537	101	9	and	and	CCONJ
ajlm-1537	101	10	does	do	AUX
ajlm-1537	101	11	not	not	PART
ajlm-1537	101	12	present	present	VERB
ajlm-1537	101	13	classically	classically	ADV
ajlm-1537	101	14	.	.	PUNCT
ajlm-1537	102	1	the	the	DET
ajlm-1537	102	2	presentation	presentation	NOUN
ajlm-1537	102	3	is	be	AUX
ajlm-1537	102	4	normally	normally	ADV
ajlm-1537	102	5	bone	bone	NOUN
ajlm-1537	102	6	marrow	marrow	PROPN
ajlm-1537	102	7	failure,12	failure,12	NOUN
ajlm-1537	102	8	which	which	PRON
ajlm-1537	102	9	exists	exist	VERB
ajlm-1537	102	10	as	as	ADP
ajlm-1537	102	11	a	a	DET
ajlm-1537	102	12	continuum	continuum	NOUN
ajlm-1537	102	13	with	with	ADP
ajlm-1537	102	14	pnh.10,24	pnh.10,24	NOUN
ajlm-1537	102	15	in	in	ADP
ajlm-1537	102	16	this	this	DET
ajlm-1537	102	17	study	study	NOUN
ajlm-1537	102	18	we	we	PRON
ajlm-1537	102	19	found	find	VERB
ajlm-1537	102	20	a	a	DET
ajlm-1537	102	21	55.6	55.6	NUM
ajlm-1537	102	22	%	%	NOUN
ajlm-1537	102	23	prevalence	prevalence	NOUN
ajlm-1537	102	24	of	of	ADP
ajlm-1537	102	25	pnh	pnh	PROPN
ajlm-1537	102	26	clones	clone	NOUN
ajlm-1537	102	27	in	in	ADP
ajlm-1537	102	28	those	those	DET
ajlm-1537	102	29	children	child	NOUN
ajlm-1537	102	30	presenting	present	VERB
ajlm-1537	102	31	with	with	ADP
ajlm-1537	102	32	aa	aa	NOUN
ajlm-1537	102	33	.	.	PUNCT
ajlm-1537	103	1	the	the	DET
ajlm-1537	103	2	clone	clone	NOUN
ajlm-1537	103	3	size	size	NOUN
ajlm-1537	103	4	had	have	VERB
ajlm-1537	103	5	no	no	DET
ajlm-1537	103	6	impact	impact	NOUN
ajlm-1537	103	7	on	on	ADP
ajlm-1537	103	8	the	the	DET
ajlm-1537	103	9	severity	severity	NOUN
ajlm-1537	103	10	of	of	ADP
ajlm-1537	103	11	the	the	DET
ajlm-1537	103	12	clinical	clinical	ADJ
ajlm-1537	103	13	presentation	presentation	NOUN
ajlm-1537	103	14	,	,	PUNCT
ajlm-1537	103	15	but	but	CCONJ
ajlm-1537	103	16	patients	patient	NOUN
ajlm-1537	103	17	appeared	appear	VERB
ajlm-1537	103	18	to	to	PART
ajlm-1537	103	19	respond	respond	VERB
ajlm-1537	103	20	well	well	ADV
ajlm-1537	103	21	to	to	PART
ajlm-1537	103	22	ist	ist	VERB
ajlm-1537	103	23	.	.	PUNCT
ajlm-1537	104	1	those	those	PRON
ajlm-1537	104	2	with	with	ADP
ajlm-1537	104	3	a	a	DET
ajlm-1537	104	4	pnh	pnh	PROPN
ajlm-1537	104	5	clone	clone	NOUN
ajlm-1537	104	6	were	be	AUX
ajlm-1537	104	7	also	also	ADV
ajlm-1537	104	8	older	old	ADJ
ajlm-1537	104	9	than	than	ADP
ajlm-1537	104	10	their	their	PRON
ajlm-1537	104	11	pnh	pnh	ADJ
ajlm-1537	104	12	-	-	PUNCT
ajlm-1537	104	13	negative	negative	ADJ
ajlm-1537	104	14	counterparts	counterpart	NOUN
ajlm-1537	104	15	and	and	CCONJ
ajlm-1537	104	16	had	have	VERB
ajlm-1537	104	17	lower	low	ADJ
ajlm-1537	104	18	total	total	ADJ
ajlm-1537	104	19	white	white	ADJ
ajlm-1537	104	20	cell	cell	NOUN
ajlm-1537	104	21	counts	count	NOUN
ajlm-1537	104	22	.	.	PUNCT
ajlm-1537	105	1	the	the	DET
ajlm-1537	105	2	differences	difference	NOUN
ajlm-1537	105	3	in	in	ADP
ajlm-1537	105	4	the	the	DET
ajlm-1537	105	5	presentation	presentation	NOUN
ajlm-1537	105	6	of	of	ADP
ajlm-1537	105	7	pnh	pnh	PROPN
ajlm-1537	105	8	between	between	ADP
ajlm-1537	105	9	adults	adult	NOUN
ajlm-1537	105	10	and	and	CCONJ
ajlm-1537	105	11	children	child	NOUN
ajlm-1537	105	12	have	have	AUX
ajlm-1537	105	13	been	be	AUX
ajlm-1537	105	14	described.8	described.8	ADP
ajlm-1537	105	15	a	a	DET
ajlm-1537	105	16	study	study	NOUN
ajlm-1537	105	17	reported	report	VERB
ajlm-1537	105	18	in	in	ADP
ajlm-1537	105	19	1991	1991	NUM
ajlm-1537	105	20	from	from	ADP
ajlm-1537	105	21	the	the	DET
ajlm-1537	105	22	united	united	PROPN
ajlm-1537	105	23	states	states	PROPN
ajlm-1537	105	24	described	describe	VERB
ajlm-1537	105	25	that	that	SCONJ
ajlm-1537	105	26	haemoglobinuria	haemoglobinuria	PROPN
ajlm-1537	105	27	was	be	AUX
ajlm-1537	105	28	detected	detect	VERB
ajlm-1537	105	29	in	in	ADP
ajlm-1537	105	30	50.0	50.0	NUM
ajlm-1537	105	31	%	%	NOUN
ajlm-1537	105	32	of	of	ADP
ajlm-1537	105	33	adult	adult	NOUN
ajlm-1537	105	34	pnh	pnh	NOUN
ajlm-1537	105	35	patients	patient	NOUN
ajlm-1537	105	36	compared	compare	VERB
ajlm-1537	105	37	to	to	ADP
ajlm-1537	105	38	15.0	15.0	NUM
ajlm-1537	105	39	%	%	NOUN
ajlm-1537	105	40	among	among	ADP
ajlm-1537	105	41	children	child	NOUN
ajlm-1537	105	42	,	,	PUNCT
ajlm-1537	105	43	and	and	CCONJ
ajlm-1537	105	44	only	only	ADV
ajlm-1537	105	45	25.0	25.0	NUM
ajlm-1537	105	46	%	%	NOUN
ajlm-1537	105	47	of	of	ADP
ajlm-1537	105	48	adult	adult	NOUN
ajlm-1537	105	49	pnh	pnh	PROPN
ajlm-1537	105	50	patients	patient	NOUN
ajlm-1537	105	51	had	have	VERB
ajlm-1537	105	52	bone	bone	NOUN
ajlm-1537	105	53	marrow	marrow	NOUN
ajlm-1537	105	54	failure	failure	NOUN
ajlm-1537	105	55	compared	compare	VERB
ajlm-1537	105	56	to	to	ADP
ajlm-1537	105	57	58.0	58.0	NUM
ajlm-1537	105	58	%	%	NOUN
ajlm-1537	105	59	among	among	ADP
ajlm-1537	105	60	children.8	children.8	ADJ
ajlm-1537	105	61	paroxysmal	paroxysmal	ADJ
ajlm-1537	105	62	nocturnal	nocturnal	ADJ
ajlm-1537	105	63	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	105	64	clone	clone	NOUN
ajlm-1537	105	65	sizes	size	NOUN
ajlm-1537	105	66	have	have	AUX
ajlm-1537	105	67	been	be	AUX
ajlm-1537	105	68	reported	report	VERB
ajlm-1537	105	69	to	to	PART
ajlm-1537	105	70	be	be	AUX
ajlm-1537	105	71	much	much	ADV
ajlm-1537	105	72	lower	low	ADJ
ajlm-1537	105	73	in	in	ADP
ajlm-1537	105	74	aa	aa	NOUN
ajlm-1537	105	75	than	than	ADP
ajlm-1537	105	76	in	in	ADP
ajlm-1537	105	77	pnh	pnh	PROPN
ajlm-1537	105	78	disease,25	disease,25	NOUN
ajlm-1537	105	79	requiring	require	VERB
ajlm-1537	105	80	high	high	ADJ
ajlm-1537	105	81	-	-	PUNCT
ajlm-1537	105	82	sensitivity	sensitivity	NOUN
ajlm-1537	105	83	fluorescent	fluorescent	ADJ
ajlm-1537	105	84	aerolysin	aerolysin	NOUN
ajlm-1537	105	85	analysis	analysis	NOUN
ajlm-1537	105	86	to	to	PART
ajlm-1537	105	87	detect	detect	VERB
ajlm-1537	105	88	clones	clone	NOUN
ajlm-1537	105	89	<	<	X
ajlm-1537	105	90	0.1%.26	0.1%.26	PUNCT
ajlm-1537	105	91	no	no	DET
ajlm-1537	105	92	patients	patient	NOUN
ajlm-1537	105	93	in	in	ADP
ajlm-1537	105	94	our	our	PRON
ajlm-1537	105	95	study	study	NOUN
ajlm-1537	105	96	presented	present	VERB
ajlm-1537	105	97	with	with	ADP
ajlm-1537	105	98	clinical	clinical	ADJ
ajlm-1537	105	99	pnh	pnh	PROPN
ajlm-1537	105	100	,	,	PUNCT
ajlm-1537	105	101	in	in	ADP
ajlm-1537	105	102	keeping	keep	VERB
ajlm-1537	105	103	with	with	ADP
ajlm-1537	105	104	a	a	DET
ajlm-1537	105	105	report	report	NOUN
ajlm-1537	105	106	from	from	ADP
ajlm-1537	105	107	japan	japan	PROPN
ajlm-1537	105	108	also	also	ADV
ajlm-1537	105	109	describing	describe	VERB
ajlm-1537	105	110	pnh	pnh	PROPN
ajlm-1537	105	111	clones	clone	NOUN
ajlm-1537	105	112	in	in	ADP
ajlm-1537	105	113	aa	aa	PROPN
ajlm-1537	105	114	patients.2	patients.2	PROPN
ajlm-1537	105	115	the	the	DET
ajlm-1537	105	116	pnh	pnh	PROPN
ajlm-1537	105	117	clone	clone	NOUN
ajlm-1537	105	118	prevalence	prevalence	NOUN
ajlm-1537	105	119	in	in	ADP
ajlm-1537	105	120	this	this	DET
ajlm-1537	105	121	study	study	NOUN
ajlm-1537	105	122	,	,	PUNCT
ajlm-1537	105	123	at	at	ADP
ajlm-1537	105	124	55.6	55.6	NUM
ajlm-1537	105	125	%	%	NOUN
ajlm-1537	105	126	,	,	PUNCT
ajlm-1537	105	127	is	be	AUX
ajlm-1537	105	128	much	much	ADV
ajlm-1537	105	129	higher	high	ADJ
ajlm-1537	105	130	than	than	ADP
ajlm-1537	105	131	the	the	DET
ajlm-1537	105	132	12.9	12.9	NUM
ajlm-1537	105	133	%	%	NOUN
ajlm-1537	105	134	prevalence	prevalence	NOUN
ajlm-1537	105	135	observed	observe	VERB
ajlm-1537	105	136	in	in	ADP
ajlm-1537	105	137	a	a	DET
ajlm-1537	105	138	paediatric	paediatric	ADJ
ajlm-1537	105	139	cohort	cohort	NOUN
ajlm-1537	105	140	in	in	ADP
ajlm-1537	105	141	india	india	PROPN
ajlm-1537	105	142	in	in	ADP
ajlm-1537	105	143	201527	201527	NUM
ajlm-1537	105	144	that	that	PRON
ajlm-1537	105	145	used	use	VERB
ajlm-1537	105	146	a	a	DET
ajlm-1537	105	147	pnh	pnh	PROPN
ajlm-1537	105	148	clone	clone	NOUN
ajlm-1537	105	149	cut	cut	NOUN
ajlm-1537	105	150	-	-	PUNCT
ajlm-1537	105	151	off	off	NOUN
ajlm-1537	105	152	of	of	ADP
ajlm-1537	105	153	>	>	DET
ajlm-1537	105	154	1.0	1.0	NUM
ajlm-1537	105	155	%	%	NOUN
ajlm-1537	105	156	.	.	PUNCT
ajlm-1537	106	1	when	when	SCONJ
ajlm-1537	106	2	a	a	DET
ajlm-1537	106	3	pnh	pnh	PROPN
ajlm-1537	106	4	clone	clone	NOUN
ajlm-1537	106	5	size	size	NOUN
ajlm-1537	106	6	of	of	ADP
ajlm-1537	106	7	<	<	X
ajlm-1537	106	8	1.0	1.0	NUM
ajlm-1537	106	9	%	%	NOUN
ajlm-1537	106	10	is	be	AUX
ajlm-1537	106	11	included	include	VERB
ajlm-1537	106	12	,	,	PUNCT
ajlm-1537	106	13	as	as	ADP
ajlm-1537	106	14	in	in	ADP
ajlm-1537	106	15	our	our	PRON
ajlm-1537	106	16	study	study	NOUN
ajlm-1537	106	17	,	,	PUNCT
ajlm-1537	106	18	some	some	DET
ajlm-1537	106	19	studies	study	NOUN
ajlm-1537	106	20	show	show	VERB
ajlm-1537	106	21	higher	high	ADJ
ajlm-1537	106	22	prevalence	prevalence	NOUN
ajlm-1537	106	23	rates	rate	NOUN
ajlm-1537	106	24	such	such	ADJ
ajlm-1537	106	25	as	as	ADP
ajlm-1537	106	26	41.0%28	41.0%28	NUM
ajlm-1537	106	27	and	and	CCONJ
ajlm-1537	106	28	46.0%.29	46.0%.29	NOUN
ajlm-1537	106	29	a	a	DET
ajlm-1537	106	30	study	study	NOUN
ajlm-1537	106	31	conducted	conduct	VERB
ajlm-1537	106	32	in	in	ADP
ajlm-1537	106	33	the	the	DET
ajlm-1537	106	34	united	united	PROPN
ajlm-1537	106	35	states30	states30	PROPN
ajlm-1537	106	36	found	find	VERB
ajlm-1537	106	37	that	that	SCONJ
ajlm-1537	106	38	40.0	40.0	NUM
ajlm-1537	106	39	%	%	NOUN
ajlm-1537	106	40	of	of	ADP
ajlm-1537	106	41	patients	patient	NOUN
ajlm-1537	106	42	were	be	AUX
ajlm-1537	106	43	affected	affect	VERB
ajlm-1537	106	44	,	,	PUNCT
ajlm-1537	106	45	even	even	ADV
ajlm-1537	106	46	at	at	ADP
ajlm-1537	106	47	a	a	DET
ajlm-1537	106	48	cut	cut	NOUN
ajlm-1537	106	49	-	-	PUNCT
ajlm-1537	106	50	off	off	NOUN
ajlm-1537	106	51	of	of	ADP
ajlm-1537	106	52	1.0	1.0	NUM
ajlm-1537	106	53	%	%	NOUN
ajlm-1537	106	54	.	.	PUNCT
ajlm-1537	107	1	in	in	ADP
ajlm-1537	107	2	an	an	DET
ajlm-1537	107	3	adult	adult	NOUN
ajlm-1537	107	4	cohort	cohort	NOUN
ajlm-1537	107	5	from	from	ADP
ajlm-1537	107	6	tanzania	tanzania	PROPN
ajlm-1537	107	7	,	,	PUNCT
ajlm-1537	107	8	a	a	DET
ajlm-1537	107	9	42.0	42.0	NUM
ajlm-1537	107	10	%	%	NOUN
ajlm-1537	107	11	prevalence	prevalence	NOUN
ajlm-1537	107	12	of	of	ADP
ajlm-1537	107	13	pnh	pnh	PROPN
ajlm-1537	107	14	clones	clone	NOUN
ajlm-1537	107	15	in	in	ADP
ajlm-1537	107	16	aa	aa	PROPN
ajlm-1537	107	17	patients	patient	NOUN
ajlm-1537	107	18	was	be	AUX
ajlm-1537	107	19	found.31	found.31	PROPN
ajlm-1537	107	20	interestingly	interestingly	ADV
ajlm-1537	107	21	,	,	PUNCT
ajlm-1537	107	22	this	this	DET
ajlm-1537	107	23	study	study	NOUN
ajlm-1537	107	24	also	also	ADV
ajlm-1537	107	25	showed	show	VERB
ajlm-1537	107	26	an	an	DET
ajlm-1537	107	27	overall	overall	ADJ
ajlm-1537	107	28	higher	high	ADJ
ajlm-1537	107	29	aa	aa	NOUN
ajlm-1537	107	30	prevalence	prevalence	NOUN
ajlm-1537	107	31	of	of	ADP
ajlm-1537	107	32	six	six	NUM
ajlm-1537	107	33	cases	case	NOUN
ajlm-1537	107	34	per	per	ADP
ajlm-1537	107	35	million	million	NUM
ajlm-1537	107	36	per	per	ADP
ajlm-1537	107	37	year	year	NOUN
ajlm-1537	107	38	,	,	PUNCT
ajlm-1537	107	39	compared	compare	VERB
ajlm-1537	107	40	to	to	ADP
ajlm-1537	107	41	two	two	NUM
ajlm-1537	107	42	per	per	ADP
ajlm-1537	107	43	million	million	NUM
ajlm-1537	107	44	per	per	ADP
ajlm-1537	107	45	year	year	NOUN
ajlm-1537	107	46	in	in	ADP
ajlm-1537	107	47	europe	europe	PROPN
ajlm-1537	107	48	and	and	CCONJ
ajlm-1537	107	49	north	north	PROPN
ajlm-1537	107	50	america	america	PROPN
ajlm-1537	107	51	.	.	PUNCT
ajlm-1537	108	1	a	a	DET
ajlm-1537	108	2	study	study	NOUN
ajlm-1537	108	3	among	among	ADP
ajlm-1537	108	4	a	a	DET
ajlm-1537	108	5	paediatric	paediatric	ADJ
ajlm-1537	108	6	cohort	cohort	NOUN
ajlm-1537	108	7	from	from	ADP
ajlm-1537	108	8	egypt	egypt	PROPN
ajlm-1537	108	9	showed	show	VERB
ajlm-1537	108	10	the	the	DET
ajlm-1537	108	11	presence	presence	NOUN
ajlm-1537	108	12	of	of	ADP
ajlm-1537	108	13	a	a	DET
ajlm-1537	108	14	pnh	pnh	PROPN
ajlm-1537	108	15	clone	clone	NOUN
ajlm-1537	108	16	in	in	ADP
ajlm-1537	108	17	36.0	36.0	NUM
ajlm-1537	108	18	%	%	NOUN
ajlm-1537	108	19	of	of	ADP
ajlm-1537	108	20	patients	patient	NOUN
ajlm-1537	108	21	using	use	VERB
ajlm-1537	108	22	the	the	DET
ajlm-1537	108	23	cd59	cd59	PROPN
ajlm-1537	108	24	immunohistochemical	immunohistochemical	ADJ
ajlm-1537	108	25	staining	stain	VERB
ajlm-1537	108	26	on	on	ADP
ajlm-1537	108	27	bone	bone	NOUN
ajlm-1537	108	28	marrow	marrow	NOUN
ajlm-1537	108	29	trephine	trephine	PROPN
ajlm-1537	108	30	biopsies.32	biopsies.32	PROPN
ajlm-1537	109	1	it	it	PRON
ajlm-1537	109	2	must	must	AUX
ajlm-1537	109	3	be	be	AUX
ajlm-1537	109	4	noted	note	VERB
ajlm-1537	109	5	that	that	SCONJ
ajlm-1537	109	6	although	although	SCONJ
ajlm-1537	109	7	we	we	PRON
ajlm-1537	109	8	included	include	VERB
ajlm-1537	109	9	very	very	ADV
ajlm-1537	109	10	small	small	ADJ
ajlm-1537	109	11	clones	clone	NOUN
ajlm-1537	109	12	in	in	ADP
ajlm-1537	109	13	our	our	PRON
ajlm-1537	109	14	study	study	NOUN
ajlm-1537	109	15	,	,	PUNCT
ajlm-1537	109	16	the	the	DET
ajlm-1537	109	17	evidence	evidence	NOUN
ajlm-1537	109	18	for	for	ADP
ajlm-1537	109	19	the	the	DET
ajlm-1537	109	20	impact	impact	NOUN
ajlm-1537	109	21	of	of	ADP
ajlm-1537	109	22	these	these	DET
ajlm-1537	109	23	minor	minor	ADJ
ajlm-1537	109	24	clones	clone	NOUN
ajlm-1537	109	25	on	on	ADP
ajlm-1537	109	26	clinical	clinical	ADJ
ajlm-1537	109	27	presentation	presentation	NOUN
ajlm-1537	109	28	is	be	AUX
ajlm-1537	109	29	not	not	PART
ajlm-1537	109	30	yet	yet	ADV
ajlm-1537	109	31	well	well	ADV
ajlm-1537	109	32	established.27	established.27	PROPN
ajlm-1537	110	1	it	it	PRON
ajlm-1537	110	2	has	have	AUX
ajlm-1537	110	3	also	also	ADV
ajlm-1537	110	4	been	be	AUX
ajlm-1537	110	5	shown	show	VERB
ajlm-1537	110	6	that	that	SCONJ
ajlm-1537	110	7	small	small	ADJ
ajlm-1537	110	8	populations	population	NOUN
ajlm-1537	110	9	of	of	ADP
ajlm-1537	110	10	granulocytes	granulocyte	NOUN
ajlm-1537	110	11	bearing	bear	VERB
ajlm-1537	110	12	the	the	DET
ajlm-1537	110	13	pnh	pnh	PROPN
ajlm-1537	110	14	phenotype	phenotype	NOUN
ajlm-1537	110	15	can	can	AUX
ajlm-1537	110	16	even	even	ADV
ajlm-1537	110	17	be	be	AUX
ajlm-1537	110	18	found	find	VERB
ajlm-1537	110	19	in	in	ADP
ajlm-1537	110	20	healthy	healthy	ADJ
ajlm-1537	110	21	individuals33	individuals33	NOUN
ajlm-1537	110	22	;	;	PUNCT
ajlm-1537	110	23	any	any	DET
ajlm-1537	110	24	specific	specific	ADJ
ajlm-1537	110	25	cut	cut	NOUN
ajlm-1537	110	26	-	-	PUNCT
ajlm-1537	110	27	off	off	ADP
ajlm-1537	110	28	value	value	NOUN
ajlm-1537	110	29	may	may	AUX
ajlm-1537	110	30	thus	thus	ADV
ajlm-1537	110	31	be	be	AUX
ajlm-1537	110	32	arbitrary	arbitrary	ADJ
ajlm-1537	110	33	.	.	PUNCT
ajlm-1537	111	1	the	the	DET
ajlm-1537	111	2	median	median	ADJ
ajlm-1537	111	3	age	age	NOUN
ajlm-1537	111	4	of	of	ADP
ajlm-1537	111	5	children	child	NOUN
ajlm-1537	111	6	presenting	present	VERB
ajlm-1537	111	7	with	with	ADP
ajlm-1537	111	8	a	a	DET
ajlm-1537	111	9	pnh	pnh	PROPN
ajlm-1537	111	10	clone	clone	NOUN
ajlm-1537	111	11	was	be	AUX
ajlm-1537	111	12	significantly	significantly	ADV
ajlm-1537	111	13	higher	high	ADJ
ajlm-1537	111	14	(	(	PUNCT
ajlm-1537	111	15	p	p	X
ajlm-1537	111	16	=	=	NOUN
ajlm-1537	111	17	0.02	0.02	NUM
ajlm-1537	111	18	)	)	PUNCT
ajlm-1537	111	19	.	.	PUNCT
ajlm-1537	112	1	there	there	PRON
ajlm-1537	112	2	is	be	VERB
ajlm-1537	112	3	also	also	ADV
ajlm-1537	112	4	evidence	evidence	NOUN
ajlm-1537	112	5	in	in	ADP
ajlm-1537	112	6	the	the	DET
ajlm-1537	112	7	literature	literature	NOUN
ajlm-1537	112	8	suggesting	suggest	VERB
ajlm-1537	112	9	that	that	SCONJ
ajlm-1537	112	10	pnh	pnh	PROPN
ajlm-1537	112	11	clones	clone	NOUN
ajlm-1537	112	12	increase	increase	VERB
ajlm-1537	112	13	with	with	ADP
ajlm-1537	112	14	age	age	NOUN
ajlm-1537	112	15	in	in	ADP
ajlm-1537	112	16	children.27,34	children.27,34	NOUN
ajlm-1537	112	17	in	in	ADP
ajlm-1537	112	18	the	the	DET
ajlm-1537	112	19	current	current	ADJ
ajlm-1537	112	20	study	study	NOUN
ajlm-1537	112	21	,	,	PUNCT
ajlm-1537	112	22	children	child	NOUN
ajlm-1537	112	23	without	without	ADP
ajlm-1537	112	24	the	the	DET
ajlm-1537	112	25	pnh	pnh	PROPN
ajlm-1537	112	26	clone	clone	NOUN
ajlm-1537	112	27	presented	present	VERB
ajlm-1537	112	28	with	with	ADP
ajlm-1537	112	29	a	a	DET
ajlm-1537	112	30	higher	high	ADJ
ajlm-1537	112	31	incidence	incidence	NOUN
ajlm-1537	112	32	of	of	ADP
ajlm-1537	112	33	haematuria	haematuria	NOUN
ajlm-1537	112	34	.	.	PUNCT
ajlm-1537	113	1	as	as	SCONJ
ajlm-1537	113	2	all	all	DET
ajlm-1537	113	3	patients	patient	NOUN
ajlm-1537	113	4	presented	present	VERB
ajlm-1537	113	5	with	with	ADP
ajlm-1537	113	6	thrombocytopenia	thrombocytopenia	PROPN
ajlm-1537	113	7	,	,	PUNCT
ajlm-1537	113	8	the	the	DET
ajlm-1537	113	9	true	true	ADJ
ajlm-1537	113	10	reason	reason	NOUN
ajlm-1537	113	11	for	for	ADP
ajlm-1537	113	12	the	the	DET
ajlm-1537	113	13	haematuria	haematuria	NOUN
ajlm-1537	113	14	could	could	AUX
ajlm-1537	113	15	not	not	PART
ajlm-1537	113	16	be	be	AUX
ajlm-1537	113	17	elucidated	elucidate	VERB
ajlm-1537	113	18	,	,	PUNCT
ajlm-1537	113	19	particularly	particularly	ADV
ajlm-1537	113	20	because	because	SCONJ
ajlm-1537	113	21	a	a	DET
ajlm-1537	113	22	urine	urine	NOUN
ajlm-1537	113	23	dipstick	dipstick	NOUN
ajlm-1537	113	24	is	be	AUX
ajlm-1537	113	25	unable	unable	ADJ
ajlm-1537	113	26	to	to	PART
ajlm-1537	113	27	distinguish	distinguish	VERB
ajlm-1537	113	28	this	this	PRON
ajlm-1537	113	29	from	from	ADP
ajlm-1537	113	30	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	113	31	,	,	PUNCT
ajlm-1537	113	32	the	the	DET
ajlm-1537	113	33	true	true	ADJ
ajlm-1537	113	34	mark	mark	NOUN
ajlm-1537	113	35	of	of	ADP
ajlm-1537	113	36	intravascular	intravascular	ADJ
ajlm-1537	113	37	haemolysis	haemolysis	NOUN
ajlm-1537	113	38	.	.	PUNCT
ajlm-1537	114	1	similarly	similarly	ADV
ajlm-1537	114	2	,	,	PUNCT
ajlm-1537	114	3	the	the	DET
ajlm-1537	114	4	median	median	ADJ
ajlm-1537	114	5	haemoglobin	haemoglobin	NOUN
ajlm-1537	114	6	concentration	concentration	NOUN
ajlm-1537	114	7	of	of	ADP
ajlm-1537	114	8	>	>	X
ajlm-1537	114	9	7	7	NUM
ajlm-1537	114	10	g	g	NOUN
ajlm-1537	114	11	/	/	SYM
ajlm-1537	114	12	dl	dl	PROPN
ajlm-1537	114	13	observed	observe	VERB
ajlm-1537	114	14	in	in	ADP
ajlm-1537	114	15	all	all	DET
ajlm-1537	114	16	patients	patient	NOUN
ajlm-1537	114	17	is	be	AUX
ajlm-1537	114	18	likely	likely	ADJ
ajlm-1537	114	19	due	due	ADP
ajlm-1537	114	20	to	to	ADP
ajlm-1537	114	21	blood	blood	NOUN
ajlm-1537	114	22	transfusions	transfusion	NOUN
ajlm-1537	114	23	received	receive	VERB
ajlm-1537	114	24	prior	prior	ADV
ajlm-1537	114	25	to	to	ADP
ajlm-1537	114	26	referral	referral	NOUN
ajlm-1537	114	27	.	.	PUNCT
ajlm-1537	115	1	according	accord	VERB
ajlm-1537	115	2	to	to	ADP
ajlm-1537	115	3	camitta	camitta	PROPN
ajlm-1537	115	4	’s	’s	PART
ajlm-1537	115	5	criteria	criterion	NOUN
ajlm-1537	115	6	for	for	ADP
ajlm-1537	115	7	the	the	DET
ajlm-1537	115	8	classification	classification	NOUN
ajlm-1537	115	9	of	of	ADP
ajlm-1537	115	10	aa	aa	PROPN
ajlm-1537	115	11	severity	severity	NOUN
ajlm-1537	115	12	(	(	PUNCT
ajlm-1537	115	13	cited	cite	VERB
ajlm-1537	115	14	by	by	ADP
ajlm-1537	115	15	marsh	marsh	PROPN
ajlm-1537	115	16	et	et	PROPN
ajlm-1537	115	17	al.),21	al.),21	PROPN
ajlm-1537	115	18	anc	anc	PROPN
ajlm-1537	115	19	(	(	PUNCT
ajlm-1537	115	20	<	<	X
ajlm-1537	115	21	0.5	0.5	NUM
ajlm-1537	115	22	×	×	NOUN
ajlm-1537	115	23	109	109	NUM
ajlm-1537	115	24	/	/	SYM
ajlm-1537	115	25	l	l	NOUN
ajlm-1537	115	26	)	)	PUNCT
ajlm-1537	115	27	,	,	PUNCT
ajlm-1537	115	28	reticulocyte	reticulocyte	NOUN
ajlm-1537	115	29	count	count	NOUN
ajlm-1537	115	30	(	(	PUNCT
ajlm-1537	115	31	<	<	X
ajlm-1537	115	32	20	20	NUM
ajlm-1537	115	33	×	×	NOUN
ajlm-1537	115	34	109	109	NUM
ajlm-1537	115	35	/	/	SYM
ajlm-1537	115	36	l	l	NOUN
ajlm-1537	115	37	)	)	PUNCT
ajlm-1537	115	38	and	and	CCONJ
ajlm-1537	115	39	platelet	platelet	NOUN
ajlm-1537	115	40	count	count	NOUN
ajlm-1537	115	41	(	(	PUNCT
ajlm-1537	115	42	<	<	X
ajlm-1537	115	43	20	20	NUM
ajlm-1537	115	44	×	×	NOUN
ajlm-1537	115	45	109	109	NUM
ajlm-1537	115	46	/	/	SYM
ajlm-1537	115	47	l	l	NOUN
ajlm-1537	115	48	)	)	PUNCT
ajlm-1537	115	49	are	be	AUX
ajlm-1537	115	50	the	the	DET
ajlm-1537	115	51	predictors	predictor	NOUN
ajlm-1537	115	52	of	of	ADP
ajlm-1537	115	53	severity	severity	NOUN
ajlm-1537	115	54	.	.	PUNCT
ajlm-1537	116	1	the	the	DET
ajlm-1537	116	2	presence	presence	NOUN
ajlm-1537	116	3	of	of	ADP
ajlm-1537	116	4	at	at	ADV
ajlm-1537	116	5	least	least	ADV
ajlm-1537	116	6	two	two	NUM
ajlm-1537	116	7	of	of	ADP
ajlm-1537	116	8	these	these	DET
ajlm-1537	116	9	three	three	NUM
ajlm-1537	116	10	criteria	criterion	NOUN
ajlm-1537	116	11	indicates	indicate	VERB
ajlm-1537	116	12	severe	severe	ADJ
ajlm-1537	116	13	aa	aa	NOUN
ajlm-1537	116	14	.	.	PUNCT
ajlm-1537	117	1	a	a	DET
ajlm-1537	117	2	study	study	NOUN
ajlm-1537	117	3	in	in	ADP
ajlm-1537	117	4	korea	korea	PROPN
ajlm-1537	117	5	highlighted	highlight	VERB
ajlm-1537	117	6	that	that	SCONJ
ajlm-1537	117	7	the	the	DET
ajlm-1537	117	8	anc	anc	PROPN
ajlm-1537	117	9	should	should	AUX
ajlm-1537	117	10	be	be	AUX
ajlm-1537	117	11	more	more	ADV
ajlm-1537	117	12	heavily	heavily	ADV
ajlm-1537	117	13	weighted	weight	VERB
ajlm-1537	117	14	,	,	PUNCT
ajlm-1537	117	15	as	as	SCONJ
ajlm-1537	117	16	it	it	PRON
ajlm-1537	117	17	has	have	VERB
ajlm-1537	117	18	the	the	DET
ajlm-1537	117	19	biggest	big	ADJ
ajlm-1537	117	20	impact	impact	NOUN
ajlm-1537	117	21	on	on	ADP
ajlm-1537	117	22	patient	patient	ADJ
ajlm-1537	117	23	complications	complication	NOUN
ajlm-1537	117	24	,	,	PUNCT
ajlm-1537	117	25	is	be	AUX
ajlm-1537	117	26	not	not	PART
ajlm-1537	117	27	influenced	influence	VERB
ajlm-1537	117	28	by	by	ADP
ajlm-1537	117	29	transfusions	transfusion	NOUN
ajlm-1537	117	30	,	,	PUNCT
ajlm-1537	117	31	and	and	CCONJ
ajlm-1537	117	32	can	can	AUX
ajlm-1537	117	33	be	be	AUX
ajlm-1537	117	34	readily	readily	ADV
ajlm-1537	117	35	used	use	VERB
ajlm-1537	117	36	to	to	PART
ajlm-1537	117	37	classify	classify	VERB
ajlm-1537	117	38	severity	severity	NOUN
ajlm-1537	117	39	in	in	ADP
ajlm-1537	117	40	patients.35	patients.35	NOUN
ajlm-1537	117	41	in	in	ADP
ajlm-1537	117	42	our	our	PRON
ajlm-1537	117	43	cohort	cohort	NOUN
ajlm-1537	117	44	,	,	PUNCT
ajlm-1537	117	45	15	15	NUM
ajlm-1537	117	46	of	of	ADP
ajlm-1537	117	47	the	the	DET
ajlm-1537	117	48	18	18	NUM
ajlm-1537	117	49	patients	patient	NOUN
ajlm-1537	117	50	had	have	VERB
ajlm-1537	117	51	a	a	DET
ajlm-1537	117	52	neutrophil	neutrophil	ADJ
ajlm-1537	117	53	count	count	NOUN
ajlm-1537	117	54	of	of	ADP
ajlm-1537	117	55	<	<	X
ajlm-1537	117	56	0.5	0.5	NUM
ajlm-1537	117	57	×	×	NOUN
ajlm-1537	117	58	109	109	NUM
ajlm-1537	117	59	/	/	SYM
ajlm-1537	117	60	l	l	NOUN
ajlm-1537	117	61	,	,	PUNCT
ajlm-1537	117	62	while	while	SCONJ
ajlm-1537	117	63	the	the	DET
ajlm-1537	117	64	haemoglobin	haemoglobin	NOUN
ajlm-1537	117	65	and	and	CCONJ
ajlm-1537	117	66	platelet	platelet	NOUN
ajlm-1537	117	67	counts	count	NOUN
ajlm-1537	117	68	remained	remain	VERB
ajlm-1537	117	69	above	above	ADP
ajlm-1537	117	70	the	the	DET
ajlm-1537	117	71	defined	define	VERB
ajlm-1537	117	72	cut	cut	NOUN
ajlm-1537	117	73	-	-	PUNCT
ajlm-1537	117	74	off	off	ADP
ajlm-1537	117	75	likely	likely	ADJ
ajlm-1537	117	76	due	due	ADP
ajlm-1537	117	77	to	to	ADP
ajlm-1537	117	78	transfusions	transfusion	NOUN
ajlm-1537	117	79	received	receive	VERB
ajlm-1537	117	80	,	,	PUNCT
ajlm-1537	117	81	suggesting	suggest	VERB
ajlm-1537	117	82	that	that	SCONJ
ajlm-1537	117	83	anc	anc	PROPN
ajlm-1537	117	84	may	may	AUX
ajlm-1537	117	85	be	be	AUX
ajlm-1537	117	86	a	a	DET
ajlm-1537	117	87	more	more	ADV
ajlm-1537	117	88	important	important	ADJ
ajlm-1537	117	89	factor	factor	NOUN
ajlm-1537	117	90	to	to	PART
ajlm-1537	117	91	consider	consider	VERB
ajlm-1537	117	92	in	in	ADP
ajlm-1537	117	93	the	the	DET
ajlm-1537	117	94	diagnosis	diagnosis	NOUN
ajlm-1537	117	95	and	and	CCONJ
ajlm-1537	117	96	severity	severity	NOUN
ajlm-1537	117	97	grading	grading	NOUN
ajlm-1537	117	98	of	of	ADP
ajlm-1537	117	99	patients	patient	NOUN
ajlm-1537	117	100	with	with	ADP
ajlm-1537	117	101	aa	aa	PROPN
ajlm-1537	117	102	.	.	PUNCT
ajlm-1537	118	1	this	this	DET
ajlm-1537	118	2	study	study	NOUN
ajlm-1537	118	3	also	also	ADV
ajlm-1537	118	4	found	find	VERB
ajlm-1537	118	5	no	no	DET
ajlm-1537	118	6	association	association	NOUN
ajlm-1537	118	7	between	between	ADP
ajlm-1537	118	8	pnh	pnh	PROPN
ajlm-1537	118	9	clone	clone	NOUN
ajlm-1537	118	10	size	size	NOUN
ajlm-1537	118	11	and	and	CCONJ
ajlm-1537	118	12	severity	severity	NOUN
ajlm-1537	118	13	of	of	ADP
ajlm-1537	118	14	clinical	clinical	ADJ
ajlm-1537	118	15	presentation	presentation	NOUN
ajlm-1537	118	16	.	.	PUNCT
ajlm-1537	119	1	a	a	DET
ajlm-1537	119	2	study	study	NOUN
ajlm-1537	119	3	from	from	ADP
ajlm-1537	119	4	india	india	PROPN
ajlm-1537	119	5	published	publish	VERB
ajlm-1537	119	6	in	in	ADP
ajlm-1537	119	7	2018	2018	NUM
ajlm-1537	119	8	also	also	ADV
ajlm-1537	119	9	showed	show	VERB
ajlm-1537	119	10	no	no	DET
ajlm-1537	119	11	correlation	correlation	NOUN
ajlm-1537	119	12	between	between	ADP
ajlm-1537	119	13	clone	clone	NOUN
ajlm-1537	119	14	size	size	NOUN
ajlm-1537	119	15	and	and	CCONJ
ajlm-1537	119	16	pnh	pnh	PROPN
ajlm-1537	119	17	symptoms	symptom	NOUN
ajlm-1537	119	18	in	in	ADP
ajlm-1537	119	19	a	a	DET
ajlm-1537	119	20	large	large	ADJ
ajlm-1537	119	21	paediatric	paediatric	ADJ
ajlm-1537	119	22	cohort.1	cohort.1	NOUN
ajlm-1537	119	23	only	only	ADV
ajlm-1537	119	24	three	three	NUM
ajlm-1537	119	25	of	of	ADP
ajlm-1537	119	26	the	the	DET
ajlm-1537	119	27	100	100	NUM
ajlm-1537	119	28	patients	patient	NOUN
ajlm-1537	119	29	in	in	ADP
ajlm-1537	119	30	the	the	DET
ajlm-1537	119	31	study	study	NOUN
ajlm-1537	119	32	presented	present	VERB
ajlm-1537	119	33	with	with	ADP
ajlm-1537	119	34	haemolysis	haemolysis	NOUN
ajlm-1537	119	35	,	,	PUNCT
ajlm-1537	119	36	all	all	PRON
ajlm-1537	119	37	of	of	ADP
ajlm-1537	119	38	whom	whom	PRON
ajlm-1537	119	39	had	have	VERB
ajlm-1537	119	40	clone	clone	NOUN
ajlm-1537	119	41	sizes	size	NOUN
ajlm-1537	119	42	>	>	X
ajlm-1537	119	43	10	10	NUM
ajlm-1537	119	44	%	%	NOUN
ajlm-1537	119	45	,	,	PUNCT
ajlm-1537	119	46	and	and	CCONJ
ajlm-1537	119	47	one	one	NUM
ajlm-1537	119	48	patient	patient	NOUN
ajlm-1537	119	49	with	with	ADP
ajlm-1537	119	50	a	a	DET
ajlm-1537	119	51	very	very	ADV
ajlm-1537	119	52	small	small	ADJ
ajlm-1537	119	53	clone	clone	NOUN
ajlm-1537	119	54	presented	present	VERB
ajlm-1537	119	55	with	with	ADP
ajlm-1537	119	56	thrombosis	thrombosis	NOUN
ajlm-1537	119	57	.	.	PUNCT
ajlm-1537	120	1	this	this	DET
ajlm-1537	120	2	highlights	highlight	VERB
ajlm-1537	120	3	the	the	DET
ajlm-1537	120	4	need	need	NOUN
ajlm-1537	120	5	for	for	ADP
ajlm-1537	120	6	screening	screen	VERB
ajlm-1537	120	7	all	all	DET
ajlm-1537	120	8	patients	patient	NOUN
ajlm-1537	120	9	for	for	ADP
ajlm-1537	120	10	signs	sign	NOUN
ajlm-1537	120	11	of	of	ADP
ajlm-1537	120	12	clinical	clinical	ADJ
ajlm-1537	120	13	pnh	pnh	PROPN
ajlm-1537	120	14	,	,	PUNCT
ajlm-1537	120	15	regardless	regardless	ADV
ajlm-1537	120	16	of	of	ADP
ajlm-1537	120	17	clone	clone	NOUN
ajlm-1537	120	18	size	size	NOUN
ajlm-1537	120	19	.	.	PUNCT
ajlm-1537	121	1	importantly	importantly	ADV
ajlm-1537	121	2	,	,	PUNCT
ajlm-1537	121	3	only	only	ADV
ajlm-1537	121	4	one	one	NUM
ajlm-1537	121	5	child	child	NOUN
ajlm-1537	121	6	in	in	ADP
ajlm-1537	121	7	our	our	PRON
ajlm-1537	121	8	cohort	cohort	NOUN
ajlm-1537	121	9	received	receive	VERB
ajlm-1537	121	10	an	an	DET
ajlm-1537	121	11	hsct	hsct	NOUN
ajlm-1537	121	12	.	.	PUNCT
ajlm-1537	122	1	two	two	NUM
ajlm-1537	122	2	patients	patient	NOUN
ajlm-1537	122	3	had	have	AUX
ajlm-1537	122	4	already	already	ADV
ajlm-1537	122	5	developed	develop	VERB
ajlm-1537	122	6	platelet	platelet	NOUN
ajlm-1537	122	7	refractoriness	refractoriness	NOUN
ajlm-1537	122	8	and	and	CCONJ
ajlm-1537	122	9	this	this	PRON
ajlm-1537	122	10	may	may	AUX
ajlm-1537	122	11	be	be	AUX
ajlm-1537	122	12	due	due	ADJ
ajlm-1537	122	13	to	to	ADP
ajlm-1537	122	14	the	the	DET
ajlm-1537	122	15	continuation	continuation	NOUN
ajlm-1537	122	16	of	of	ADP
ajlm-1537	122	17	platelet	platelet	NOUN
ajlm-1537	122	18	transfusions	transfusion	NOUN
ajlm-1537	122	19	while	while	SCONJ
ajlm-1537	122	20	awaiting	await	VERB
ajlm-1537	122	21	the	the	DET
ajlm-1537	122	22	hla	hla	NOUN
ajlm-1537	122	23	results	result	NOUN
ajlm-1537	122	24	.	.	PUNCT
ajlm-1537	123	1	our	our	PRON
ajlm-1537	123	2	findings	finding	NOUN
ajlm-1537	123	3	show	show	VERB
ajlm-1537	123	4	an	an	DET
ajlm-1537	123	5	improved	improved	ADJ
ajlm-1537	123	6	atg	atg	PROPN
ajlm-1537	123	7	response	response	NOUN
ajlm-1537	123	8	in	in	ADP
ajlm-1537	123	9	the	the	DET
ajlm-1537	123	10	pnh	pnh	PROPN
ajlm-1537	123	11	-	-	PUNCT
ajlm-1537	123	12	positive	positive	ADJ
ajlm-1537	123	13	cohort	cohort	NOUN
ajlm-1537	123	14	;	;	PUNCT
ajlm-1537	123	15	however	however	ADV
ajlm-1537	123	16	,	,	PUNCT
ajlm-1537	123	17	the	the	DET
ajlm-1537	123	18	small	small	ADJ
ajlm-1537	123	19	size	size	NOUN
ajlm-1537	123	20	of	of	ADP
ajlm-1537	123	21	the	the	DET
ajlm-1537	123	22	study	study	NOUN
ajlm-1537	123	23	population	population	NOUN
ajlm-1537	123	24	makes	make	VERB
ajlm-1537	123	25	it	it	PRON
ajlm-1537	123	26	impossible	impossible	ADJ
ajlm-1537	123	27	to	to	PART
ajlm-1537	123	28	reach	reach	VERB
ajlm-1537	123	29	a	a	DET
ajlm-1537	123	30	definitive	definitive	ADJ
ajlm-1537	123	31	conclusion	conclusion	NOUN
ajlm-1537	123	32	.	.	PUNCT
ajlm-1537	124	1	some	some	DET
ajlm-1537	124	2	studies	study	NOUN
ajlm-1537	124	3	have	have	AUX
ajlm-1537	124	4	either	either	CCONJ
ajlm-1537	124	5	shown	show	VERB
ajlm-1537	124	6	,	,	PUNCT
ajlm-1537	124	7	suggested	suggest	VERB
ajlm-1537	124	8	or	or	CCONJ
ajlm-1537	124	9	referenced	reference	VERB
ajlm-1537	124	10	an	an	DET
ajlm-1537	124	11	improved	improved	ADJ
ajlm-1537	124	12	response	response	NOUN
ajlm-1537	124	13	to	to	PART
ajlm-1537	124	14	ist	ist	VERB
ajlm-1537	124	15	in	in	ADP
ajlm-1537	124	16	patients	patient	NOUN
ajlm-1537	124	17	with	with	ADP
ajlm-1537	124	18	aa	aa	NOUN
ajlm-1537	124	19	presenting	present	VERB
ajlm-1537	124	20	with	with	ADP
ajlm-1537	124	21	a	a	DET
ajlm-1537	124	22	pnh	pnh	NOUN
ajlm-1537	124	23	clone,18,27,36,37	clone,18,27,36,37	NOUN
ajlm-1537	124	24	or	or	CCONJ
ajlm-1537	124	25	have	have	AUX
ajlm-1537	124	26	found	find	VERB
ajlm-1537	124	27	no	no	DET
ajlm-1537	124	28	difference	difference	NOUN
ajlm-1537	124	29	in	in	ADP
ajlm-1537	124	30	response.1,28,30	response.1,28,30	PROPN
ajlm-1537	124	31	however	however	ADV
ajlm-1537	124	32	,	,	PUNCT
ajlm-1537	124	33	a	a	DET
ajlm-1537	124	34	recent	recent	ADJ
ajlm-1537	124	35	meta	meta	ADJ
ajlm-1537	124	36	-	-	PUNCT
ajlm-1537	124	37	analysis	analysis	NOUN
ajlm-1537	124	38	that	that	PRON
ajlm-1537	124	39	included	include	VERB
ajlm-1537	124	40	1236	1236	NUM
ajlm-1537	124	41	participants	participant	NOUN
ajlm-1537	124	42	from	from	ADP
ajlm-1537	124	43	11	11	NUM
ajlm-1537	124	44	studies	study	NOUN
ajlm-1537	124	45	showed	show	VERB
ajlm-1537	124	46	a	a	DET
ajlm-1537	124	47	statistically	statistically	ADV
ajlm-1537	124	48	significant	significant	ADJ
ajlm-1537	124	49	improved	improved	ADJ
ajlm-1537	124	50	response	response	NOUN
ajlm-1537	124	51	to	to	PART
ajlm-1537	124	52	ist	ist	VERB
ajlm-1537	124	53	in	in	ADP
ajlm-1537	124	54	patients	patient	NOUN
ajlm-1537	124	55	with	with	ADP
ajlm-1537	124	56	pnh	pnh	PROPN
ajlm-1537	124	57	clones.38	clones.38	PROPN
ajlm-1537	124	58	in	in	ADP
ajlm-1537	124	59	determining	determine	VERB
ajlm-1537	124	60	ist	ist	ADJ
ajlm-1537	124	61	response	response	NOUN
ajlm-1537	124	62	in	in	ADP
ajlm-1537	124	63	aa	aa	NOUN
ajlm-1537	124	64	as	as	ADP
ajlm-1537	124	65	a	a	DET
ajlm-1537	124	66	whole	whole	NOUN
ajlm-1537	124	67	,	,	PUNCT
ajlm-1537	124	68	the	the	DET
ajlm-1537	124	69	north	north	ADJ
ajlm-1537	124	70	american	american	ADJ
ajlm-1537	124	71	pediatric	pediatric	ADJ
ajlm-1537	124	72	aplastic	aplastic	ADJ
ajlm-1537	124	73	anemia	anemia	NOUN
ajlm-1537	124	74	consortium	consortium	NOUN
ajlm-1537	124	75	published	publish	VERB
ajlm-1537	124	76	results	result	NOUN
ajlm-1537	124	77	from	from	ADP
ajlm-1537	124	78	314	314	NUM
ajlm-1537	124	79	paediatric	paediatric	ADJ
ajlm-1537	124	80	aa	aa	NOUN
ajlm-1537	124	81	patients	patient	NOUN
ajlm-1537	124	82	wherein	wherein	SCONJ
ajlm-1537	124	83	complete	complete	ADJ
ajlm-1537	124	84	response	response	NOUN
ajlm-1537	124	85	was	be	AUX
ajlm-1537	124	86	observed	observe	VERB
ajlm-1537	124	87	in	in	ADP
ajlm-1537	124	88	59.8	59.8	NUM
ajlm-1537	124	89	%	%	NOUN
ajlm-1537	124	90	of	of	ADP
ajlm-1537	124	91	patients	patient	NOUN
ajlm-1537	124	92	,	,	PUNCT
ajlm-1537	124	93	and	and	CCONJ
ajlm-1537	124	94	the	the	DET
ajlm-1537	124	95	5	5	NUM
ajlm-1537	124	96	-	-	PUNCT
ajlm-1537	124	97	year	year	NOUN
ajlm-1537	124	98	event	event	NOUN
ajlm-1537	124	99	-	-	PUNCT
ajlm-1537	124	100	free	free	ADJ
ajlm-1537	124	101	survival	survival	NOUN
ajlm-1537	124	102	was	be	AUX
ajlm-1537	124	103	64.0%.39	64.0%.39	ADV
ajlm-1537	124	104	relapsed	relapse	VERB
ajlm-1537	124	105	or	or	CCONJ
ajlm-1537	124	106	refractory	refractory	NOUN
ajlm-1537	124	107	disease	disease	NOUN
ajlm-1537	124	108	is	be	AUX
ajlm-1537	124	109	thus	thus	ADV
ajlm-1537	124	110	still	still	ADV
ajlm-1537	124	111	an	an	DET
ajlm-1537	124	112	important	important	ADJ
ajlm-1537	124	113	factor	factor	NOUN
ajlm-1537	124	114	to	to	PART
ajlm-1537	124	115	consider	consider	VERB
ajlm-1537	124	116	in	in	ADP
ajlm-1537	124	117	the	the	DET
ajlm-1537	124	118	outcomes	outcome	NOUN
ajlm-1537	124	119	of	of	ADP
ajlm-1537	124	120	these	these	DET
ajlm-1537	124	121	patients	patient	NOUN
ajlm-1537	124	122	,	,	PUNCT
ajlm-1537	124	123	with	with	ADP
ajlm-1537	124	124	many	many	ADJ
ajlm-1537	124	125	either	either	CCONJ
ajlm-1537	124	126	needing	need	VERB
ajlm-1537	124	127	a	a	DET
ajlm-1537	124	128	second	second	ADJ
ajlm-1537	124	129	course	course	NOUN
ajlm-1537	124	130	of	of	ADP
ajlm-1537	124	131	ist	ist	NOUN
ajlm-1537	124	132	or	or	CCONJ
ajlm-1537	124	133	an	an	DET
ajlm-1537	124	134	hsct	hsct	NOUN
ajlm-1537	124	135	.	.	PUNCT
ajlm-1537	125	1	this	this	DET
ajlm-1537	125	2	group	group	NOUN
ajlm-1537	125	3	found	find	VERB
ajlm-1537	125	4	that	that	SCONJ
ajlm-1537	125	5	hsct	hsct	NOUN
ajlm-1537	125	6	in	in	ADP
ajlm-1537	125	7	relapsed	relapse	VERB
ajlm-1537	125	8	/	/	SYM
ajlm-1537	125	9	refractory	refractory	NOUN
ajlm-1537	125	10	disease	disease	NOUN
ajlm-1537	125	11	was	be	AUX
ajlm-1537	125	12	the	the	DET
ajlm-1537	125	13	preferred	preferred	ADJ
ajlm-1537	125	14	treatment	treatment	NOUN
ajlm-1537	125	15	modality	modality	NOUN
ajlm-1537	125	16	,	,	PUNCT
ajlm-1537	125	17	rather	rather	ADV
ajlm-1537	125	18	than	than	ADP
ajlm-1537	125	19	a	a	DET
ajlm-1537	125	20	second	second	ADJ
ajlm-1537	125	21	course	course	NOUN
ajlm-1537	125	22	of	of	ADP
ajlm-1537	125	23	ist	ist	NOUN
ajlm-1537	125	24	.	.	PUNCT
ajlm-1537	126	1	while	while	SCONJ
ajlm-1537	126	2	hsct	hsct	PROPN
ajlm-1537	126	3	has	have	AUX
ajlm-1537	126	4	historically	historically	ADV
ajlm-1537	126	5	only	only	ADV
ajlm-1537	126	6	been	be	AUX
ajlm-1537	126	7	the	the	DET
ajlm-1537	126	8	preferred	prefer	VERB
ajlm-1537	126	9	front	front	ADJ
ajlm-1537	126	10	-	-	PUNCT
ajlm-1537	126	11	line	line	NOUN
ajlm-1537	126	12	therapy	therapy	NOUN
ajlm-1537	126	13	in	in	ADP
ajlm-1537	126	14	patients	patient	NOUN
ajlm-1537	126	15	having	have	VERB
ajlm-1537	126	16	a	a	DET
ajlm-1537	126	17	matched	match	VERB
ajlm-1537	126	18	sibling	sible	VERB
ajlm-1537	126	19	donor	donor	NOUN
ajlm-1537	126	20	,	,	PUNCT
ajlm-1537	126	21	a	a	DET
ajlm-1537	126	22	recent	recent	ADJ
ajlm-1537	126	23	report	report	NOUN
ajlm-1537	126	24	by	by	ADP
ajlm-1537	126	25	the	the	DET
ajlm-1537	126	26	united	united	PROPN
ajlm-1537	126	27	kingdom	kingdom	PROPN
ajlm-1537	126	28	paediatric	paediatric	PROPN
ajlm-1537	126	29	bmt	bmt	PROPN
ajlm-1537	126	30	working	working	PROPN
ajlm-1537	126	31	party	party	NOUN
ajlm-1537	126	32	,	,	PUNCT
ajlm-1537	126	33	paediatric	paediatric	ADJ
ajlm-1537	126	34	diseases	disease	NOUN
ajlm-1537	126	35	working	work	VERB
ajlm-1537	126	36	party	party	PROPN
ajlm-1537	126	37	and	and	CCONJ
ajlm-1537	126	38	severe	severe	ADJ
ajlm-1537	126	39	aplastic	aplastic	ADJ
ajlm-1537	126	40	anaemia	anaemia	NOUN
ajlm-1537	126	41	working	work	VERB
ajlm-1537	126	42	party	party	PROPN
ajlm-1537	126	43	of	of	ADP
ajlm-1537	126	44	the	the	DET
ajlm-1537	126	45	european	european	PROPN
ajlm-1537	126	46	society	society	PROPN
ajlm-1537	126	47	for	for	ADP
ajlm-1537	126	48	blood	blood	NOUN
ajlm-1537	126	49	and	and	CCONJ
ajlm-1537	126	50	marrow	marrow	NOUN
ajlm-1537	126	51	transplantation	transplantation	NOUN
ajlm-1537	126	52	showed	show	VERB
ajlm-1537	126	53	that	that	SCONJ
ajlm-1537	126	54	using	use	VERB
ajlm-1537	126	55	a	a	DET
ajlm-1537	126	56	matched	match	VERB
ajlm-1537	126	57	unrelated	unrelated	ADJ
ajlm-1537	126	58	-	-	PUNCT
ajlm-1537	126	59	donor	donor	NOUN
ajlm-1537	126	60	upfront	upfront	NOUN
ajlm-1537	126	61	had	have	VERB
ajlm-1537	126	62	similar	similar	ADJ
ajlm-1537	126	63	results	result	NOUN
ajlm-1537	126	64	to	to	PART
ajlm-1537	126	65	matched	match	VERB
ajlm-1537	126	66	sibling	sible	VERB
ajlm-1537	126	67	donors.40	donors.40	NOUN
ajlm-1537	126	68	importantly	importantly	ADV
ajlm-1537	126	69	,	,	PUNCT
ajlm-1537	126	70	patients	patient	NOUN
ajlm-1537	126	71	with	with	ADP
ajlm-1537	126	72	an	an	DET
ajlm-1537	126	73	upfront	upfront	ADJ
ajlm-1537	126	74	-	-	PUNCT
ajlm-1537	126	75	matched	match	VERB
ajlm-1537	126	76	unrelated	unrelated	ADJ
ajlm-1537	126	77	-	-	PUNCT
ajlm-1537	126	78	donor	donor	NOUN
ajlm-1537	126	79	hsct	hsct	NOUN
ajlm-1537	126	80	had	have	VERB
ajlm-1537	126	81	superior	superior	ADJ
ajlm-1537	126	82	outcomes	outcome	NOUN
ajlm-1537	126	83	than	than	ADP
ajlm-1537	126	84	patients	patient	NOUN
ajlm-1537	126	85	who	who	PRON
ajlm-1537	126	86	initially	initially	ADV
ajlm-1537	126	87	failed	fail	VERB
ajlm-1537	126	88	ist	ist	NOUN
ajlm-1537	126	89	and	and	CCONJ
ajlm-1537	126	90	then	then	ADV
ajlm-1537	126	91	went	go	VERB
ajlm-1537	126	92	on	on	ADP
ajlm-1537	126	93	to	to	PART
ajlm-1537	126	94	receive	receive	VERB
ajlm-1537	126	95	a	a	DET
ajlm-1537	126	96	matched	match	VERB
ajlm-1537	126	97	unrelated	unrelated	ADJ
ajlm-1537	126	98	-	-	PUNCT
ajlm-1537	126	99	donor	donor	NOUN
ajlm-1537	126	100	hsct	hsct	NOUN
ajlm-1537	126	101	.	.	PUNCT
ajlm-1537	127	1	regarding	regard	VERB
ajlm-1537	127	2	the	the	DET
ajlm-1537	127	3	timing	timing	NOUN
ajlm-1537	127	4	of	of	ADP
ajlm-1537	127	5	ist	ist	NOUN
ajlm-1537	127	6	administration	administration	NOUN
ajlm-1537	127	7	,	,	PUNCT
ajlm-1537	127	8	it	it	PRON
ajlm-1537	127	9	is	be	AUX
ajlm-1537	127	10	important	important	ADJ
ajlm-1537	127	11	to	to	PART
ajlm-1537	127	12	note	note	VERB
ajlm-1537	127	13	that	that	SCONJ
ajlm-1537	127	14	in	in	ADP
ajlm-1537	127	15	south	south	PROPN
ajlm-1537	127	16	africa	africa	PROPN
ajlm-1537	127	17	,	,	PUNCT
ajlm-1537	127	18	the	the	DET
ajlm-1537	127	19	genetic	genetic	ADJ
ajlm-1537	127	20	diversity	diversity	NOUN
ajlm-1537	127	21	of	of	ADP
ajlm-1537	127	22	the	the	DET
ajlm-1537	127	23	population	population	NOUN
ajlm-1537	127	24	is	be	AUX
ajlm-1537	127	25	such	such	ADJ
ajlm-1537	127	26	that	that	SCONJ
ajlm-1537	127	27	less	less	ADJ
ajlm-1537	127	28	than	than	ADP
ajlm-1537	127	29	20.0	20.0	NUM
ajlm-1537	127	30	%	%	NOUN
ajlm-1537	127	31	of	of	ADP
ajlm-1537	127	32	patients	patient	NOUN
ajlm-1537	127	33	(	(	PUNCT
ajlm-1537	127	34	non	non	ADJ
ajlm-1537	127	35	-	-	ADJ
ajlm-1537	127	36	european	european	ADJ
ajlm-1537	127	37	)	)	PUNCT
ajlm-1537	127	38	will	will	AUX
ajlm-1537	127	39	have	have	VERB
ajlm-1537	127	40	an	an	DET
ajlm-1537	127	41	hla	hla	PROPN
ajlm-1537	127	42	match	match	NOUN
ajlm-1537	127	43	for	for	ADP
ajlm-1537	127	44	hsct.41,42	hsct.41,42	NOUN
ajlm-1537	127	45	although	although	SCONJ
ajlm-1537	127	46	the	the	DET
ajlm-1537	127	47	paucity	paucity	NOUN
ajlm-1537	127	48	of	of	ADP
ajlm-1537	127	49	african	african	ADJ
ajlm-1537	127	50	donors	donor	NOUN
ajlm-1537	127	51	is	be	AUX
ajlm-1537	127	52	certainly	certainly	ADV
ajlm-1537	127	53	a	a	DET
ajlm-1537	127	54	problem	problem	NOUN
ajlm-1537	127	55	,	,	PUNCT
ajlm-1537	127	56	the	the	DET
ajlm-1537	127	57	diversity	diversity	NOUN
ajlm-1537	127	58	within	within	ADP
ajlm-1537	127	59	the	the	DET
ajlm-1537	127	60	hla	hla	PROPN
ajlm-1537	127	61	region	region	NOUN
ajlm-1537	127	62	is	be	AUX
ajlm-1537	127	63	significant	significant	ADJ
ajlm-1537	127	64	,	,	PUNCT
ajlm-1537	127	65	even	even	ADV
ajlm-1537	127	66	among	among	ADP
ajlm-1537	127	67	typed	type	VERB
ajlm-1537	127	68	donors.20,43	donors.20,43	NOUN
ajlm-1537	127	69	once	once	SCONJ
ajlm-1537	127	70	abnormal	abnormal	ADJ
ajlm-1537	127	71	cytogenetics	cytogenetic	NOUN
ajlm-1537	127	72	,	,	PUNCT
ajlm-1537	127	73	inherited	inherit	VERB
ajlm-1537	127	74	bone	bone	NOUN
ajlm-1537	127	75	marrow	marrow	NOUN
ajlm-1537	127	76	failure	failure	NOUN
ajlm-1537	127	77	syndromes	syndrome	NOUN
ajlm-1537	127	78	and	and	CCONJ
ajlm-1537	127	79	malignancies	malignancy	NOUN
ajlm-1537	127	80	have	have	AUX
ajlm-1537	127	81	been	be	AUX
ajlm-1537	127	82	excluded	exclude	VERB
ajlm-1537	127	83	,	,	PUNCT
ajlm-1537	127	84	early	early	ADJ
ajlm-1537	127	85	initiation	initiation	NOUN
ajlm-1537	127	86	of	of	ADP
ajlm-1537	127	87	ist	ist	NOUN
ajlm-1537	127	88	is	be	AUX
ajlm-1537	127	89	recommended	recommend	VERB
ajlm-1537	127	90	as	as	ADP
ajlm-1537	127	91	a	a	DET
ajlm-1537	127	92	delay	delay	NOUN
ajlm-1537	127	93	may	may	AUX
ajlm-1537	127	94	lead	lead	VERB
ajlm-1537	127	95	to	to	ADP
ajlm-1537	127	96	increased	increase	VERB
ajlm-1537	127	97	morbidity	morbidity	NOUN
ajlm-1537	127	98	and	and	CCONJ
ajlm-1537	127	99	risk	risk	NOUN
ajlm-1537	127	100	of	of	ADP
ajlm-1537	127	101	mortality	mortality	NOUN
ajlm-1537	127	102	.	.	PUNCT
ajlm-1537	128	1	some	some	DET
ajlm-1537	128	2	studies	study	NOUN
ajlm-1537	128	3	suggest	suggest	VERB
ajlm-1537	128	4	that	that	SCONJ
ajlm-1537	128	5	the	the	DET
ajlm-1537	128	6	presence	presence	NOUN
ajlm-1537	128	7	of	of	ADP
ajlm-1537	128	8	a	a	DET
ajlm-1537	128	9	pnh	pnh	NOUN
ajlm-1537	128	10	clone	clone	NOUN
ajlm-1537	128	11	in	in	ADP
ajlm-1537	128	12	and	and	CCONJ
ajlm-1537	128	13	of	of	ADP
ajlm-1537	128	14	itself	itself	PRON
ajlm-1537	128	15	rules	rule	VERB
ajlm-1537	128	16	out	out	ADP
ajlm-1537	128	17	an	an	DET
ajlm-1537	128	18	inherited	inherit	VERB
ajlm-1537	128	19	bone	bone	NOUN
ajlm-1537	128	20	marrow	marrow	NOUN
ajlm-1537	128	21	failure	failure	NOUN
ajlm-1537	128	22	syndrome.1,29	syndrome.1,29	PROPN
ajlm-1537	129	1	this	this	PRON
ajlm-1537	129	2	may	may	AUX
ajlm-1537	129	3	further	far	ADV
ajlm-1537	129	4	aid	aid	VERB
ajlm-1537	129	5	the	the	DET
ajlm-1537	129	6	timeous	timeous	ADJ
ajlm-1537	129	7	initiation	initiation	NOUN
ajlm-1537	129	8	of	of	ADP
ajlm-1537	129	9	therapy	therapy	NOUN
ajlm-1537	129	10	.	.	PUNCT
ajlm-1537	130	1	limitations	limitation	NOUN
ajlm-1537	130	2	the	the	DET
ajlm-1537	130	3	lower	low	ADJ
ajlm-1537	130	4	limit	limit	NOUN
ajlm-1537	130	5	of	of	ADP
ajlm-1537	130	6	quantitation	quantitation	NOUN
ajlm-1537	130	7	or	or	CCONJ
ajlm-1537	130	8	detection	detection	NOUN
ajlm-1537	130	9	for	for	ADP
ajlm-1537	130	10	pnh	pnh	PROPN
ajlm-1537	130	11	clones	clone	NOUN
ajlm-1537	130	12	has	have	AUX
ajlm-1537	130	13	not	not	PART
ajlm-1537	130	14	been	be	AUX
ajlm-1537	130	15	defined	define	VERB
ajlm-1537	130	16	by	by	ADP
ajlm-1537	130	17	our	our	PRON
ajlm-1537	130	18	laboratory	laboratory	NOUN
ajlm-1537	130	19	.	.	PUNCT
ajlm-1537	131	1	the	the	DET
ajlm-1537	131	2	quantitative	quantitative	ADJ
ajlm-1537	131	3	values	value	NOUN
ajlm-1537	131	4	below	below	ADP
ajlm-1537	131	5	1.0	1.0	NUM
ajlm-1537	131	6	%	%	NOUN
ajlm-1537	131	7	must	must	AUX
ajlm-1537	131	8	thus	thus	ADV
ajlm-1537	131	9	be	be	AUX
ajlm-1537	131	10	interpreted	interpret	VERB
ajlm-1537	131	11	cautiously	cautiously	ADV
ajlm-1537	131	12	as	as	SCONJ
ajlm-1537	131	13	the	the	DET
ajlm-1537	131	14	external	external	ADJ
ajlm-1537	131	15	quality	quality	NOUN
ajlm-1537	131	16	assurance	assurance	NOUN
ajlm-1537	131	17	samples	sample	NOUN
ajlm-1537	131	18	analysed	analyse	VERB
ajlm-1537	131	19	in	in	ADP
ajlm-1537	131	20	the	the	DET
ajlm-1537	131	21	laboratory	laboratory	NOUN
ajlm-1537	131	22	have	have	VERB
ajlm-1537	131	23	clone	clone	NOUN
ajlm-1537	131	24	sizes	size	NOUN
ajlm-1537	131	25	greater	great	ADJ
ajlm-1537	131	26	than	than	ADP
ajlm-1537	131	27	1.0	1.0	NUM
ajlm-1537	131	28	%	%	NOUN
ajlm-1537	131	29	.	.	PUNCT
ajlm-1537	132	1	however	however	ADV
ajlm-1537	132	2	,	,	PUNCT
ajlm-1537	132	3	the	the	DET
ajlm-1537	132	4	external	external	ADJ
ajlm-1537	132	5	quality	quality	NOUN
ajlm-1537	132	6	assurance	assurance	NOUN
ajlm-1537	132	7	programme	programme	NOUN
ajlm-1537	132	8	used	use	VERB
ajlm-1537	132	9	for	for	ADP
ajlm-1537	132	10	minimal	minimal	ADJ
ajlm-1537	132	11	residual	residual	ADJ
ajlm-1537	132	12	disease	disease	NOUN
ajlm-1537	132	13	monitoring	monitor	VERB
ajlm-1537	132	14	verifies	verifie	NOUN
ajlm-1537	132	15	the	the	DET
ajlm-1537	132	16	accuracy	accuracy	NOUN
ajlm-1537	132	17	of	of	ADP
ajlm-1537	132	18	the	the	DET
ajlm-1537	132	19	laboratory	laboratory	NOUN
ajlm-1537	132	20	in	in	ADP
ajlm-1537	132	21	defining	define	VERB
ajlm-1537	132	22	clone	clone	NOUN
ajlm-1537	132	23	sizes	size	NOUN
ajlm-1537	132	24	below	below	ADP
ajlm-1537	132	25	0.1	0.1	NUM
ajlm-1537	132	26	%	%	NOUN
ajlm-1537	132	27	and	and	CCONJ
ajlm-1537	132	28	the	the	DET
ajlm-1537	132	29	identification	identification	NOUN
ajlm-1537	132	30	of	of	ADP
ajlm-1537	132	31	very	very	ADV
ajlm-1537	132	32	small	small	ADJ
ajlm-1537	132	33	clones	clone	NOUN
ajlm-1537	132	34	in	in	ADP
ajlm-1537	132	35	patients	patient	NOUN
ajlm-1537	132	36	with	with	ADP
ajlm-1537	132	37	bone	bone	NOUN
ajlm-1537	132	38	marrow	marrow	NOUN
ajlm-1537	132	39	failure	failure	NOUN
ajlm-1537	132	40	has	have	AUX
ajlm-1537	132	41	been	be	AUX
ajlm-1537	132	42	consistently	consistently	ADV
ajlm-1537	132	43	reported	report	VERB
ajlm-1537	132	44	in	in	ADP
ajlm-1537	132	45	the	the	DET
ajlm-1537	132	46	literature	literature	NOUN
ajlm-1537	132	47	.	.	PUNCT
ajlm-1537	133	1	for	for	ADP
ajlm-1537	133	2	this	this	DET
ajlm-1537	133	3	reason	reason	NOUN
ajlm-1537	133	4	,	,	PUNCT
ajlm-1537	133	5	we	we	PRON
ajlm-1537	133	6	have	have	AUX
ajlm-1537	133	7	opted	opt	VERB
ajlm-1537	133	8	to	to	PART
ajlm-1537	133	9	include	include	VERB
ajlm-1537	133	10	all	all	DET
ajlm-1537	133	11	clones	clone	NOUN
ajlm-1537	133	12	.	.	PUNCT
ajlm-1537	134	1	the	the	DET
ajlm-1537	134	2	sample	sample	NOUN
ajlm-1537	134	3	size	size	NOUN
ajlm-1537	134	4	is	be	AUX
ajlm-1537	134	5	small	small	ADJ
ajlm-1537	134	6	;	;	PUNCT
ajlm-1537	134	7	however	however	ADV
ajlm-1537	134	8	,	,	PUNCT
ajlm-1537	134	9	this	this	PRON
ajlm-1537	134	10	is	be	AUX
ajlm-1537	134	11	attributable	attributable	ADJ
ajlm-1537	134	12	to	to	ADP
ajlm-1537	134	13	the	the	DET
ajlm-1537	134	14	rarity	rarity	NOUN
ajlm-1537	134	15	of	of	ADP
ajlm-1537	134	16	pnh	pnh	PROPN
ajlm-1537	134	17	in	in	ADP
ajlm-1537	134	18	the	the	DET
ajlm-1537	134	19	paediatric	paediatric	ADJ
ajlm-1537	134	20	population	population	NOUN
ajlm-1537	134	21	and	and	CCONJ
ajlm-1537	134	22	the	the	DET
ajlm-1537	134	23	lack	lack	NOUN
ajlm-1537	134	24	of	of	ADP
ajlm-1537	134	25	testing	testing	NOUN
ajlm-1537	134	26	in	in	ADP
ajlm-1537	134	27	all	all	DET
ajlm-1537	134	28	paediatric	paediatric	ADJ
ajlm-1537	134	29	patients	patient	NOUN
ajlm-1537	134	30	with	with	ADP
ajlm-1537	134	31	aa	aa	NOUN
ajlm-1537	134	32	.	.	PUNCT
ajlm-1537	135	1	it	it	PRON
ajlm-1537	135	2	is	be	AUX
ajlm-1537	135	3	thus	thus	ADV
ajlm-1537	135	4	not	not	PART
ajlm-1537	135	5	possible	possible	ADJ
ajlm-1537	135	6	to	to	PART
ajlm-1537	135	7	make	make	VERB
ajlm-1537	135	8	any	any	DET
ajlm-1537	135	9	definitive	definitive	ADJ
ajlm-1537	135	10	conclusions	conclusion	NOUN
ajlm-1537	135	11	regarding	regard	VERB
ajlm-1537	135	12	any	any	DET
ajlm-1537	135	13	observed	observed	ADJ
ajlm-1537	135	14	differences	difference	NOUN
ajlm-1537	135	15	between	between	ADP
ajlm-1537	135	16	the	the	DET
ajlm-1537	135	17	two	two	NUM
ajlm-1537	135	18	populations	population	NOUN
ajlm-1537	135	19	.	.	PUNCT
ajlm-1537	136	1	additionally	additionally	ADV
ajlm-1537	136	2	,	,	PUNCT
ajlm-1537	136	3	the	the	DET
ajlm-1537	136	4	pnh	pnh	PROPN
ajlm-1537	136	5	-	-	PUNCT
ajlm-1537	136	6	negative	negative	ADJ
ajlm-1537	136	7	group	group	NOUN
ajlm-1537	136	8	was	be	AUX
ajlm-1537	136	9	not	not	PART
ajlm-1537	136	10	monitored	monitor	VERB
ajlm-1537	136	11	for	for	ADP
ajlm-1537	136	12	the	the	DET
ajlm-1537	136	13	subsequent	subsequent	ADJ
ajlm-1537	136	14	development	development	NOUN
ajlm-1537	136	15	of	of	ADP
ajlm-1537	136	16	a	a	DET
ajlm-1537	136	17	pnh	pnh	PROPN
ajlm-1537	136	18	clone	clone	NOUN
ajlm-1537	136	19	and	and	CCONJ
ajlm-1537	136	20	the	the	DET
ajlm-1537	136	21	clone	clone	NOUN
ajlm-1537	136	22	sizes	size	NOUN
ajlm-1537	136	23	in	in	ADP
ajlm-1537	136	24	pnh	pnh	PROPN
ajlm-1537	136	25	-	-	PUNCT
ajlm-1537	136	26	positive	positive	ADJ
ajlm-1537	136	27	patients	patient	NOUN
ajlm-1537	136	28	were	be	AUX
ajlm-1537	136	29	not	not	PART
ajlm-1537	136	30	monitored	monitor	VERB
ajlm-1537	136	31	and	and	CCONJ
ajlm-1537	136	32	correlated	correlate	VERB
ajlm-1537	136	33	to	to	ADP
ajlm-1537	136	34	clinical	clinical	ADJ
ajlm-1537	136	35	outcomes	outcome	NOUN
ajlm-1537	136	36	.	.	PUNCT
ajlm-1537	137	1	with	with	ADP
ajlm-1537	137	2	clear	clear	ADJ
ajlm-1537	137	3	evidence	evidence	NOUN
ajlm-1537	137	4	of	of	ADP
ajlm-1537	137	5	the	the	DET
ajlm-1537	137	6	risk	risk	NOUN
ajlm-1537	137	7	of	of	ADP
ajlm-1537	137	8	developing	develop	VERB
ajlm-1537	137	9	clinical	clinical	ADJ
ajlm-1537	137	10	pnh	pnh	PROPN
ajlm-1537	137	11	in	in	ADP
ajlm-1537	137	12	future,2	future,2	NOUN
ajlm-1537	137	13	these	these	PRON
ajlm-1537	137	14	are	be	AUX
ajlm-1537	137	15	important	important	ADJ
ajlm-1537	137	16	factors	factor	NOUN
ajlm-1537	137	17	to	to	PART
ajlm-1537	137	18	consider	consider	VERB
ajlm-1537	137	19	in	in	ADP
ajlm-1537	137	20	the	the	DET
ajlm-1537	137	21	future	future	ADJ
ajlm-1537	137	22	management	management	NOUN
ajlm-1537	137	23	of	of	ADP
ajlm-1537	137	24	these	these	DET
ajlm-1537	137	25	patients	patient	NOUN
ajlm-1537	137	26	.	.	PUNCT
ajlm-1537	138	1	conclusion	conclusion	VERB
ajlm-1537	138	2	our	our	PRON
ajlm-1537	138	3	study	study	NOUN
ajlm-1537	138	4	found	find	VERB
ajlm-1537	138	5	a	a	DET
ajlm-1537	138	6	very	very	ADV
ajlm-1537	138	7	high	high	ADJ
ajlm-1537	138	8	prevalence	prevalence	NOUN
ajlm-1537	138	9	of	of	ADP
ajlm-1537	138	10	pnh	pnh	PROPN
ajlm-1537	138	11	clones	clone	NOUN
ajlm-1537	138	12	in	in	ADP
ajlm-1537	138	13	patients	patient	NOUN
ajlm-1537	138	14	with	with	ADP
ajlm-1537	138	15	aa	aa	PROPN
ajlm-1537	138	16	.	.	PUNCT
ajlm-1537	139	1	patients	patient	NOUN
ajlm-1537	139	2	with	with	ADP
ajlm-1537	139	3	pnh	pnh	PROPN
ajlm-1537	139	4	clones	clone	NOUN
ajlm-1537	139	5	were	be	AUX
ajlm-1537	139	6	older	old	ADJ
ajlm-1537	139	7	at	at	ADP
ajlm-1537	139	8	presentation	presentation	NOUN
ajlm-1537	139	9	and	and	CCONJ
ajlm-1537	139	10	had	have	VERB
ajlm-1537	139	11	significantly	significantly	ADV
ajlm-1537	139	12	lower	low	ADJ
ajlm-1537	139	13	total	total	ADJ
ajlm-1537	139	14	white	white	ADJ
ajlm-1537	139	15	cell	cell	NOUN
ajlm-1537	139	16	counts	count	NOUN
ajlm-1537	139	17	.	.	PUNCT
ajlm-1537	140	1	a	a	DET
ajlm-1537	140	2	higher	high	ADJ
ajlm-1537	140	3	clone	clone	NOUN
ajlm-1537	140	4	size	size	NOUN
ajlm-1537	140	5	was	be	AUX
ajlm-1537	140	6	not	not	PART
ajlm-1537	140	7	associated	associate	VERB
ajlm-1537	140	8	with	with	ADP
ajlm-1537	140	9	a	a	DET
ajlm-1537	140	10	worse	bad	ADJ
ajlm-1537	140	11	clinical	clinical	ADJ
ajlm-1537	140	12	presentation	presentation	NOUN
ajlm-1537	140	13	.	.	PUNCT
ajlm-1537	141	1	patients	patient	NOUN
ajlm-1537	141	2	with	with	ADP
ajlm-1537	141	3	pnh	pnh	PROPN
ajlm-1537	141	4	clones	clone	NOUN
ajlm-1537	141	5	who	who	PRON
ajlm-1537	141	6	received	receive	VERB
ajlm-1537	141	7	ist	ist	NOUN
ajlm-1537	141	8	survived	survive	VERB
ajlm-1537	141	9	.	.	PUNCT
ajlm-1537	142	1	in	in	ADP
ajlm-1537	142	2	similar	similar	ADJ
ajlm-1537	142	3	settings	setting	NOUN
ajlm-1537	142	4	where	where	SCONJ
ajlm-1537	142	5	significant	significant	ADJ
ajlm-1537	142	6	hla	hla	NOUN
ajlm-1537	142	7	diversity	diversity	NOUN
ajlm-1537	142	8	exists	exist	VERB
ajlm-1537	142	9	and	and	CCONJ
ajlm-1537	142	10	in	in	ADP
ajlm-1537	142	11	the	the	DET
ajlm-1537	142	12	absence	absence	NOUN
ajlm-1537	142	13	of	of	ADP
ajlm-1537	142	14	a	a	DET
ajlm-1537	142	15	potential	potential	ADJ
ajlm-1537	142	16	sibling	sible	VERB
ajlm-1537	142	17	donor	donor	NOUN
ajlm-1537	142	18	,	,	PUNCT
ajlm-1537	142	19	once	once	SCONJ
ajlm-1537	142	20	malignancies	malignancy	NOUN
ajlm-1537	142	21	and	and	CCONJ
ajlm-1537	142	22	inherited	inherit	VERB
ajlm-1537	142	23	bone	bone	NOUN
ajlm-1537	142	24	marrow	marrow	NOUN
ajlm-1537	142	25	failure	failure	NOUN
ajlm-1537	142	26	syndromes	syndrome	NOUN
ajlm-1537	142	27	have	have	AUX
ajlm-1537	142	28	been	be	AUX
ajlm-1537	142	29	excluded	exclude	VERB
ajlm-1537	142	30	,	,	PUNCT
ajlm-1537	142	31	patients	patient	NOUN
ajlm-1537	142	32	presenting	present	VERB
ajlm-1537	142	33	with	with	ADP
ajlm-1537	142	34	aa	aa	NOUN
ajlm-1537	142	35	should	should	AUX
ajlm-1537	142	36	be	be	AUX
ajlm-1537	142	37	initiated	initiate	VERB
ajlm-1537	142	38	on	on	ADP
ajlm-1537	142	39	ist	ist	NOUN
ajlm-1537	142	40	even	even	ADV
ajlm-1537	142	41	while	while	SCONJ
ajlm-1537	142	42	awaiting	await	VERB
ajlm-1537	142	43	hla	hla	NOUN
ajlm-1537	142	44	typing	typing	NOUN
ajlm-1537	142	45	results	result	NOUN
ajlm-1537	142	46	.	.	PUNCT
ajlm-1537	143	1	larger	large	ADJ
ajlm-1537	143	2	studies	study	NOUN
ajlm-1537	143	3	are	be	AUX
ajlm-1537	143	4	needed	need	VERB
ajlm-1537	143	5	to	to	PART
ajlm-1537	143	6	further	far	ADV
ajlm-1537	143	7	determine	determine	VERB
ajlm-1537	143	8	the	the	DET
ajlm-1537	143	9	impact	impact	NOUN
ajlm-1537	143	10	of	of	ADP
ajlm-1537	143	11	pnh	pnh	PROPN
ajlm-1537	143	12	clones	clone	NOUN
ajlm-1537	143	13	on	on	ADP
ajlm-1537	143	14	the	the	DET
ajlm-1537	143	15	disease	disease	NOUN
ajlm-1537	143	16	course	course	NOUN
ajlm-1537	143	17	in	in	ADP
ajlm-1537	143	18	paediatric	paediatric	ADJ
ajlm-1537	143	19	patients	patient	NOUN
ajlm-1537	143	20	with	with	ADP
ajlm-1537	143	21	aa	aa	PROPN
ajlm-1537	143	22	.	.	PUNCT
ajlm-1537	144	1	acknowledgements	acknowledgement	NOUN
ajlm-1537	144	2	the	the	DET
ajlm-1537	144	3	authors	author	NOUN
ajlm-1537	144	4	acknowledge	acknowledge	VERB
ajlm-1537	144	5	dr	dr	PROPN
ajlm-1537	144	6	hamida	hamida	PROPN
ajlm-1537	144	7	van	van	PROPN
ajlm-1537	144	8	staaden	staaden	PROPN
ajlm-1537	144	9	who	who	PRON
ajlm-1537	144	10	assisted	assist	VERB
ajlm-1537	144	11	with	with	ADP
ajlm-1537	144	12	data	datum	NOUN
ajlm-1537	144	13	collection	collection	NOUN
ajlm-1537	144	14	for	for	ADP
ajlm-1537	144	15	the	the	DET
ajlm-1537	144	16	project	project	NOUN
ajlm-1537	144	17	.	.	PUNCT
ajlm-1537	145	1	competing	compete	VERB
ajlm-1537	145	2	interests	interest	NOUN
ajlm-1537	145	3	the	the	DET
ajlm-1537	145	4	authors	author	NOUN
ajlm-1537	145	5	declare	declare	VERB
ajlm-1537	145	6	that	that	SCONJ
ajlm-1537	145	7	they	they	PRON
ajlm-1537	145	8	have	have	VERB
ajlm-1537	145	9	no	no	DET
ajlm-1537	145	10	financial	financial	ADJ
ajlm-1537	145	11	or	or	CCONJ
ajlm-1537	145	12	personal	personal	ADJ
ajlm-1537	145	13	relationships	relationship	NOUN
ajlm-1537	145	14	that	that	PRON
ajlm-1537	145	15	may	may	AUX
ajlm-1537	145	16	have	have	AUX
ajlm-1537	145	17	inappropriately	inappropriately	ADV
ajlm-1537	145	18	influenced	influence	VERB
ajlm-1537	145	19	them	they	PRON
ajlm-1537	145	20	in	in	ADP
ajlm-1537	145	21	writing	write	VERB
ajlm-1537	145	22	this	this	DET
ajlm-1537	145	23	article	article	NOUN
ajlm-1537	145	24	.	.	PUNCT
ajlm-1537	146	1	authors	author	NOUN
ajlm-1537	146	2	’	’	PART
ajlm-1537	146	3	contributions	contribution	NOUN
ajlm-1537	146	4	c.l.h	c.l.h	NOUN
ajlm-1537	146	5	.	.	PUNCT
ajlm-1537	146	6	,	,	PUNCT
ajlm-1537	146	7	a.n	a.n	PROPN
ajlm-1537	146	8	.	.	PROPN
ajlm-1537	146	9	and	and	CCONJ
ajlm-1537	146	10	s.b	s.b	PROPN
ajlm-1537	146	11	.	.	PROPN
ajlm-1537	146	12	were	be	AUX
ajlm-1537	146	13	responsible	responsible	ADJ
ajlm-1537	146	14	for	for	ADP
ajlm-1537	146	15	conceptualisation	conceptualisation	NOUN
ajlm-1537	146	16	of	of	ADP
ajlm-1537	146	17	the	the	DET
ajlm-1537	146	18	study	study	NOUN
ajlm-1537	146	19	,	,	PUNCT
ajlm-1537	146	20	protocol	protocol	NOUN
ajlm-1537	146	21	preparation	preparation	NOUN
ajlm-1537	146	22	,	,	PUNCT
ajlm-1537	146	23	data	data	VERB
ajlm-1537	146	24	analysis	analysis	NOUN
ajlm-1537	146	25	and	and	CCONJ
ajlm-1537	146	26	write	write	VERB
ajlm-1537	146	27	up	up	ADP
ajlm-1537	146	28	of	of	ADP
ajlm-1537	146	29	the	the	DET
ajlm-1537	146	30	manuscript	manuscript	NOUN
ajlm-1537	146	31	;	;	PUNCT
ajlm-1537	146	32	r.t	r.t	PROPN
ajlm-1537	146	33	.	.	PROPN
ajlm-1537	146	34	,	,	PUNCT
ajlm-1537	146	35	n.r	n.r	PROPN
ajlm-1537	146	36	.	.	PROPN
ajlm-1537	146	37	,	,	PUNCT
ajlm-1537	146	38	b.n	b.n	PROPN
ajlm-1537	146	39	.	.	PROPN
ajlm-1537	146	40	and	and	CCONJ
ajlm-1537	146	41	y.g	y.g	PROPN
ajlm-1537	146	42	.	.	PROPN
ajlm-1537	146	43	were	be	AUX
ajlm-1537	146	44	responsible	responsible	ADJ
ajlm-1537	146	45	for	for	ADP
ajlm-1537	146	46	data	data	NOUN
ajlm-1537	146	47	analysis	analysis	NOUN
ajlm-1537	146	48	,	,	PUNCT
ajlm-1537	146	49	and	and	CCONJ
ajlm-1537	146	50	write	write	VERB
ajlm-1537	146	51	up	up	ADP
ajlm-1537	146	52	of	of	ADP
ajlm-1537	146	53	the	the	DET
ajlm-1537	146	54	manuscript	manuscript	NOUN
ajlm-1537	146	55	;	;	PUNCT
ajlm-1537	146	56	c.l.h	c.l.h	PROPN
ajlm-1537	146	57	.	.	PUNCT
ajlm-1537	147	1	collected	collect	VERB
ajlm-1537	147	2	the	the	DET
ajlm-1537	147	3	data	datum	NOUN
ajlm-1537	147	4	.	.	PUNCT
ajlm-1537	148	1	sources	source	NOUN
ajlm-1537	148	2	of	of	ADP
ajlm-1537	148	3	support	support	NOUN
ajlm-1537	148	4	this	this	DET
ajlm-1537	148	5	research	research	NOUN
ajlm-1537	148	6	received	receive	VERB
ajlm-1537	148	7	no	no	DET
ajlm-1537	148	8	specific	specific	ADJ
ajlm-1537	148	9	grant	grant	NOUN
ajlm-1537	148	10	from	from	ADP
ajlm-1537	148	11	any	any	DET
ajlm-1537	148	12	funding	funding	NOUN
ajlm-1537	148	13	agency	agency	NOUN
ajlm-1537	148	14	in	in	ADP
ajlm-1537	148	15	the	the	DET
ajlm-1537	148	16	public	public	ADJ
ajlm-1537	148	17	,	,	PUNCT
ajlm-1537	148	18	commercial	commercial	ADJ
ajlm-1537	148	19	or	or	CCONJ
ajlm-1537	148	20	not	not	PART
ajlm-1537	148	21	-	-	PUNCT
ajlm-1537	148	22	for	for	ADP
ajlm-1537	148	23	-	-	PUNCT
ajlm-1537	148	24	profit	profit	NOUN
ajlm-1537	148	25	sectors	sector	NOUN
ajlm-1537	148	26	.	.	PUNCT
ajlm-1537	149	1	data	datum	NOUN
ajlm-1537	149	2	availability	availability	NOUN
ajlm-1537	149	3	data	datum	NOUN
ajlm-1537	149	4	supporting	support	VERB
ajlm-1537	149	5	the	the	DET
ajlm-1537	149	6	findings	finding	NOUN
ajlm-1537	149	7	of	of	ADP
ajlm-1537	149	8	this	this	DET
ajlm-1537	149	9	study	study	NOUN
ajlm-1537	149	10	are	be	AUX
ajlm-1537	149	11	available	available	ADJ
ajlm-1537	149	12	from	from	ADP
ajlm-1537	149	13	the	the	DET
ajlm-1537	149	14	corresponding	corresponding	ADJ
ajlm-1537	149	15	author	author	NOUN
ajlm-1537	149	16	,	,	PUNCT
ajlm-1537	149	17	c.l.h	c.l.h	PROPN
ajlm-1537	149	18	.	.	PUNCT
ajlm-1537	149	19	,	,	PUNCT
ajlm-1537	149	20	on	on	ADP
ajlm-1537	149	21	request	request	NOUN
ajlm-1537	149	22	.	.	PUNCT
ajlm-1537	150	1	disclaimer	disclaimer	VERB
ajlm-1537	150	2	the	the	DET
ajlm-1537	150	3	views	view	NOUN
ajlm-1537	150	4	and	and	CCONJ
ajlm-1537	150	5	opinions	opinion	NOUN
ajlm-1537	150	6	expressed	express	VERB
ajlm-1537	150	7	in	in	ADP
ajlm-1537	150	8	this	this	DET
ajlm-1537	150	9	article	article	NOUN
ajlm-1537	150	10	are	be	AUX
ajlm-1537	150	11	those	those	PRON
ajlm-1537	150	12	of	of	ADP
ajlm-1537	150	13	the	the	DET
ajlm-1537	150	14	authors	author	NOUN
ajlm-1537	150	15	and	and	CCONJ
ajlm-1537	150	16	do	do	AUX
ajlm-1537	150	17	not	not	PART
ajlm-1537	150	18	necessarily	necessarily	ADV
ajlm-1537	150	19	reflect	reflect	VERB
ajlm-1537	150	20	the	the	DET
ajlm-1537	150	21	official	official	ADJ
ajlm-1537	150	22	policy	policy	NOUN
ajlm-1537	150	23	or	or	CCONJ
ajlm-1537	150	24	position	position	NOUN
ajlm-1537	150	25	of	of	ADP
ajlm-1537	150	26	any	any	DET
ajlm-1537	150	27	affiliated	affiliated	ADJ
ajlm-1537	150	28	agency	agency	NOUN
ajlm-1537	150	29	of	of	ADP
ajlm-1537	150	30	the	the	DET
ajlm-1537	150	31	authors	author	NOUN
ajlm-1537	150	32	.	.	PUNCT
ajlm-1537	151	1	references	reference	NOUN
ajlm-1537	151	2	rahman	rahman	PROPN
ajlm-1537	151	3	k	k	PROPN
ajlm-1537	151	4	,	,	PUNCT
ajlm-1537	151	5	mittal	mittal	PROPN
ajlm-1537	151	6	n	n	CCONJ
ajlm-1537	151	7	,	,	PUNCT
ajlm-1537	151	8	gupta	gupta	PROPN
ajlm-1537	151	9	r	r	NOUN
ajlm-1537	151	10	,	,	PUNCT
ajlm-1537	151	11	et	et	PROPN
ajlm-1537	151	12	al	al	PROPN
ajlm-1537	151	13	.	.	PROPN
ajlm-1537	151	14	clinicopathological	clinicopathological	ADJ
ajlm-1537	151	15	profile	profile	NOUN
ajlm-1537	151	16	of	of	ADP
ajlm-1537	151	17	paroxysmal	paroxysmal	ADJ
ajlm-1537	151	18	nocturnal	nocturnal	ADJ
ajlm-1537	151	19	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	151	20	clone	clone	NOUN
ajlm-1537	151	21	-	-	PUNCT
ajlm-1537	151	22	positive	positive	ADJ
ajlm-1537	151	23	aplastic	aplastic	ADJ
ajlm-1537	151	24	anaemia	anaemia	NOUN
ajlm-1537	151	25	paediatric	paediatric	ADJ
ajlm-1537	151	26	patients	patient	NOUN
ajlm-1537	151	27	–	–	PUNCT
ajlm-1537	151	28	a	a	DET
ajlm-1537	151	29	single	single	ADJ
ajlm-1537	151	30	centre	centre	NOUN
ajlm-1537	151	31	study	study	NOUN
ajlm-1537	151	32	from	from	ADP
ajlm-1537	151	33	north	north	PROPN
ajlm-1537	151	34	india	india	PROPN
ajlm-1537	151	35	.	.	PUNCT
ajlm-1537	152	1	int	int	PROPN
ajlm-1537	152	2	j	j	PROPN
ajlm-1537	152	3	lab	lab	NOUN
ajlm-1537	152	4	hematol	hematol	NOUN
ajlm-1537	152	5	.	.	PUNCT
ajlm-1537	153	1	2018;40(5):604–610	2018;40(5):604–610	NUM
ajlm-1537	153	2	.	.	PUNCT
ajlm-1537	153	3	https://doi.org/10.1111/ijlh.12875	https://doi.org/10.1111/ijlh.12875	PROPN
ajlm-1537	153	4	narita	narita	PROPN
ajlm-1537	153	5	a	a	X
ajlm-1537	153	6	,	,	PUNCT
ajlm-1537	153	7	muramatsu	muramatsu	ADJ
ajlm-1537	153	8	h	h	NOUN
ajlm-1537	153	9	,	,	PUNCT
ajlm-1537	153	10	okuno	okuno	PROPN
ajlm-1537	153	11	y	y	PROPN
ajlm-1537	153	12	,	,	PUNCT
ajlm-1537	153	13	et	et	PROPN
ajlm-1537	153	14	al	al	PROPN
ajlm-1537	153	15	.	.	PUNCT
ajlm-1537	153	16	development	development	NOUN
ajlm-1537	153	17	of	of	ADP
ajlm-1537	153	18	clinical	clinical	ADJ
ajlm-1537	153	19	paroxysmal	paroxysmal	ADJ
ajlm-1537	153	20	nocturnal	nocturnal	ADJ
ajlm-1537	153	21	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	153	22	in	in	ADP
ajlm-1537	153	23	children	child	NOUN
ajlm-1537	153	24	with	with	ADP
ajlm-1537	153	25	aplastic	aplastic	ADJ
ajlm-1537	153	26	anaemia	anaemia	NOUN
ajlm-1537	153	27	.	.	PUNCT
ajlm-1537	154	1	br	br	PROPN
ajlm-1537	154	2	j	j	PROPN
ajlm-1537	154	3	haematol	haematol	NOUN
ajlm-1537	154	4	.	.	PUNCT
ajlm-1537	155	1	2017;178(6):954–958	2017;178(6):954–958	NUM
ajlm-1537	155	2	.	.	PUNCT
ajlm-1537	156	1	https://doi.org/10.1111/bjh.14790	https://doi.org/10.1111/bjh.14790	NOUN
ajlm-1537	156	2	fletcher	fletcher	PROPN
ajlm-1537	156	3	m	m	PROPN
ajlm-1537	156	4	,	,	PUNCT
ajlm-1537	156	5	whitby	whitby	PROPN
ajlm-1537	156	6	l	l	PROPN
ajlm-1537	156	7	,	,	PUNCT
ajlm-1537	156	8	whitby	whitby	PROPN
ajlm-1537	156	9	a	a	X
ajlm-1537	156	10	,	,	PUNCT
ajlm-1537	156	11	barnett	barnett	PROPN
ajlm-1537	156	12	d.	d.	PROPN
ajlm-1537	156	13	current	current	PROPN
ajlm-1537	156	14	international	international	PROPN
ajlm-1537	156	15	flow	flow	NOUN
ajlm-1537	156	16	cytometric	cytometric	ADJ
ajlm-1537	156	17	practices	practice	NOUN
ajlm-1537	156	18	for	for	ADP
ajlm-1537	156	19	the	the	DET
ajlm-1537	156	20	detection	detection	NOUN
ajlm-1537	156	21	and	and	CCONJ
ajlm-1537	156	22	monitoring	monitoring	NOUN
ajlm-1537	156	23	of	of	ADP
ajlm-1537	156	24	paroxysmal	paroxysmal	ADJ
ajlm-1537	156	25	nocturnal	nocturnal	ADJ
ajlm-1537	156	26	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	156	27	clones	clone	NOUN
ajlm-1537	156	28	:	:	PUNCT
ajlm-1537	156	29	a	a	DET
ajlm-1537	156	30	uk	uk	PROPN
ajlm-1537	156	31	neqas	neqas	NOUN
ajlm-1537	156	32	survey	survey	NOUN
ajlm-1537	156	33	.	.	PUNCT
ajlm-1537	157	1	cytom	cytom	PROPN
ajlm-1537	157	2	part	part	PROPN
ajlm-1537	157	3	b	b	PROPN
ajlm-1537	157	4	clin	clin	PROPN
ajlm-1537	157	5	cytom	cytom	PROPN
ajlm-1537	157	6	.	.	PUNCT
ajlm-1537	158	1	2017;92(4):266–274	2017;92(4):266–274	NUM
ajlm-1537	158	2	.	.	PUNCT
ajlm-1537	158	3	https://doi.org/10.1002/cyto.b.21368	https://doi.org/10.1002/cyto.b.21368	PUNCT
ajlm-1537	159	1	van	van	PROPN
ajlm-1537	159	2	den	den	PROPN
ajlm-1537	159	3	heuvel	heuvel	PROPN
ajlm-1537	159	4	-	-	PUNCT
ajlm-1537	159	5	eibrink	eibrink	VERB
ajlm-1537	159	6	mm	mm	PROPN
ajlm-1537	159	7	,	,	PUNCT
ajlm-1537	159	8	bredius	bredius	PROPN
ajlm-1537	159	9	rgm	rgm	PROPN
ajlm-1537	159	10	,	,	PUNCT
ajlm-1537	159	11	te	te	PROPN
ajlm-1537	159	12	winkel	winkel	PROPN
ajlm-1537	159	13	ml	ml	PROPN
ajlm-1537	159	14	,	,	PUNCT
ajlm-1537	159	15	et	et	PROPN
ajlm-1537	159	16	al	al	PROPN
ajlm-1537	159	17	.	.	PUNCT
ajlm-1537	160	1	childhood	childhood	PROPN
ajlm-1537	160	2	paroxysmal	paroxysmal	ADJ
ajlm-1537	160	3	nocturnal	nocturnal	ADJ
ajlm-1537	160	4	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	160	5	(	(	PUNCT
ajlm-1537	160	6	pnh	pnh	PROPN
ajlm-1537	160	7	)	)	PUNCT
ajlm-1537	160	8	,	,	PUNCT
ajlm-1537	160	9	a	a	DET
ajlm-1537	160	10	report	report	NOUN
ajlm-1537	160	11	of	of	ADP
ajlm-1537	160	12	11	11	NUM
ajlm-1537	160	13	cases	case	NOUN
ajlm-1537	160	14	in	in	ADP
ajlm-1537	160	15	the	the	DET
ajlm-1537	160	16	netherlands	netherlands	PROPN
ajlm-1537	160	17	.	.	PUNCT
ajlm-1537	161	1	br	br	PROPN
ajlm-1537	161	2	j	j	PROPN
ajlm-1537	161	3	haematol	haematol	NOUN
ajlm-1537	161	4	.	.	PUNCT
ajlm-1537	162	1	2005;128(4):571–577	2005;128(4):571–577	NUM
ajlm-1537	162	2	.	.	PUNCT
ajlm-1537	162	3	https://doi.org/10.1111/j.1365-2141.2004.05337.x	https://doi.org/10.1111/j.1365-2141.2004.05337.x	PROPN
ajlm-1537	162	4	luzzatto	luzzatto	PROPN
ajlm-1537	162	5	l	l	PROPN
ajlm-1537	162	6	,	,	PUNCT
ajlm-1537	162	7	risitano	risitano	PROPN
ajlm-1537	162	8	am	be	AUX
ajlm-1537	162	9	.	.	PUNCT
ajlm-1537	163	1	advances	advance	NOUN
ajlm-1537	163	2	in	in	ADP
ajlm-1537	163	3	understanding	understand	VERB
ajlm-1537	163	4	the	the	DET
ajlm-1537	163	5	pathogenesis	pathogenesis	NOUN
ajlm-1537	163	6	of	of	ADP
ajlm-1537	163	7	acquired	acquire	VERB
ajlm-1537	163	8	aplastic	aplastic	ADJ
ajlm-1537	163	9	anaemia	anaemia	NOUN
ajlm-1537	163	10	.	.	PUNCT
ajlm-1537	164	1	br	br	PROPN
ajlm-1537	164	2	j	j	PROPN
ajlm-1537	164	3	haematol	haematol	NOUN
ajlm-1537	164	4	.	.	PUNCT
ajlm-1537	165	1	2018;182(6):758–776	2018;182(6):758–776	X
ajlm-1537	165	2	.	.	PROPN
ajlm-1537	166	1	https://doi.org/10.1111/bjh.15443	https://doi.org/10.1111/bjh.15443	PROPN
ajlm-1537	166	2	schubert	schubert	PROPN
ajlm-1537	166	3	j	j	PROPN
ajlm-1537	166	4	,	,	PUNCT
ajlm-1537	166	5	röth	röth	NOUN
ajlm-1537	166	6	a.	a.	NOUN
ajlm-1537	166	7	update	update	NOUN
ajlm-1537	166	8	on	on	ADP
ajlm-1537	166	9	paroxysmal	paroxysmal	ADJ
ajlm-1537	166	10	nocturnal	nocturnal	ADJ
ajlm-1537	166	11	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	166	12	:	:	PUNCT
ajlm-1537	166	13	on	on	ADP
ajlm-1537	166	14	the	the	DET
ajlm-1537	166	15	long	long	ADJ
ajlm-1537	166	16	way	way	NOUN
ajlm-1537	166	17	to	to	PART
ajlm-1537	166	18	understand	understand	VERB
ajlm-1537	166	19	the	the	DET
ajlm-1537	166	20	principles	principle	NOUN
ajlm-1537	166	21	of	of	ADP
ajlm-1537	166	22	the	the	DET
ajlm-1537	166	23	disease	disease	NOUN
ajlm-1537	166	24	.	.	PUNCT
ajlm-1537	167	1	eur	eur	PROPN
ajlm-1537	167	2	j	j	PROPN
ajlm-1537	167	3	haematol	haematol	NOUN
ajlm-1537	167	4	.	.	PUNCT
ajlm-1537	168	1	2015;94(6):464–473	2015;94(6):464–473	X
ajlm-1537	168	2	.	.	PUNCT
ajlm-1537	168	3	https://doi.org/10.1111/ejh.12520	https://doi.org/10.1111/ejh.12520	PROPN
ajlm-1537	168	4	dezern	dezern	PROPN
ajlm-1537	168	5	ae	ae	PROPN
ajlm-1537	168	6	,	,	PUNCT
ajlm-1537	168	7	borowitz	borowitz	PROPN
ajlm-1537	168	8	mj	mj	PROPN
ajlm-1537	168	9	.	.	PROPN
ajlm-1537	168	10	iccs	iccs	PROPN
ajlm-1537	168	11	/	/	SYM
ajlm-1537	168	12	escca	escca	NOUN
ajlm-1537	168	13	consensus	consensus	NOUN
ajlm-1537	168	14	guidelines	guideline	NOUN
ajlm-1537	168	15	to	to	PART
ajlm-1537	168	16	detect	detect	VERB
ajlm-1537	168	17	gpi	gpi	PROPN
ajlm-1537	168	18	-	-	PUNCT
ajlm-1537	168	19	deficient	deficient	ADJ
ajlm-1537	168	20	cells	cell	NOUN
ajlm-1537	168	21	in	in	ADP
ajlm-1537	168	22	paroxysmal	paroxysmal	ADJ
ajlm-1537	168	23	nocturnal	nocturnal	ADJ
ajlm-1537	168	24	hemoglobinuria	hemoglobinuria	NOUN
ajlm-1537	168	25	(	(	PUNCT
ajlm-1537	168	26	pnh	pnh	PROPN
ajlm-1537	168	27	)	)	PUNCT
ajlm-1537	168	28	and	and	CCONJ
ajlm-1537	168	29	related	related	ADJ
ajlm-1537	168	30	disorders	disorder	NOUN
ajlm-1537	168	31	part	part	NOUN
ajlm-1537	168	32	1	1	NUM
ajlm-1537	168	33	–	–	PUNCT
ajlm-1537	168	34	clinical	clinical	ADJ
ajlm-1537	168	35	utility	utility	NOUN
ajlm-1537	168	36	.	.	PUNCT
ajlm-1537	169	1	cytom	cytom	PROPN
ajlm-1537	169	2	part	part	PROPN
ajlm-1537	169	3	b	b	PROPN
ajlm-1537	169	4	clin	clin	PROPN
ajlm-1537	169	5	cytom	cytom	NOUN
ajlm-1537	169	6	.	.	PUNCT
ajlm-1537	170	1	2018;94(1):16–22	2018;94(1):16–22	X
ajlm-1537	170	2	.	.	PUNCT
ajlm-1537	170	3	https://doi.org/10.1002/cyto.b.21608	https://doi.org/10.1002/cyto.b.21608	PROPN
ajlm-1537	170	4	ware	ware	VERB
ajlm-1537	170	5	re	re	PROPN
ajlm-1537	170	6	,	,	PUNCT
ajlm-1537	170	7	hall	hall	PROPN
ajlm-1537	170	8	se	se	PROPN
ajlm-1537	170	9	,	,	PUNCT
ajlm-1537	170	10	rosse	rosse	PROPN
ajlm-1537	170	11	wf	wf	PROPN
ajlm-1537	170	12	.	.	PUNCT
ajlm-1537	171	1	paroxysmal	paroxysmal	ADJ
ajlm-1537	171	2	nocturnal	nocturnal	ADJ
ajlm-1537	171	3	hemoglobinuria	hemoglobinuria	NOUN
ajlm-1537	171	4	with	with	ADP
ajlm-1537	171	5	onset	onset	NOUN
ajlm-1537	171	6	in	in	ADP
ajlm-1537	171	7	childhood	childhood	NOUN
ajlm-1537	171	8	and	and	CCONJ
ajlm-1537	171	9	adolescence	adolescence	NOUN
ajlm-1537	171	10	.	.	PUNCT
ajlm-1537	172	1	n	n	PROPN
ajlm-1537	172	2	engl	engl	PROPN
ajlm-1537	172	3	j	j	PROPN
ajlm-1537	172	4	med	med	PROPN
ajlm-1537	172	5	.	.	PUNCT
ajlm-1537	173	1	1991;325(14):991–996	1991;325(14):991–996	NUM
ajlm-1537	173	2	.	.	PUNCT
ajlm-1537	173	3	https://doi.org/10.1056/nejm199110033251403	https://doi.org/10.1056/nejm199110033251403	PROPN
ajlm-1537	173	4	luzzatto	luzzatto	PROPN
ajlm-1537	173	5	l	l	PROPN
ajlm-1537	173	6	,	,	PUNCT
ajlm-1537	173	7	bessler	bessler	PROPN
ajlm-1537	173	8	m	m	PROPN
ajlm-1537	173	9	,	,	PUNCT
ajlm-1537	173	10	rotoli	rotoli	PROPN
ajlm-1537	173	11	b.	b.	PROPN
ajlm-1537	173	12	somatic	somatic	ADJ
ajlm-1537	173	13	mutations	mutation	NOUN
ajlm-1537	173	14	in	in	ADP
ajlm-1537	173	15	paroxysmal	paroxysmal	ADJ
ajlm-1537	173	16	nocturnal	nocturnal	ADJ
ajlm-1537	173	17	hemoglobinuria	hemoglobinuria	NOUN
ajlm-1537	173	18	:	:	PUNCT
ajlm-1537	173	19	a	a	DET
ajlm-1537	173	20	blessing	blessing	NOUN
ajlm-1537	173	21	in	in	ADP
ajlm-1537	173	22	disguise	disguise	NOUN
ajlm-1537	173	23	?	?	PUNCT
ajlm-1537	174	1	cell	cell	NOUN
ajlm-1537	174	2	.	.	PUNCT
ajlm-1537	175	1	1997;88(1):1–4	1997;88(1):1–4	NOUN
ajlm-1537	175	2	.	.	PUNCT
ajlm-1537	176	1	https://doi.org/10.1016/s0092-8674(00)81850-4	https://doi.org/10.1016/s0092-8674(00)81850-4	PROPN
ajlm-1537	176	2	luzzatto	luzzatto	PROPN
ajlm-1537	176	3	l.	l.	PROPN
ajlm-1537	176	4	pnh	pnh	PROPN
ajlm-1537	176	5	phenotypes	phenotype	NOUN
ajlm-1537	176	6	and	and	CCONJ
ajlm-1537	176	7	their	their	PRON
ajlm-1537	176	8	genesis	genesis	NOUN
ajlm-1537	176	9	.	.	PUNCT
ajlm-1537	177	1	br	br	PROPN
ajlm-1537	177	2	j	j	PROPN
ajlm-1537	177	3	haematol	haematol	NOUN
ajlm-1537	177	4	.	.	PUNCT
ajlm-1537	178	1	2020;189(5):802–805	2020;189(5):802–805	NUM
ajlm-1537	178	2	.	.	PUNCT
ajlm-1537	179	1	https://doi.org/10.1111/bjh.16473	https://doi.org/10.1111/bjh.16473	PROPN
ajlm-1537	179	2	hill	hill	PROPN
ajlm-1537	179	3	a	a	PRON
ajlm-1537	179	4	,	,	PUNCT
ajlm-1537	179	5	richards	richard	NOUN
ajlm-1537	179	6	sj	sj	PROPN
ajlm-1537	179	7	,	,	PUNCT
ajlm-1537	179	8	hillmen	hillmen	PROPN
ajlm-1537	179	9	p.	p.	PROPN
ajlm-1537	179	10	recent	recent	ADJ
ajlm-1537	179	11	developments	development	NOUN
ajlm-1537	179	12	in	in	ADP
ajlm-1537	179	13	the	the	DET
ajlm-1537	179	14	understanding	understanding	NOUN
ajlm-1537	179	15	and	and	CCONJ
ajlm-1537	179	16	management	management	NOUN
ajlm-1537	179	17	of	of	ADP
ajlm-1537	179	18	paroxysmal	paroxysmal	ADJ
ajlm-1537	179	19	nocturnal	nocturnal	ADJ
ajlm-1537	179	20	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	179	21	.	.	PUNCT
ajlm-1537	180	1	br	br	PROPN
ajlm-1537	180	2	j	j	PROPN
ajlm-1537	180	3	haematol	haematol	NOUN
ajlm-1537	180	4	.	.	PUNCT
ajlm-1537	181	1	2007;137(3):181–192	2007;137(3):181–192	X
ajlm-1537	181	2	.	.	PUNCT
ajlm-1537	181	3	https://doi.org/10.1111/j.1365-2141.2007.06554.x	https://doi.org/10.1111/j.1365-2141.2007.06554.x	PROPN
ajlm-1537	181	4	andolina	andolina	PROPN
ajlm-1537	181	5	jr	jr	PROPN
ajlm-1537	181	6	,	,	PUNCT
ajlm-1537	181	7	reinish	reinish	PROPN
ajlm-1537	181	8	al	al	PROPN
ajlm-1537	181	9	,	,	PUNCT
ajlm-1537	181	10	akhtar	akhtar	PROPN
ajlm-1537	181	11	r	r	PROPN
ajlm-1537	181	12	,	,	PUNCT
ajlm-1537	181	13	et	et	PROPN
ajlm-1537	181	14	al	al	PROPN
ajlm-1537	181	15	.	.	PROPN
ajlm-1537	182	1	successful	successful	ADJ
ajlm-1537	182	2	reduced	reduce	VERB
ajlm-1537	182	3	-	-	PUNCT
ajlm-1537	182	4	intensity	intensity	NOUN
ajlm-1537	182	5	conditioning	conditioning	NOUN
ajlm-1537	182	6	hematopoietic	hematopoietic	ADJ
ajlm-1537	182	7	stem	stem	NOUN
ajlm-1537	182	8	cell	cell	NOUN
ajlm-1537	182	9	transplantation	transplantation	NOUN
ajlm-1537	182	10	for	for	ADP
ajlm-1537	182	11	paroxysmal	paroxysmal	ADJ
ajlm-1537	182	12	nocturnal	nocturnal	ADJ
ajlm-1537	182	13	hemoglobinuria	hemoglobinuria	NOUN
ajlm-1537	182	14	with	with	ADP
ajlm-1537	182	15	aplastic	aplastic	ADJ
ajlm-1537	182	16	anemia	anemia	NOUN
ajlm-1537	182	17	in	in	ADP
ajlm-1537	182	18	two	two	NUM
ajlm-1537	182	19	children	child	NOUN
ajlm-1537	182	20	.	.	PUNCT
ajlm-1537	183	1	pediatr	pediatr	ADJ
ajlm-1537	183	2	blood	blood	NOUN
ajlm-1537	183	3	cancer	cancer	NOUN
ajlm-1537	183	4	.	.	PUNCT
ajlm-1537	184	1	2018;65(8):e27218	2018;65(8):e27218	X
ajlm-1537	184	2	.	.	PUNCT
ajlm-1537	185	1	https://doi.org/10.1002/pbc.27218	https://doi.org/10.1002/pbc.27218	PROPN
ajlm-1537	185	2	luzzatto	luzzatto	PROPN
ajlm-1537	185	3	l	l	PROPN
ajlm-1537	185	4	,	,	PUNCT
ajlm-1537	185	5	gianfaldoni	gianfaldoni	ADJ
ajlm-1537	185	6	g	g	NOUN
ajlm-1537	185	7	,	,	PUNCT
ajlm-1537	185	8	notaro	notaro	PROPN
ajlm-1537	185	9	r.	r.	PROPN
ajlm-1537	185	10	management	management	PROPN
ajlm-1537	185	11	of	of	ADP
ajlm-1537	185	12	paroxysmal	paroxysmal	ADJ
ajlm-1537	185	13	nocturnal	nocturnal	ADJ
ajlm-1537	185	14	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	185	15	:	:	PUNCT
ajlm-1537	185	16	a	a	DET
ajlm-1537	185	17	personal	personal	ADJ
ajlm-1537	185	18	view	view	NOUN
ajlm-1537	185	19	.	.	PUNCT
ajlm-1537	186	1	br	br	X
ajlm-1537	187	1	j	j	PROPN
ajlm-1537	187	2	haematol	haematol	NOUN
ajlm-1537	187	3	.	.	PUNCT
ajlm-1537	188	1	2011;153(6):709–720	2011;153(6):709–720	X
ajlm-1537	188	2	.	.	PUNCT
ajlm-1537	188	3	https://doi.org/10.1111/j.1365-2141.2011.08690.x	https://doi.org/10.1111/j.1365-2141.2011.08690.x	PROPN
ajlm-1537	188	4	galiba	galiba	PROPN
ajlm-1537	188	5	atipo	atipo	PROPN
ajlm-1537	188	6	tsiba	tsiba	PROPN
ajlm-1537	188	7	fo	fo	PROPN
ajlm-1537	188	8	,	,	PUNCT
ajlm-1537	188	9	kocko	kocko	PROPN
ajlm-1537	188	10	i	i	PROPN
ajlm-1537	188	11	,	,	PUNCT
ajlm-1537	188	12	okouango	okouango	PROPN
ajlm-1537	188	13	ova	ova	X
ajlm-1537	188	14	guelongo	guelongo	NOUN
ajlm-1537	188	15	jd	jd	PROPN
ajlm-1537	188	16	,	,	PUNCT
ajlm-1537	188	17	ondzotto	ondzotto	ADJ
ajlm-1537	188	18	ibatta	ibatta	PROPN
ajlm-1537	188	19	ci	ci	PROPN
ajlm-1537	188	20	,	,	PUNCT
ajlm-1537	188	21	malanda	malanda	NOUN
ajlm-1537	188	22	f	f	PROPN
ajlm-1537	188	23	,	,	PUNCT
ajlm-1537	188	24	elira	elira	PROPN
ajlm-1537	188	25	dockekias	dockekias	PROPN
ajlm-1537	188	26	a.	a.	PROPN
ajlm-1537	188	27	severe	severe	ADJ
ajlm-1537	188	28	aplastic	aplastic	ADJ
ajlm-1537	188	29	anemia	anemia	NOUN
ajlm-1537	188	30	:	:	PUNCT
ajlm-1537	188	31	management	management	NOUN
ajlm-1537	188	32	challenges	challenge	NOUN
ajlm-1537	188	33	at	at	ADP
ajlm-1537	188	34	the	the	DET
ajlm-1537	188	35	university	university	NOUN
ajlm-1537	188	36	teaching	teaching	NOUN
ajlm-1537	188	37	hospital	hospital	NOUN
ajlm-1537	188	38	of	of	ADP
ajlm-1537	188	39	brazzaville	brazzaville	PROPN
ajlm-1537	188	40	.	.	PUNCT
ajlm-1537	189	1	rwanda	rwanda	PROPN
ajlm-1537	189	2	med	me	VERB
ajlm-1537	189	3	j.	j.	PROPN
ajlm-1537	190	1	2016;73(2):22–25	2016;73(2):22–25	PROPN
ajlm-1537	190	2	.	.	PUNCT
ajlm-1537	191	1	arewa	arewa	NOUN
ajlm-1537	191	2	op	op	PROPN
ajlm-1537	191	3	,	,	PUNCT
ajlm-1537	191	4	akinola	akinola	PROPN
ajlm-1537	191	5	no	no	INTJ
ajlm-1537	192	1	.	.	PUNCT
ajlm-1537	192	2	survival	survival	NOUN
ajlm-1537	192	3	in	in	ADP
ajlm-1537	192	4	primary	primary	ADJ
ajlm-1537	192	5	a	a	DET
ajlm-1537	192	6	plastic	plastic	NOUN
ajlm-1537	192	7	anaemia	anaemia	NOUN
ajlm-1537	192	8	;	;	PUNCT
ajlm-1537	192	9	experience	experience	NOUN
ajlm-1537	192	10	with	with	ADP
ajlm-1537	192	11	20	20	NUM
ajlm-1537	192	12	cases	case	NOUN
ajlm-1537	192	13	from	from	ADP
ajlm-1537	192	14	a	a	DET
ajlm-1537	192	15	tertiary	tertiary	ADJ
ajlm-1537	192	16	hospital	hospital	NOUN
ajlm-1537	192	17	in	in	ADP
ajlm-1537	192	18	nigeria	nigeria	PROPN
ajlm-1537	192	19	.	.	PUNCT
ajlm-1537	193	1	afr	afr	PROPN
ajlm-1537	193	2	health	health	PROPN
ajlm-1537	193	3	sci	sci	PROPN
ajlm-1537	193	4	.	.	PUNCT
ajlm-1537	194	1	2009;9(4):290–293	2009;9(4):290–293	NUM
ajlm-1537	194	2	.	.	PUNCT
ajlm-1537	194	3	williams	williams	PROPN
ajlm-1537	194	4	da	da	PROPN
ajlm-1537	194	5	,	,	PUNCT
ajlm-1537	194	6	bennett	bennett	PROPN
ajlm-1537	194	7	c	c	PROPN
ajlm-1537	194	8	,	,	PUNCT
ajlm-1537	194	9	bertuch	bertuch	ADJ
ajlm-1537	194	10	a	a	X
ajlm-1537	194	11	,	,	PUNCT
ajlm-1537	194	12	et	et	PROPN
ajlm-1537	194	13	al	al	PROPN
ajlm-1537	194	14	.	.	PUNCT
ajlm-1537	194	15	diagnosis	diagnosis	NOUN
ajlm-1537	194	16	and	and	CCONJ
ajlm-1537	194	17	treatment	treatment	NOUN
ajlm-1537	194	18	of	of	ADP
ajlm-1537	194	19	pediatric	pediatric	ADJ
ajlm-1537	194	20	acquired	acquire	VERB
ajlm-1537	194	21	aplastic	aplastic	ADJ
ajlm-1537	194	22	anemia	anemia	NOUN
ajlm-1537	194	23	(	(	PUNCT
ajlm-1537	194	24	aaa	aaa	NOUN
ajlm-1537	194	25	):	):	PUNCT
ajlm-1537	194	26	an	an	DET
ajlm-1537	194	27	initial	initial	ADJ
ajlm-1537	194	28	survey	survey	NOUN
ajlm-1537	194	29	of	of	ADP
ajlm-1537	194	30	the	the	DET
ajlm-1537	194	31	north	north	ADJ
ajlm-1537	194	32	american	american	ADJ
ajlm-1537	194	33	pediatric	pediatric	ADJ
ajlm-1537	194	34	aplastic	aplastic	ADJ
ajlm-1537	194	35	anemia	anemia	NOUN
ajlm-1537	194	36	consortium	consortium	NOUN
ajlm-1537	194	37	(	(	PUNCT
ajlm-1537	194	38	napaac	napaac	ADV
ajlm-1537	194	39	)	)	PUNCT
ajlm-1537	194	40	.	.	PUNCT
ajlm-1537	195	1	pediatr	pediatr	ADJ
ajlm-1537	195	2	blood	blood	NOUN
ajlm-1537	195	3	cancer	cancer	NOUN
ajlm-1537	195	4	.	.	PUNCT
ajlm-1537	196	1	2014;61(5):869–874	2014;61(5):869–874	NUM
ajlm-1537	196	2	.	.	PUNCT
ajlm-1537	197	1	https://doi.org/10.1002/pbc.24875	https://doi.org/10.1002/pbc.24875	PROPN
ajlm-1537	197	2	cheung	cheung	PROPN
ajlm-1537	197	3	wc	wc	PROPN
ajlm-1537	197	4	,	,	PUNCT
ajlm-1537	197	5	lam	lam	PROPN
ajlm-1537	197	6	cck	cck	PROPN
ajlm-1537	197	7	,	,	PUNCT
ajlm-1537	197	8	kwong	kwong	PROPN
ajlm-1537	197	9	yl	yl	NOUN
ajlm-1537	197	10	.	.	PUNCT
ajlm-1537	198	1	anti	anti	ADJ
ajlm-1537	198	2	-	-	ADJ
ajlm-1537	198	3	thymocyte	thymocyte	ADJ
ajlm-1537	198	4	globulin	globulin	NOUN
ajlm-1537	198	5	treatment	treatment	NOUN
ajlm-1537	198	6	of	of	ADP
ajlm-1537	198	7	marrow	marrow	PROPN
ajlm-1537	198	8	aplasia	aplasia	NOUN
ajlm-1537	198	9	associated	associate	VERB
ajlm-1537	198	10	with	with	ADP
ajlm-1537	198	11	paroxysmal	paroxysmal	ADJ
ajlm-1537	198	12	nocturnal	nocturnal	ADJ
ajlm-1537	198	13	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	198	14	(	(	PUNCT
ajlm-1537	198	15	pnh	pnh	PROPN
ajlm-1537	198	16	)	)	PUNCT
ajlm-1537	198	17	resulted	result	VERB
ajlm-1537	198	18	in	in	ADP
ajlm-1537	198	19	haematological	haematological	ADJ
ajlm-1537	198	20	improvement	improvement	NOUN
ajlm-1537	198	21	due	due	ADP
ajlm-1537	198	22	to	to	ADP
ajlm-1537	198	23	an	an	DET
ajlm-1537	198	24	expansion	expansion	NOUN
ajlm-1537	198	25	of	of	ADP
ajlm-1537	198	26	the	the	DET
ajlm-1537	198	27	pnh	pnh	PROPN
ajlm-1537	198	28	clone	clone	NOUN
ajlm-1537	198	29	.	.	PUNCT
ajlm-1537	199	1	br	br	PROPN
ajlm-1537	199	2	j	j	PROPN
ajlm-1537	199	3	haematol	haematol	NOUN
ajlm-1537	199	4	.	.	PUNCT
ajlm-1537	200	1	2003;120(2):325–328	2003;120(2):325–328	NUM
ajlm-1537	200	2	.	.	PUNCT
ajlm-1537	201	1	https://doi.org/10.1046/j.1365-2141.2003.04046.x	https://doi.org/10.1046/j.1365-2141.2003.04046.x	PROPN
ajlm-1537	201	2	narita	narita	PROPN
ajlm-1537	201	3	a	a	PRON
ajlm-1537	201	4	,	,	PUNCT
ajlm-1537	201	5	muramatsu	muramatsu	ADJ
ajlm-1537	201	6	h	h	NOUN
ajlm-1537	201	7	,	,	PUNCT
ajlm-1537	201	8	sekiya	sekiya	ADJ
ajlm-1537	201	9	y	y	PROPN
ajlm-1537	201	10	,	,	PUNCT
ajlm-1537	201	11	et	et	PROPN
ajlm-1537	201	12	al	al	PROPN
ajlm-1537	201	13	.	.	PROPN
ajlm-1537	202	1	paroxysmal	paroxysmal	ADJ
ajlm-1537	202	2	nocturnal	nocturnal	ADJ
ajlm-1537	202	3	hemoglobinuria	hemoglobinuria	NOUN
ajlm-1537	202	4	and	and	CCONJ
ajlm-1537	202	5	telomere	telomere	NOUN
ajlm-1537	202	6	length	length	NOUN
ajlm-1537	202	7	predicts	predict	VERB
ajlm-1537	202	8	response	response	NOUN
ajlm-1537	202	9	to	to	ADP
ajlm-1537	202	10	immunosuppressive	immunosuppressive	ADJ
ajlm-1537	202	11	therapy	therapy	NOUN
ajlm-1537	202	12	in	in	ADP
ajlm-1537	202	13	pediatric	pediatric	ADJ
ajlm-1537	202	14	aplastic	aplastic	ADJ
ajlm-1537	202	15	anemia	anemia	NOUN
ajlm-1537	202	16	.	.	PUNCT
ajlm-1537	203	1	haematologica	haematologica	PROPN
ajlm-1537	203	2	.	.	PUNCT
ajlm-1537	204	1	2015	2015	NUM
ajlm-1537	204	2	dec	dec	PROPN
ajlm-1537	204	3	1;100(12):1546–1552	1;100(12):1546–1552	NUM
ajlm-1537	204	4	.	.	PUNCT
ajlm-1537	205	1	https://doi.org/10.3324/haematol.2015.132530	https://doi.org/10.3324/haematol.2015.132530	PROPN
ajlm-1537	205	2	tshabalala	tshabalala	NOUN
ajlm-1537	205	3	m	m	PROPN
ajlm-1537	205	4	,	,	PUNCT
ajlm-1537	205	5	mellet	mellet	PROPN
ajlm-1537	205	6	j	j	PROPN
ajlm-1537	205	7	,	,	PUNCT
ajlm-1537	205	8	pepper	pepper	PROPN
ajlm-1537	205	9	ms	ms	PROPN
ajlm-1537	205	10	.	.	PROPN
ajlm-1537	205	11	human	human	ADJ
ajlm-1537	205	12	leukocyte	leukocyte	NOUN
ajlm-1537	205	13	antigen	antigen	NOUN
ajlm-1537	205	14	diversity	diversity	NOUN
ajlm-1537	205	15	:	:	PUNCT
ajlm-1537	205	16	a	a	DET
ajlm-1537	205	17	southern	southern	ADJ
ajlm-1537	205	18	african	african	ADJ
ajlm-1537	205	19	perspective	perspective	NOUN
ajlm-1537	205	20	.	.	PUNCT
ajlm-1537	206	1	j	j	PROPN
ajlm-1537	206	2	immunol	immunol	NOUN
ajlm-1537	206	3	res	re	NOUN
ajlm-1537	206	4	.	.	PUNCT
ajlm-1537	207	1	2015;2015(class	2015;2015(class	NUM
ajlm-1537	207	2	i):1–11	i):1–11	NOUN
ajlm-1537	207	3	.	.	PUNCT
ajlm-1537	208	1	https://doi.org/10.1155/2015/746151	https://doi.org/10.1155/2015/746151	PROPN
ajlm-1537	208	2	viljoen	viljoen	VERB
ajlm-1537	208	3	i	i	PRON
ajlm-1537	208	4	m	m	PROPN
ajlm-1537	208	5	,	,	PUNCT
ajlm-1537	208	6	hendricks	hendrick	NOUN
ajlm-1537	208	7	cl	cl	PROPN
ajlm-1537	208	8	,	,	PUNCT
ajlm-1537	208	9	mellet	mellet	PROPN
ajlm-1537	208	10	j	j	PROPN
ajlm-1537	208	11	,	,	PUNCT
ajlm-1537	208	12	pepper	pepper	PROPN
ajlm-1537	208	13	ms	ms	PROPN
ajlm-1537	208	14	.	.	PROPN
ajlm-1537	208	15	perspectives	perspective	NOUN
ajlm-1537	208	16	on	on	ADP
ajlm-1537	208	17	establishing	establish	VERB
ajlm-1537	208	18	a	a	DET
ajlm-1537	208	19	public	public	ADJ
ajlm-1537	208	20	cord	cord	NOUN
ajlm-1537	208	21	blood	blood	NOUN
ajlm-1537	208	22	inventory	inventory	NOUN
ajlm-1537	208	23	in	in	ADP
ajlm-1537	208	24	south	south	PROPN
ajlm-1537	208	25	africa	africa	PROPN
ajlm-1537	208	26	.	.	PUNCT
ajlm-1537	209	1	cytotherapy	cytotherapy	NOUN
ajlm-1537	209	2	.	.	PUNCT
ajlm-1537	210	1	2021;23(6):548–557	2021;23(6):548–557	X
ajlm-1537	210	2	.	.	PUNCT
ajlm-1537	211	1	https://doi.org/10.1016/j.jcyt.2021.02.116	https://doi.org/10.1016/j.jcyt.2021.02.116	PROPN
ajlm-1537	211	2	marsh	marsh	PROPN
ajlm-1537	211	3	jcw	jcw	PROPN
ajlm-1537	211	4	,	,	PUNCT
ajlm-1537	211	5	ball	ball	PROPN
ajlm-1537	211	6	se	se	PROPN
ajlm-1537	211	7	,	,	PUNCT
ajlm-1537	211	8	cavenagh	cavenagh	PROPN
ajlm-1537	211	9	j	j	PROPN
ajlm-1537	211	10	,	,	PUNCT
ajlm-1537	211	11	et	et	PROPN
ajlm-1537	211	12	al	al	PROPN
ajlm-1537	211	13	.	.	PUNCT
ajlm-1537	211	14	guidelines	guideline	NOUN
ajlm-1537	211	15	for	for	ADP
ajlm-1537	211	16	the	the	DET
ajlm-1537	211	17	diagnosis	diagnosis	NOUN
ajlm-1537	211	18	and	and	CCONJ
ajlm-1537	211	19	management	management	NOUN
ajlm-1537	211	20	of	of	ADP
ajlm-1537	211	21	aplastic	aplastic	ADJ
ajlm-1537	211	22	anaemia	anaemia	NOUN
ajlm-1537	211	23	.	.	PUNCT
ajlm-1537	212	1	br	br	PROPN
ajlm-1537	212	2	j	j	PROPN
ajlm-1537	212	3	haematol	haematol	NOUN
ajlm-1537	212	4	.	.	PUNCT
ajlm-1537	213	1	2009;147(1):43–70	2009;147(1):43–70	NUM
ajlm-1537	213	2	.	.	PUNCT
ajlm-1537	214	1	https://doi.org/10.1111/j.1365-2141.2009.07842.x	https://doi.org/10.1111/j.1365-2141.2009.07842.x	PROPN
ajlm-1537	214	2	mercuri	mercuri	PROPN
ajlm-1537	214	3	a	a	PROPN
ajlm-1537	214	4	,	,	PUNCT
ajlm-1537	214	5	farruggia	farruggia	NOUN
ajlm-1537	214	6	p	p	NOUN
ajlm-1537	214	7	,	,	PUNCT
ajlm-1537	214	8	timeus	timeus	PROPN
ajlm-1537	214	9	f	f	PROPN
ajlm-1537	214	10	,	,	PUNCT
ajlm-1537	214	11	et	et	PROPN
ajlm-1537	214	12	al	al	PROPN
ajlm-1537	214	13	.	.	PUNCT
ajlm-1537	215	1	a	a	DET
ajlm-1537	215	2	retrospective	retrospective	ADJ
ajlm-1537	215	3	study	study	NOUN
ajlm-1537	215	4	of	of	ADP
ajlm-1537	215	5	paroxysmal	paroxysmal	ADJ
ajlm-1537	215	6	nocturnal	nocturnal	ADJ
ajlm-1537	215	7	hemoglobinuria	hemoglobinuria	NOUN
ajlm-1537	215	8	in	in	ADP
ajlm-1537	215	9	pediatric	pediatric	ADJ
ajlm-1537	215	10	and	and	CCONJ
ajlm-1537	215	11	adolescent	adolescent	ADJ
ajlm-1537	215	12	patients	patient	NOUN
ajlm-1537	215	13	.	.	PUNCT
ajlm-1537	216	1	blood	blood	NOUN
ajlm-1537	216	2	cells	cell	NOUN
ajlm-1537	216	3	,	,	PUNCT
ajlm-1537	216	4	mol	mol	ADP
ajlm-1537	216	5	dis	dis	PROPN
ajlm-1537	216	6	.	.	PUNCT
ajlm-1537	217	1	2017;64:45–50	2017;64:45–50	NUM
ajlm-1537	217	2	.	.	PUNCT
ajlm-1537	218	1	https://doi.org/10.1016/j.bcmd.2017.03.006	https://doi.org/10.1016/j.bcmd.2017.03.006	NOUN
ajlm-1537	218	2	illingworth	illingworth	PROPN
ajlm-1537	218	3	aj	aj	PROPN
ajlm-1537	218	4	,	,	PUNCT
ajlm-1537	218	5	marinov	marinov	PROPN
ajlm-1537	218	6	i	i	PROPN
ajlm-1537	218	7	,	,	PUNCT
ajlm-1537	218	8	sutherland	sutherland	PROPN
ajlm-1537	218	9	dr	dr	PROPN
ajlm-1537	218	10	.	.	PROPN
ajlm-1537	218	11	sensitive	sensitive	ADJ
ajlm-1537	218	12	and	and	CCONJ
ajlm-1537	218	13	accurate	accurate	ADJ
ajlm-1537	218	14	identification	identification	NOUN
ajlm-1537	218	15	of	of	ADP
ajlm-1537	218	16	pnh	pnh	PROPN
ajlm-1537	218	17	clones	clone	NOUN
ajlm-1537	218	18	based	base	VERB
ajlm-1537	218	19	on	on	ADP
ajlm-1537	218	20	iccs	iccs	PROPN
ajlm-1537	218	21	/	/	SYM
ajlm-1537	218	22	escca	escca	PROPN
ajlm-1537	218	23	pnh	pnh	PROPN
ajlm-1537	218	24	consensus	consensus	NOUN
ajlm-1537	218	25	guidelines	guideline	NOUN
ajlm-1537	218	26	–	–	PUNCT
ajlm-1537	218	27	a	a	DET
ajlm-1537	218	28	summary	summary	NOUN
ajlm-1537	218	29	.	.	PUNCT
ajlm-1537	219	1	int	int	NOUN
ajlm-1537	219	2	j	j	PROPN
ajlm-1537	219	3	lab	lab	NOUN
ajlm-1537	219	4	hematol	hematol	NOUN
ajlm-1537	219	5	.	.	PUNCT
ajlm-1537	220	1	2019;41(s1):73–81	2019;41(s1):73–81	NUM
ajlm-1537	220	2	.	.	PUNCT
ajlm-1537	220	3	https://doi.org/10.1111/ijlh.13011	https://doi.org/10.1111/ijlh.13011	PROPN
ajlm-1537	220	4	olutogun	olutogun	PROPN
ajlm-1537	220	5	t	t	PROPN
ajlm-1537	220	6	,	,	PUNCT
ajlm-1537	220	7	cutini	cutini	PROPN
ajlm-1537	220	8	i	i	PROPN
ajlm-1537	220	9	,	,	PUNCT
ajlm-1537	220	10	notaro	notaro	NOUN
ajlm-1537	220	11	r	r	NOUN
ajlm-1537	220	12	,	,	PUNCT
ajlm-1537	220	13	luzzatto	luzzatto	PROPN
ajlm-1537	220	14	l.	l.	PROPN
ajlm-1537	220	15	complement	complement	PROPN
ajlm-1537	220	16	-	-	PUNCT
ajlm-1537	220	17	mediated	mediate	VERB
ajlm-1537	220	18	haemolysis	haemolysis	NOUN
ajlm-1537	220	19	and	and	CCONJ
ajlm-1537	220	20	the	the	DET
ajlm-1537	220	21	role	role	NOUN
ajlm-1537	220	22	of	of	ADP
ajlm-1537	220	23	blood	blood	NOUN
ajlm-1537	220	24	transfusion	transfusion	NOUN
ajlm-1537	220	25	in	in	ADP
ajlm-1537	220	26	paroxysmal	paroxysmal	ADJ
ajlm-1537	220	27	nocturnal	nocturnal	ADJ
ajlm-1537	220	28	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	220	29	.	.	PUNCT
ajlm-1537	221	1	blood	blood	NOUN
ajlm-1537	221	2	transfus	transfus	PROPN
ajlm-1537	221	3	.	.	PUNCT
ajlm-1537	222	1	2015;13(3):363–369	2015;13(3):363–369	NUM
ajlm-1537	222	2	.	.	PUNCT
ajlm-1537	223	1	agarwal	agarwal	PROPN
ajlm-1537	223	2	r	r	PROPN
ajlm-1537	223	3	,	,	PUNCT
ajlm-1537	223	4	chapple	chapple	PROPN
ajlm-1537	223	5	p	p	PROPN
ajlm-1537	223	6	,	,	PUNCT
ajlm-1537	223	7	brown	brown	ADJ
ajlm-1537	223	8	m	m	PROPN
ajlm-1537	223	9	,	,	PUNCT
ajlm-1537	223	10	szer	szer	PROPN
ajlm-1537	223	11	j	j	PROPN
ajlm-1537	223	12	,	,	PUNCT
ajlm-1537	223	13	juneja	juneja	ADJ
ajlm-1537	223	14	s.	s.	PROPN
ajlm-1537	223	15	analysis	analysis	NOUN
ajlm-1537	223	16	of	of	ADP
ajlm-1537	223	17	abnormal	abnormal	ADJ
ajlm-1537	223	18	clones	clone	NOUN
ajlm-1537	223	19	by	by	ADP
ajlm-1537	223	20	the	the	DET
ajlm-1537	223	21	fluorescent	fluorescent	ADJ
ajlm-1537	223	22	aerolysin	aerolysin	NOUN
ajlm-1537	223	23	method	method	NOUN
ajlm-1537	223	24	in	in	ADP
ajlm-1537	223	25	paroxysmal	paroxysmal	ADJ
ajlm-1537	223	26	nocturnal	nocturnal	ADJ
ajlm-1537	223	27	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	223	28	and	and	CCONJ
ajlm-1537	223	29	other	other	ADJ
ajlm-1537	223	30	marrow	marrow	NOUN
ajlm-1537	223	31	disorders	disorder	NOUN
ajlm-1537	223	32	.	.	PUNCT
ajlm-1537	224	1	int	int	NOUN
ajlm-1537	224	2	j	j	PROPN
ajlm-1537	224	3	lab	lab	NOUN
ajlm-1537	224	4	hematol	hematol	NOUN
ajlm-1537	224	5	.	.	PUNCT
ajlm-1537	225	1	2015;37(1):14–21	2015;37(1):14–21	X
ajlm-1537	225	2	.	.	PUNCT
ajlm-1537	226	1	https://doi.org/10.1111/ijlh.12207	https://doi.org/10.1111/ijlh.12207	NOUN
ajlm-1537	226	2	raza	raza	VERB
ajlm-1537	226	3	a	a	PRON
ajlm-1537	226	4	,	,	PUNCT
ajlm-1537	226	5	ravandi	ravandi	NOUN
ajlm-1537	226	6	f	f	NOUN
ajlm-1537	226	7	,	,	PUNCT
ajlm-1537	226	8	rastogi	rastogi	ADV
ajlm-1537	226	9	a	a	PRON
ajlm-1537	226	10	,	,	PUNCT
ajlm-1537	226	11	et	et	PROPN
ajlm-1537	226	12	al	al	PROPN
ajlm-1537	226	13	.	.	PUNCT
ajlm-1537	227	1	a	a	DET
ajlm-1537	227	2	prospective	prospective	ADJ
ajlm-1537	227	3	multicenter	multicenter	NOUN
ajlm-1537	227	4	study	study	NOUN
ajlm-1537	227	5	of	of	ADP
ajlm-1537	227	6	paroxysmal	paroxysmal	ADJ
ajlm-1537	227	7	nocturnal	nocturnal	ADJ
ajlm-1537	227	8	hemoglobinuria	hemoglobinuria	NOUN
ajlm-1537	227	9	cells	cell	NOUN
ajlm-1537	227	10	in	in	ADP
ajlm-1537	227	11	patients	patient	NOUN
ajlm-1537	227	12	with	with	ADP
ajlm-1537	227	13	bone	bone	NOUN
ajlm-1537	227	14	marrow	marrow	NOUN
ajlm-1537	227	15	failure	failure	NOUN
ajlm-1537	227	16	.	.	PUNCT
ajlm-1537	228	1	cytom	cytom	PROPN
ajlm-1537	228	2	part	part	PROPN
ajlm-1537	228	3	b	b	PROPN
ajlm-1537	228	4	clin	clin	PROPN
ajlm-1537	228	5	cytom	cytom	PROPN
ajlm-1537	228	6	.	.	PUNCT
ajlm-1537	229	1	2014;86(3):175–182	2014;86(3):175–182	NUM
ajlm-1537	229	2	.	.	PUNCT
ajlm-1537	230	1	https://doi.org/10.1002/cyto.b.21139	https://doi.org/10.1002/cyto.b.21139	VERB
ajlm-1537	230	2	sreedharanunni	sreedharanunni	PROPN
ajlm-1537	230	3	s	s	PROPN
ajlm-1537	230	4	,	,	PUNCT
ajlm-1537	230	5	sachdeva	sachdeva	PROPN
ajlm-1537	230	6	mus	mus	PROPN
ajlm-1537	230	7	,	,	PUNCT
ajlm-1537	230	8	bose	bose	PROPN
ajlm-1537	230	9	p	p	X
ajlm-1537	230	10	,	,	PUNCT
ajlm-1537	230	11	varma	varma	PROPN
ajlm-1537	230	12	n	n	CCONJ
ajlm-1537	230	13	,	,	PUNCT
ajlm-1537	230	14	bansal	bansal	NOUN
ajlm-1537	230	15	d	d	PROPN
ajlm-1537	230	16	,	,	PUNCT
ajlm-1537	230	17	trehan	trehan	ADJ
ajlm-1537	230	18	a.	a.	NOUN
ajlm-1537	230	19	frequency	frequency	NOUN
ajlm-1537	230	20	of	of	ADP
ajlm-1537	230	21	paroxysmal	paroxysmal	ADJ
ajlm-1537	230	22	nocturnal	nocturnal	ADJ
ajlm-1537	230	23	hemoglobinuria	hemoglobinuria	NOUN
ajlm-1537	230	24	clones	clone	NOUN
ajlm-1537	230	25	by	by	ADP
ajlm-1537	230	26	multiparametric	multiparametric	ADJ
ajlm-1537	230	27	flow	flow	NOUN
ajlm-1537	230	28	cytometry	cytometry	NOUN
ajlm-1537	230	29	in	in	ADP
ajlm-1537	230	30	pediatric	pediatric	ADJ
ajlm-1537	230	31	aplastic	aplastic	ADJ
ajlm-1537	230	32	anemia	anemia	NOUN
ajlm-1537	230	33	patients	patient	NOUN
ajlm-1537	230	34	of	of	ADP
ajlm-1537	230	35	indian	indian	ADJ
ajlm-1537	230	36	ethnic	ethnic	ADJ
ajlm-1537	230	37	origin	origin	NOUN
ajlm-1537	230	38	.	.	PUNCT
ajlm-1537	231	1	pediatr	pediatr	ADJ
ajlm-1537	231	2	blood	blood	NOUN
ajlm-1537	231	3	cancer	cancer	NOUN
ajlm-1537	231	4	.	.	PUNCT
ajlm-1537	232	1	2016;63(1):93–97	2016;63(1):93–97	X
ajlm-1537	232	2	.	.	PUNCT
ajlm-1537	233	1	https://doi.org/10.1002/pbc.25691	https://doi.org/10.1002/pbc.25691	PROPN
ajlm-1537	233	2	timeus	timeus	PROPN
ajlm-1537	233	3	f	f	PROPN
ajlm-1537	233	4	,	,	PUNCT
ajlm-1537	233	5	crescenzio	crescenzio	NOUN
ajlm-1537	233	6	n	n	CCONJ
ajlm-1537	233	7	,	,	PUNCT
ajlm-1537	233	8	longoni	longoni	ADJ
ajlm-1537	233	9	d	d	NOUN
ajlm-1537	233	10	,	,	PUNCT
ajlm-1537	233	11	et	et	PROPN
ajlm-1537	233	12	al	al	PROPN
ajlm-1537	233	13	.	.	PROPN
ajlm-1537	234	1	paroxysmal	paroxysmal	ADJ
ajlm-1537	234	2	nocturnal	nocturnal	ADJ
ajlm-1537	234	3	hemoglobinuria	hemoglobinuria	NOUN
ajlm-1537	234	4	clones	clone	NOUN
ajlm-1537	234	5	in	in	ADP
ajlm-1537	234	6	children	child	NOUN
ajlm-1537	234	7	with	with	ADP
ajlm-1537	234	8	acquired	acquire	VERB
ajlm-1537	234	9	aplastic	aplastic	ADJ
ajlm-1537	234	10	anemia	anemia	NOUN
ajlm-1537	234	11	:	:	PUNCT
ajlm-1537	234	12	a	a	DET
ajlm-1537	234	13	multicentre	multicentre	NOUN
ajlm-1537	234	14	study	study	NOUN
ajlm-1537	234	15	.	.	PUNCT
ajlm-1537	235	1	plos	plos	PROPN
ajlm-1537	235	2	one	one	NUM
ajlm-1537	235	3	.	.	PUNCT
ajlm-1537	236	1	2014;9(7):e101948	2014;9(7):e101948	X
ajlm-1537	236	2	.	.	PUNCT
ajlm-1537	237	1	https://doi.org/10.1371/journal.pone.0101948	https://doi.org/10.1371/journal.pone.0101948	PROPN
ajlm-1537	237	2	dezern	dezern	PROPN
ajlm-1537	237	3	ae	ae	PROPN
ajlm-1537	237	4	,	,	PUNCT
ajlm-1537	237	5	symons	symons	PROPN
ajlm-1537	237	6	hj	hj	PROPN
ajlm-1537	237	7	,	,	PUNCT
ajlm-1537	237	8	resar	resar	PROPN
ajlm-1537	237	9	ls	ls	PROPN
ajlm-1537	237	10	,	,	PUNCT
ajlm-1537	237	11	borowitz	borowitz	PROPN
ajlm-1537	237	12	mj	mj	PROPN
ajlm-1537	237	13	,	,	PUNCT
ajlm-1537	237	14	armanios	armanio	VERB
ajlm-1537	237	15	my	my	PRON
ajlm-1537	237	16	,	,	PUNCT
ajlm-1537	237	17	brodsky	brodsky	PROPN
ajlm-1537	237	18	ra	ra	PROPN
ajlm-1537	237	19	.	.	PUNCT
ajlm-1537	238	1	detection	detection	NOUN
ajlm-1537	238	2	of	of	ADP
ajlm-1537	238	3	paroxysmal	paroxysmal	ADJ
ajlm-1537	238	4	nocturnal	nocturnal	ADJ
ajlm-1537	238	5	hemoglobinuria	hemoglobinuria	NOUN
ajlm-1537	238	6	clones	clone	NOUN
ajlm-1537	238	7	to	to	PART
ajlm-1537	238	8	exclude	exclude	VERB
ajlm-1537	238	9	inherited	inherit	VERB
ajlm-1537	238	10	bone	bone	NOUN
ajlm-1537	238	11	marrow	marrow	NOUN
ajlm-1537	238	12	failure	failure	NOUN
ajlm-1537	238	13	syndromes	syndrome	NOUN
ajlm-1537	238	14	.	.	PUNCT
ajlm-1537	239	1	eur	eur	PROPN
ajlm-1537	239	2	j	j	PROPN
ajlm-1537	239	3	haematol	haematol	NOUN
ajlm-1537	239	4	.	.	PUNCT
ajlm-1537	240	1	2014;92(6):467–470	2014;92(6):467–470	X
ajlm-1537	240	2	.	.	PUNCT
ajlm-1537	241	1	https://doi.org/10.1111/ejh.12299	https://doi.org/10.1111/ejh.12299	NOUN
ajlm-1537	241	2	scheinberg	scheinberg	PROPN
ajlm-1537	241	3	p	p	PROPN
ajlm-1537	241	4	,	,	PUNCT
ajlm-1537	241	5	marte	marte	PROPN
ajlm-1537	241	6	m	m	PROPN
ajlm-1537	241	7	,	,	PUNCT
ajlm-1537	241	8	nunez	nunez	PROPN
ajlm-1537	241	9	o	o	NOUN
ajlm-1537	241	10	,	,	PUNCT
ajlm-1537	241	11	young	young	ADJ
ajlm-1537	241	12	ns	ns	ADJ
ajlm-1537	241	13	.	.	PROPN
ajlm-1537	241	14	paroxysmal	paroxysmal	ADJ
ajlm-1537	241	15	nocturnal	nocturnal	ADJ
ajlm-1537	241	16	hemoglobinuria	hemoglobinuria	NOUN
ajlm-1537	241	17	clones	clone	NOUN
ajlm-1537	241	18	in	in	ADP
ajlm-1537	241	19	severe	severe	ADJ
ajlm-1537	241	20	aplastic	aplastic	ADJ
ajlm-1537	241	21	anemia	anemia	NOUN
ajlm-1537	241	22	patients	patient	NOUN
ajlm-1537	241	23	treated	treat	VERB
ajlm-1537	241	24	with	with	ADP
ajlm-1537	241	25	horse	horse	NOUN
ajlm-1537	241	26	anti	anti	ADJ
ajlm-1537	241	27	-	-	ADJ
ajlm-1537	241	28	thymocyte	thymocyte	ADJ
ajlm-1537	241	29	globulin	globulin	NOUN
ajlm-1537	241	30	plus	plus	CCONJ
ajlm-1537	241	31	cyclosporine	cyclosporine	PROPN
ajlm-1537	241	32	.	.	PUNCT
ajlm-1537	242	1	haematologica	haematologica	PROPN
ajlm-1537	242	2	.	.	PUNCT
ajlm-1537	243	1	2010;95(7):1075–1080	2010;95(7):1075–1080	NUM
ajlm-1537	243	2	.	.	PUNCT
ajlm-1537	244	1	https://doi.org/10.3324/haematol.2009.017889	https://doi.org/10.3324/haematol.2009.017889	PROPN
ajlm-1537	244	2	ally	ally	NOUN
ajlm-1537	244	3	m	m	PROPN
ajlm-1537	244	4	,	,	PUNCT
ajlm-1537	244	5	magesa	magesa	PROPN
ajlm-1537	244	6	p	p	NOUN
ajlm-1537	244	7	,	,	PUNCT
ajlm-1537	244	8	luzzatto	luzzatto	PROPN
ajlm-1537	244	9	l.	l.	PROPN
ajlm-1537	244	10	high	high	PROPN
ajlm-1537	244	11	frequency	frequency	NOUN
ajlm-1537	244	12	of	of	ADP
ajlm-1537	244	13	acquired	acquire	VERB
ajlm-1537	244	14	aplastic	aplastic	ADJ
ajlm-1537	244	15	anemia	anemia	NOUN
ajlm-1537	244	16	in	in	ADP
ajlm-1537	244	17	tanzania	tanzania	PROPN
ajlm-1537	244	18	.	.	PUNCT
ajlm-1537	244	19	am	be	AUX
ajlm-1537	244	20	j	j	PROPN
ajlm-1537	244	21	hematol	hematol	NOUN
ajlm-1537	244	22	.	.	PUNCT
ajlm-1537	245	1	2019;94(4):e86	2019;94(4):e86	X
ajlm-1537	245	2	–	–	PUNCT
ajlm-1537	245	3	e88	e88	NOUN
ajlm-1537	245	4	.	.	PUNCT
ajlm-1537	246	1	https://doi.org/10.1002/ajh.25388	https://doi.org/10.1002/ajh.25388	PROPN
ajlm-1537	246	2	rizk	rizk	PROPN
ajlm-1537	246	3	s.	s.	PROPN
ajlm-1537	246	4	screening	screen	VERB
ajlm-1537	246	5	for	for	ADP
ajlm-1537	246	6	paroxysmal	paroxysmal	ADJ
ajlm-1537	246	7	nocturnal	nocturnal	ADJ
ajlm-1537	246	8	hemoglobinuria	hemoglobinuria	NOUN
ajlm-1537	246	9	(	(	PUNCT
ajlm-1537	246	10	pnh	pnh	NOUN
ajlm-1537	246	11	)	)	PUNCT
ajlm-1537	246	12	clone	clone	NOUN
ajlm-1537	246	13	in	in	ADP
ajlm-1537	246	14	egyptian	egyptian	ADJ
ajlm-1537	246	15	children	child	NOUN
ajlm-1537	246	16	with	with	ADP
ajlm-1537	246	17	aplastic	aplastic	ADJ
ajlm-1537	246	18	anemia	anemia	NOUN
ajlm-1537	246	19	.	.	PUNCT
ajlm-1537	247	1	j	j	PROPN
ajlm-1537	247	2	trop	trop	X
ajlm-1537	247	3	pediatr	pediatr	PROPN
ajlm-1537	247	4	.	.	PUNCT
ajlm-1537	248	1	2002;48(3):132–137	2002;48(3):132–137	NUM
ajlm-1537	248	2	.	.	PUNCT
ajlm-1537	249	1	https://doi.org/10.1093/tropej/48.3.132	https://doi.org/10.1093/tropej/48.3.132	PROPN
ajlm-1537	249	2	araten	araten	PROPN
ajlm-1537	249	3	dj	dj	PROPN
ajlm-1537	249	4	,	,	PUNCT
ajlm-1537	249	5	nafa	nafa	PROPN
ajlm-1537	249	6	k	k	PROPN
ajlm-1537	249	7	,	,	PUNCT
ajlm-1537	249	8	pakdeesuwan	pakdeesuwan	PROPN
ajlm-1537	249	9	k	k	NOUN
ajlm-1537	249	10	,	,	PUNCT
ajlm-1537	249	11	luzzatto	luzzatto	PROPN
ajlm-1537	249	12	l.	l.	PROPN
ajlm-1537	249	13	clonal	clonal	PROPN
ajlm-1537	249	14	populations	population	NOUN
ajlm-1537	249	15	of	of	ADP
ajlm-1537	249	16	hematopoietic	hematopoietic	ADJ
ajlm-1537	249	17	cells	cell	NOUN
ajlm-1537	249	18	with	with	ADP
ajlm-1537	249	19	paroxysmal	paroxysmal	ADJ
ajlm-1537	249	20	nocturnal	nocturnal	ADJ
ajlm-1537	249	21	hemoglobinuria	hemoglobinuria	NOUN
ajlm-1537	249	22	genotype	genotype	NOUN
ajlm-1537	249	23	and	and	CCONJ
ajlm-1537	249	24	phenotype	phenotype	NOUN
ajlm-1537	249	25	are	be	AUX
ajlm-1537	249	26	present	present	ADJ
ajlm-1537	249	27	in	in	ADP
ajlm-1537	249	28	normal	normal	ADJ
ajlm-1537	249	29	individuals	individual	NOUN
ajlm-1537	249	30	.	.	PUNCT
ajlm-1537	250	1	proc	proc	PROPN
ajlm-1537	250	2	natl	natl	PROPN
ajlm-1537	250	3	acad	acad	PROPN
ajlm-1537	250	4	sci	sci	PROPN
ajlm-1537	250	5	.	.	PUNCT
ajlm-1537	250	6	1999;96(9):5209–5214	1999;96(9):5209–5214	PROPN
ajlm-1537	250	7	.	.	PUNCT
ajlm-1537	251	1	https://doi.org/10.1073/pnas.96.9.5209	https://doi.org/10.1073/pnas.96.9.5209	PROPN
ajlm-1537	251	2	reiss	reiss	PROPN
ajlm-1537	251	3	um	um	INTJ
ajlm-1537	251	4	,	,	PUNCT
ajlm-1537	251	5	schwartz	schwartz	PROPN
ajlm-1537	251	6	j	j	PROPN
ajlm-1537	251	7	,	,	PUNCT
ajlm-1537	251	8	sakamoto	sakamoto	PROPN
ajlm-1537	251	9	km	km	PROPN
ajlm-1537	251	10	,	,	PUNCT
ajlm-1537	251	11	et	et	PROPN
ajlm-1537	251	12	al	al	PROPN
ajlm-1537	251	13	.	.	PROPN
ajlm-1537	251	14	efficacy	efficacy	NOUN
ajlm-1537	251	15	and	and	CCONJ
ajlm-1537	251	16	safety	safety	NOUN
ajlm-1537	251	17	of	of	ADP
ajlm-1537	251	18	eculizumab	eculizumab	NOUN
ajlm-1537	251	19	in	in	ADP
ajlm-1537	251	20	children	child	NOUN
ajlm-1537	251	21	and	and	CCONJ
ajlm-1537	251	22	adolescents	adolescent	NOUN
ajlm-1537	251	23	with	with	ADP
ajlm-1537	251	24	paroxysmal	paroxysmal	ADJ
ajlm-1537	251	25	nocturnal	nocturnal	ADJ
ajlm-1537	251	26	hemoglobinuria	hemoglobinuria	NOUN
ajlm-1537	251	27	.	.	PUNCT
ajlm-1537	252	1	pediatr	pediatr	ADJ
ajlm-1537	252	2	blood	blood	NOUN
ajlm-1537	252	3	cancer	cancer	NOUN
ajlm-1537	252	4	.	.	PUNCT
ajlm-1537	253	1	2014;61(9):1544–1550	2014;61(9):1544–1550	NOUN
ajlm-1537	253	2	.	.	PUNCT
ajlm-1537	254	1	https://doi.org/10.1002/pbc.25068	https://doi.org/10.1002/pbc.25068	NOUN
ajlm-1537	254	2	yoon	yoon	PROPN
ajlm-1537	254	3	hh	hh	PROPN
ajlm-1537	254	4	,	,	PUNCT
ajlm-1537	254	5	huh	huh	INTJ
ajlm-1537	254	6	sj	sj	PROPN
ajlm-1537	254	7	,	,	PUNCT
ajlm-1537	254	8	lee	lee	PROPN
ajlm-1537	254	9	jh	jh	PROPN
ajlm-1537	254	10	,	,	PUNCT
ajlm-1537	254	11	et	et	PROPN
ajlm-1537	254	12	al	al	PROPN
ajlm-1537	254	13	.	.	PUNCT
ajlm-1537	255	1	should	should	AUX
ajlm-1537	255	2	we	we	PRON
ajlm-1537	255	3	still	still	ADV
ajlm-1537	255	4	use	use	VERB
ajlm-1537	255	5	camitta	camitta	NOUN
ajlm-1537	255	6	’s	’s	PART
ajlm-1537	255	7	criteria	criterion	NOUN
ajlm-1537	255	8	for	for	ADP
ajlm-1537	255	9	severe	severe	ADJ
ajlm-1537	255	10	aplastic	aplastic	ADJ
ajlm-1537	255	11	anemia	anemia	NOUN
ajlm-1537	255	12	?	?	PUNCT
ajlm-1537	256	1	korean	korean	PROPN
ajlm-1537	256	2	j	j	PROPN
ajlm-1537	256	3	hematol	hematol	NOUN
ajlm-1537	256	4	.	.	PUNCT
ajlm-1537	257	1	2012;47(2):126	2012;47(2):126	NOUN
ajlm-1537	257	2	.	.	PUNCT
ajlm-1537	258	1	https://doi.org/10.5045/kjh.2012.47.2.126	https://doi.org/10.5045/kjh.2012.47.2.126	NOUN
ajlm-1537	258	2	borowitz	borowitz	PROPN
ajlm-1537	258	3	mj	mj	PROPN
ajlm-1537	258	4	,	,	PUNCT
ajlm-1537	258	5	craig	craig	PROPN
ajlm-1537	258	6	fe	fe	PROPN
ajlm-1537	258	7	,	,	PUNCT
ajlm-1537	258	8	digiuseppe	digiuseppe	PROPN
ajlm-1537	258	9	ja	ja	PROPN
ajlm-1537	258	10	,	,	PUNCT
ajlm-1537	258	11	et	et	PROPN
ajlm-1537	258	12	al	al	PROPN
ajlm-1537	258	13	.	.	PUNCT
ajlm-1537	258	14	guidelines	guideline	NOUN
ajlm-1537	258	15	for	for	ADP
ajlm-1537	258	16	the	the	DET
ajlm-1537	258	17	diagnosis	diagnosis	NOUN
ajlm-1537	258	18	and	and	CCONJ
ajlm-1537	258	19	monitoring	monitoring	NOUN
ajlm-1537	258	20	of	of	ADP
ajlm-1537	258	21	paroxysmal	paroxysmal	ADJ
ajlm-1537	258	22	nocturnal	nocturnal	ADJ
ajlm-1537	258	23	hemoglobinuria	hemoglobinuria	NOUN
ajlm-1537	258	24	and	and	CCONJ
ajlm-1537	258	25	related	related	ADJ
ajlm-1537	258	26	disorders	disorder	NOUN
ajlm-1537	258	27	by	by	ADP
ajlm-1537	258	28	flow	flow	NOUN
ajlm-1537	258	29	cytometry	cytometry	NOUN
ajlm-1537	258	30	.	.	PUNCT
ajlm-1537	259	1	cytom	cytom	PROPN
ajlm-1537	259	2	part	part	PROPN
ajlm-1537	259	3	b	b	PROPN
ajlm-1537	259	4	clin	clin	PROPN
ajlm-1537	259	5	cytom	cytom	NOUN
ajlm-1537	259	6	.	.	PUNCT
ajlm-1537	260	1	2010;78(4):211–230	2010;78(4):211–230	X
ajlm-1537	260	2	.	.	PUNCT
ajlm-1537	260	3	https://doi.org/10.1002/cyto.b.20525	https://doi.org/10.1002/cyto.b.20525	X
ajlm-1537	260	4	tutelman	tutelman	PROPN
ajlm-1537	260	5	pr	pr	PROPN
ajlm-1537	260	6	,	,	PUNCT
ajlm-1537	260	7	aubert	aubert	NOUN
ajlm-1537	260	8	g	g	PROPN
ajlm-1537	260	9	,	,	PUNCT
ajlm-1537	260	10	milner	milner	PROPN
ajlm-1537	260	11	ra	ra	PROPN
ajlm-1537	260	12	,	,	PUNCT
ajlm-1537	260	13	dalal	dalal	PROPN
ajlm-1537	260	14	bi	bi	PROPN
ajlm-1537	260	15	,	,	PUNCT
ajlm-1537	260	16	schultz	schultz	PROPN
ajlm-1537	260	17	kr	kr	PROPN
ajlm-1537	260	18	,	,	PUNCT
ajlm-1537	260	19	deyell	deyell	PROPN
ajlm-1537	260	20	rj	rj	PROPN
ajlm-1537	260	21	.	.	PROPN
ajlm-1537	260	22	paroxysmal	paroxysmal	ADJ
ajlm-1537	260	23	nocturnal	nocturnal	ADJ
ajlm-1537	260	24	haemoglobinuria	haemoglobinuria	NOUN
ajlm-1537	260	25	phenotype	phenotype	NOUN
ajlm-1537	260	26	cells	cell	NOUN
ajlm-1537	260	27	and	and	CCONJ
ajlm-1537	260	28	leucocyte	leucocyte	PROPN
ajlm-1537	260	29	subset	subset	VERB
ajlm-1537	260	30	telomere	telomere	PROPN
ajlm-1537	260	31	length	length	NOUN
ajlm-1537	260	32	in	in	ADP
ajlm-1537	260	33	childhood	childhood	NOUN
ajlm-1537	260	34	acquired	acquire	VERB
ajlm-1537	260	35	aplastic	aplastic	ADJ
ajlm-1537	260	36	anaemia	anaemia	NOUN
ajlm-1537	260	37	.	.	PUNCT
ajlm-1537	261	1	br	br	PROPN
ajlm-1537	261	2	j	j	PROPN
ajlm-1537	261	3	haematol	haematol	NOUN
ajlm-1537	261	4	.	.	PUNCT
ajlm-1537	262	1	2014;164(5):717–721	2014;164(5):717–721	PROPN
ajlm-1537	262	2	.	.	PUNCT
ajlm-1537	263	1	https://doi.org/10.1111/bjh.12656	https://doi.org/10.1111/bjh.12656	PROPN
ajlm-1537	263	2	tu	tu	PROPN
ajlm-1537	263	3	j	j	PROPN
ajlm-1537	263	4	,	,	PUNCT
ajlm-1537	263	5	pan	pan	PROPN
ajlm-1537	263	6	h	h	PROPN
ajlm-1537	263	7	,	,	PUNCT
ajlm-1537	263	8	li	li	PROPN
ajlm-1537	263	9	r	r	PROPN
ajlm-1537	263	10	,	,	PUNCT
ajlm-1537	263	11	et	et	PROPN
ajlm-1537	263	12	al	al	PROPN
ajlm-1537	263	13	.	.	PUNCT
ajlm-1537	264	1	pnh	pnh	PROPN
ajlm-1537	264	2	clones	clone	NOUN
ajlm-1537	264	3	for	for	ADP
ajlm-1537	264	4	aplastic	aplastic	ADJ
ajlm-1537	264	5	anemia	anemia	NOUN
ajlm-1537	264	6	with	with	ADP
ajlm-1537	264	7	immunosuppressive	immunosuppressive	ADJ
ajlm-1537	264	8	therapy	therapy	NOUN
ajlm-1537	264	9	:	:	PUNCT
ajlm-1537	264	10	a	a	DET
ajlm-1537	264	11	systematic	systematic	ADJ
ajlm-1537	264	12	review	review	NOUN
ajlm-1537	264	13	and	and	CCONJ
ajlm-1537	264	14	meta	meta	ADJ
ajlm-1537	264	15	-	-	PUNCT
ajlm-1537	264	16	analysis	analysis	NOUN
ajlm-1537	264	17	.	.	PUNCT
ajlm-1537	265	1	acta	acta	PROPN
ajlm-1537	265	2	haematol	haematol	PROPN
ajlm-1537	265	3	.	.	PUNCT
ajlm-1537	266	1	2021;144(1):34–43	2021;144(1):34–43	X
ajlm-1537	266	2	.	.	PUNCT
ajlm-1537	266	3	https://doi.org/10.1159/000506387	https://doi.org/10.1159/000506387	PROPN
ajlm-1537	266	4	rogers	rogers	PROPN
ajlm-1537	266	5	zr	zr	PROPN
ajlm-1537	266	6	,	,	PUNCT
ajlm-1537	266	7	nakano	nakano	PROPN
ajlm-1537	266	8	ta	ta	PROPN
ajlm-1537	266	9	,	,	PUNCT
ajlm-1537	266	10	olson	olson	NOUN
ajlm-1537	266	11	ts	ts	PROPN
ajlm-1537	266	12	,	,	PUNCT
ajlm-1537	266	13	et	et	PROPN
ajlm-1537	266	14	al	al	PROPN
ajlm-1537	266	15	.	.	PROPN
ajlm-1537	267	1	immunosuppressive	immunosuppressive	ADJ
ajlm-1537	267	2	therapy	therapy	NOUN
ajlm-1537	267	3	for	for	ADP
ajlm-1537	267	4	pediatric	pediatric	ADJ
ajlm-1537	267	5	aplastic	aplastic	ADJ
ajlm-1537	267	6	anemia	anemia	NOUN
ajlm-1537	267	7	:	:	PUNCT
ajlm-1537	267	8	a	a	DET
ajlm-1537	267	9	north	north	ADJ
ajlm-1537	267	10	american	american	ADJ
ajlm-1537	267	11	pediatric	pediatric	ADJ
ajlm-1537	267	12	aplastic	aplastic	ADJ
ajlm-1537	267	13	anemia	anemia	NOUN
ajlm-1537	267	14	consortium	consortium	NOUN
ajlm-1537	267	15	study	study	NOUN
ajlm-1537	267	16	.	.	PUNCT
ajlm-1537	268	1	haematologica	haematologica	PROPN
ajlm-1537	268	2	.	.	PUNCT
ajlm-1537	269	1	2019;104(10):1974–1983	2019;104(10):1974–1983	NUM
ajlm-1537	269	2	.	.	PUNCT
ajlm-1537	270	1	https://doi.org/10.3324/haematol.2018.206540	https://doi.org/10.3324/haematol.2018.206540	PROPN
ajlm-1537	270	2	dufour	dufour	PROPN
ajlm-1537	270	3	c	c	PROPN
ajlm-1537	270	4	,	,	PUNCT
ajlm-1537	270	5	veys	vey	NOUN
ajlm-1537	270	6	p	p	NOUN
ajlm-1537	270	7	,	,	PUNCT
ajlm-1537	270	8	carraro	carraro	NOUN
ajlm-1537	270	9	e	e	NOUN
ajlm-1537	270	10	,	,	PUNCT
ajlm-1537	270	11	et	et	PROPN
ajlm-1537	270	12	al	al	PROPN
ajlm-1537	270	13	.	.	PROPN
ajlm-1537	270	14	similar	similar	ADJ
ajlm-1537	270	15	outcome	outcome	NOUN
ajlm-1537	270	16	of	of	ADP
ajlm-1537	270	17	upfront	upfront	NOUN
ajlm-1537	270	18	-	-	PUNCT
ajlm-1537	270	19	unrelated	unrelated	ADJ
ajlm-1537	270	20	and	and	CCONJ
ajlm-1537	270	21	matched	match	VERB
ajlm-1537	270	22	sibling	sible	VERB
ajlm-1537	270	23	stem	stem	NOUN
ajlm-1537	270	24	cell	cell	NOUN
ajlm-1537	270	25	transplantation	transplantation	NOUN
ajlm-1537	270	26	in	in	ADP
ajlm-1537	270	27	idiopathic	idiopathic	ADJ
ajlm-1537	270	28	paediatric	paediatric	ADJ
ajlm-1537	270	29	aplastic	aplastic	ADJ
ajlm-1537	270	30	anaemia	anaemia	NOUN
ajlm-1537	270	31	.	.	PUNCT
ajlm-1537	271	1	a	a	DET
ajlm-1537	271	2	study	study	NOUN
ajlm-1537	271	3	on	on	ADP
ajlm-1537	271	4	behalf	behalf	NOUN
ajlm-1537	271	5	of	of	ADP
ajlm-1537	271	6	the	the	DET
ajlm-1537	271	7	uk	uk	PROPN
ajlm-1537	271	8	paediatric	paediatric	PROPN
ajlm-1537	271	9	bmt	bmt	PROPN
ajlm-1537	271	10	working	working	PROPN
ajlm-1537	271	11	party	party	NOUN
ajlm-1537	271	12	,	,	PUNCT
ajlm-1537	271	13	paediatric	paediatric	ADJ
ajlm-1537	271	14	diseases	disease	NOUN
ajlm-1537	271	15	working	work	VERB
ajlm-1537	271	16	party	party	PROPN
ajlm-1537	271	17	and	and	CCONJ
ajlm-1537	271	18	severe	severe	ADJ
ajlm-1537	271	19	aplastic	aplastic	ADJ
ajlm-1537	271	20	anaemia	anaemia	NOUN
ajlm-1537	271	21	working	work	VERB
ajlm-1537	271	22	party	party	PROPN
ajlm-1537	271	23	of	of	ADP
ajlm-1537	271	24	ebmt	ebmt	PROPN
ajlm-1537	271	25	br	br	PROPN
ajlm-1537	271	26	j	j	PROPN
ajlm-1537	271	27	haematol	haematol	NOUN
ajlm-1537	271	28	.	.	PUNCT
ajlm-1537	272	1	2015;171(4):585–594	2015;171(4):585–594	X
ajlm-1537	272	2	.	.	PUNCT
ajlm-1537	273	1	https://doi.org/10.1111/bjh.13614	https://doi.org/10.1111/bjh.13614	PROPN
ajlm-1537	273	2	dessels	dessel	NOUN
ajlm-1537	273	3	c	c	NOUN
ajlm-1537	273	4	,	,	PUNCT
ajlm-1537	273	5	alessandrini	alessandrini	PROPN
ajlm-1537	273	6	m	m	PROPN
ajlm-1537	273	7	,	,	PUNCT
ajlm-1537	273	8	pepper	pepper	PROPN
ajlm-1537	273	9	ms	ms	PROPN
ajlm-1537	273	10	.	.	PROPN
ajlm-1537	273	11	factors	factor	NOUN
ajlm-1537	273	12	influencing	influence	VERB
ajlm-1537	273	13	the	the	DET
ajlm-1537	273	14	umbilical	umbilical	ADJ
ajlm-1537	273	15	cord	cord	NOUN
ajlm-1537	273	16	blood	blood	NOUN
ajlm-1537	273	17	stem	stem	NOUN
ajlm-1537	273	18	cell	cell	NOUN
ajlm-1537	273	19	industry	industry	NOUN
ajlm-1537	273	20	:	:	PUNCT
ajlm-1537	273	21	an	an	DET
ajlm-1537	273	22	evolving	evolve	VERB
ajlm-1537	273	23	treatment	treatment	NOUN
ajlm-1537	273	24	landscape	landscape	NOUN
ajlm-1537	273	25	.	.	PUNCT
ajlm-1537	274	1	stem	stem	NOUN
ajlm-1537	274	2	cells	cell	NOUN
ajlm-1537	274	3	transl	transl	PROPN
ajlm-1537	274	4	med	me	VERB
ajlm-1537	274	5	.	.	PUNCT
ajlm-1537	275	1	2018;7(9):643–650	2018;7(9):643–650	X
ajlm-1537	275	2	.	.	PUNCT
ajlm-1537	276	1	https://doi.org/10.1002/sctm.17-0244	https://doi.org/10.1002/sctm.17-0244	PROPN
ajlm-1537	276	2	tshabalala	tshabalala	NOUN
ajlm-1537	276	3	m	m	PROPN
ajlm-1537	276	4	,	,	PUNCT
ajlm-1537	276	5	ingram	ingram	PROPN
ajlm-1537	276	6	c	c	PROPN
ajlm-1537	276	7	,	,	PUNCT
ajlm-1537	276	8	schlaphoff	schlaphoff	PROPN
ajlm-1537	276	9	t	t	PROPN
ajlm-1537	276	10	,	,	PUNCT
ajlm-1537	276	11	borrill	borrill	NOUN
ajlm-1537	276	12	v	v	NOUN
ajlm-1537	276	13	,	,	PUNCT
ajlm-1537	276	14	christoffels	christoffel	VERB
ajlm-1537	276	15	a	a	PRON
ajlm-1537	276	16	,	,	PUNCT
ajlm-1537	276	17	pepper	pepper	PROPN
ajlm-1537	276	18	ms	ms	PROPN
ajlm-1537	276	19	.	.	PROPN
ajlm-1537	276	20	human	human	ADJ
ajlm-1537	276	21	leukocyte	leukocyte	NOUN
ajlm-1537	276	22	antigen	antigen	NOUN
ajlm-1537	276	23	-	-	PUNCT
ajlm-1537	276	24	a	a	NOUN
ajlm-1537	276	25	,	,	PUNCT
ajlm-1537	276	26	b	b	NOUN
ajlm-1537	276	27	,	,	PUNCT
ajlm-1537	276	28	c	c	NOUN
ajlm-1537	276	29	,	,	PUNCT
ajlm-1537	276	30	drb1	drb1	NOUN
ajlm-1537	276	31	,	,	PUNCT
ajlm-1537	276	32	and	and	CCONJ
ajlm-1537	276	33	dqb1	dqb1	ADJ
ajlm-1537	276	34	allele	allele	NOUN
ajlm-1537	276	35	and	and	CCONJ
ajlm-1537	276	36	haplotype	haplotype	ADJ
ajlm-1537	276	37	frequencies	frequency	NOUN
ajlm-1537	276	38	in	in	ADP
ajlm-1537	276	39	a	a	DET
ajlm-1537	276	40	subset	subset	NOUN
ajlm-1537	276	41	of	of	ADP
ajlm-1537	276	42	237	237	NUM
ajlm-1537	276	43	donors	donor	NOUN
ajlm-1537	276	44	in	in	ADP
ajlm-1537	276	45	the	the	DET
ajlm-1537	276	46	south	south	ADJ
ajlm-1537	276	47	african	african	ADJ
ajlm-1537	276	48	bone	bone	NOUN
ajlm-1537	276	49	marrow	marrow	PROPN
ajlm-1537	276	50	registry	registry	PROPN
ajlm-1537	276	51	.	.	PUNCT
ajlm-1537	277	1	j	j	PROPN
ajlm-1537	277	2	immunol	immunol	NOUN
ajlm-1537	277	3	res	re	NOUN
ajlm-1537	277	4	.	.	PUNCT
ajlm-1537	277	5	2018;2018:1–8	2018;2018:1–8	NUM
ajlm-1537	277	6	.	.	PUNCT
ajlm-1537	278	1	https://doi.org/10.1155/2018/2031571	https://doi.org/10.1155/2018/2031571	PROPN
ajlm-1537	278	2	cao	cao	PROPN
ajlm-1537	278	3	k	k	PROPN
ajlm-1537	278	4	,	,	PUNCT
ajlm-1537	278	5	moormann	moormann	PROPN
ajlm-1537	278	6	am	be	AUX
ajlm-1537	278	7	,	,	PUNCT
ajlm-1537	278	8	lyke	lyke	PROPN
ajlm-1537	278	9	ke	ke	PROPN
ajlm-1537	278	10	,	,	PUNCT
ajlm-1537	278	11	et	et	PROPN
ajlm-1537	278	12	al	al	PROPN
ajlm-1537	278	13	.	.	PUNCT
ajlm-1537	279	1	differentiation	differentiation	NOUN
ajlm-1537	279	2	between	between	ADP
ajlm-1537	279	3	african	african	ADJ
ajlm-1537	279	4	populations	population	NOUN
ajlm-1537	279	5	is	be	AUX
ajlm-1537	279	6	evidenced	evidence	VERB
ajlm-1537	279	7	by	by	ADP
ajlm-1537	279	8	the	the	DET
ajlm-1537	279	9	diversity	diversity	NOUN
ajlm-1537	279	10	of	of	ADP
ajlm-1537	279	11	alleles	allele	NOUN
ajlm-1537	279	12	and	and	CCONJ
ajlm-1537	279	13	haplotypes	haplotype	NOUN
ajlm-1537	279	14	of	of	ADP
ajlm-1537	279	15	hla	hla	NOUN
ajlm-1537	279	16	class	class	NOUN
ajlm-1537	279	17	i	i	PROPN
ajlm-1537	279	18	loci	locus	NOUN
ajlm-1537	279	19	.	.	PUNCT
ajlm-1537	280	1	tissue	tissue	NOUN
ajlm-1537	280	2	antigens	antigen	NOUN
ajlm-1537	280	3	.	.	PUNCT
ajlm-1537	281	1	2004;63(4):293–325	2004;63(4):293–325	NUM
ajlm-1537	281	2	.	.	PUNCT
ajlm-1537	281	3	https://doi.org/10.1111/j.0001-2815.2004.00192.x	https://doi.org/10.1111/j.0001-2815.2004.00192.x	PROPN